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Abstract  
Scientific evidences support the protective role of diets rich in fruit and vegetables 
against chronic diseases, like cancer and cardiovascular disease. In particular two 
classes of chemopreventive phytochemicals, i.e. isothiocyanates presence in Cruciferae 
and anthocyanins (ACNs) presence in berries and other colored fruits and vegetables, 
are considered in this thesis. 
Cruciferae and especially Brassica genus contain high concentration of 
constituents with antioxidant properties (e.g. carotenoids, vitamin C, folate) as well as 
glucosinolate precursors of isothiocyanates (ITCs) and indoles that modulate 
xenobiotic biotransformation enzymes, such as Glutathione S-Transferase (GST). The 
protective effect of broccoli (Brassica oleracea L. var. italica) was tested through two 
different study protocols: a regular-intake intervention study with daily consumption 
of one serving of steamed broccoli for 10 days and a single-meal study (i.e. single 
consumption of broccoli, 250g). Analyzed broccoli resulted to be a good source of 
antioxidant compounds (carotenoids, vitamin C) and glucosinolates as ITCs.  
Subjects involved in the study were young male smokers recruited on the basis of 
anthropometric characteristics, food habits and their GSTM1 genotype. 
Thirty subjects were enrolled for the regular-intake study. A single blind 
randomized cross-over experimental design was scheduled. Fasting blood samples 
were collected at the beginning and at the end of each treatment period (0, 10, 30, 40 
days). Concentration of carotenoids, lutein, β-carotene and folate was assessed in 
plasma and serum samples. Lymphocytes were used for the determination of 
biomarkers of oxidative stress: cell resistance against oxidative stress, endogenous 
DNA damage (i.e. oxidized purines), in vitro DNA repair activity and mRNA 
expression of OGG1, NUDT1 and HO-1 levels. Cell protection against H2O2-induced 
DNA damage was higher after broccoli diet with respect to control diet in the whole 
group of subjects. Folate and lutein concentrations increased significantly after broccoli 
diet. Broccoli intake caused a more consistent and significant effect of protection 
against DNA damage in GSTM1 null (-27.6%) subjects compared to GSTM1 positive (-
13.1%) individuals (p<0.05). Oxidized purines decreased significantly (p<0.05) after 
broccoli intake (-22.6%) while no effect of polymorphism was observed. DNA repair 
activity and OGG1, HO-1 and NUDT1 mRNA expression levels did not differ 
throughout the intervention study. 
Twelve volunteers were selected for the single-meal study. Fasting blood 
samples were collected before broccoli consumption and after 3, 6, 8 and 24 h from 
broccoli intake in order to evaluate: cell resistance to oxidative DNA damage, 
bioavailability of bioactive compounds (folate, lutein, β-carotene and vitamin C) and 
total GST activity. In particular, serum folate, plasma vitamin C and β-carotene 
concentrations significantly increased. Furthermore, plasma GST activity increased 
significantly in individuals with GSTM1 positive genotype at 6 h with respect to 3 h 
and 24 h but not compared to baseline. Interestingly, ex-vivo induced DNA damage 
was significantly reduced after 24 h from broccoli consumption. 
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In conclusion, these two studies demonstrated that 10 days of consumption of steamed 
broccoli could improve defence against DNA damage, without affecting repair activity 
in young healthy smokers. Moreover, a single portion of steamed broccoli was able to 
decrease DNA damage and to modulate GST activity. Even if preliminary, our data 
suggest a “diet/genetic” interaction. 
Delphinidin-3-glucoside (Dp-3-glc) and cyanidin-3-glucoside (Cy-3-glc) are two 
ACNs able to inhibit tumor cell proliferation.  
An in vitro study was designed to investigate the effect of Dp-3-glc and Cy-3-glc on the 
angiogenic and Dp-3-glc on the procoagulant activities of human microvascular 
endothelial cells (HMEC-1).  
HMEC-1 were incubated for up to 24h with culture media ± ACNs (0.1, 1, 10, 100 µM) 
alone or in combination with purified proangiogenic factor (VEGF), or bacterial 
endotoxin (LPS). Angiogenesis was evaluated by the capillary-like tube formation in 
Matrigel and the wound healing assay; while the pro-coagulant activity was tested by 
the thrombin generation (TG) assay and Tissue Factor (TF) expression as antigen, one-
stage recalcification assay and mRNA quantitation. 
Results showed that Dp-3-glc was able to inhibit angiogenesis in resting cells and in 
VEGF-stimulated conditions at 100 µM; interestingly, the inhibition of the migratory 
VEGF-dependent stimulus started at the Dp-3-glc concentration of 1 µM. In the TG 
assay Dp-3-glc significantly contrasted with the pro-thrombotic stimulus of LPS 
starting from 10 µM on HMEC-1 intact monolayer and TF expression at 100 µM 
concentration. Differently, Cy-3-glc did not show any effect on angiogenesis. 
In conclusion, this study, in terms of anti-angiogenic and anti-coagulant properties of 
Dp-3-glc make this compound a potential cancer chemopreventive agent. 
Together our results, from both in vivo studies on humans and in vitro cell 
culture models, support potential health benefits derived from the intake of fruit 
(coloured berries) and vegetable (broccoli). 
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Riassunto 
Evidenze scientifiche dimostrano il ruolo protettivo frutta e verdura nei confronti delle 
malattie croniche, come cancro e patologie cardiovascolari. In particolare due classi di 
composti chemopreventivi sono stati presi in considerazione in questa tesi: 
isotiocianati (Cruciferae) ed antocianine (ACN) (bacche e vegetali colorati). 
Le Cruciferae, specialmente il genere Brassica contengono un’elevata 
concentrazione di composti ad attività antiossidante (carotenoidi, vitamina C e folati) e 
glucosinolati, precursori di isotiocianati (ITCs) e indoli che modulano enzimi di 
biotrasformazione degli xenobiotici, come la Glutatione-S-Trasferasi (GST).  
L’effetto protettivo dei broccoli (Brassica oleracea L. var. italica) è stato valutato tramite 
due protocolli: uno studio d’intervento con consumo regolare di una porzione di 
broccoli cotti a vapore al giorno per 10 giorni, e uno studio singola porzione (250g). I 
broccoli analizzati sono una buona fonte di composti ad attività antiossidante 
(carotenoidi, vitamina C) e glucosinolati come ITCs. I soggetti coinvolti nello studio 
erano giovani maschi fumatori reclutati sulla base di caratteristiche antropometriche, 
abitudini alimentari e genotipo GSTM1. 
Trenta soggetti sono stati arruolati per lo studio sul consumo regolare (singolo 
cieco randomizzato cross-over), raccogliendo i campioni di sangue all’inizio e alla fine 
di ogni periodo di trattamento (0, 10, 30, 40 giorni). La concentrazione di carotenoidi, 
luteina, β-carotene e folati è stata determinata in plasma e siero. I linfociti sono stati 
usati per determinare biomarker di stress ossidativo: resistenza del DNA contro stress 
ossidativo, danno endogeno al DNA (purine ossidate), attività di riparazione del DNA 
ed espressione dell’mRNA di OGG1, NUDT1 e HO-1. La protezione contro danno al 
DNA indotto da H2O2 era più elevata dopo la dieta broccoli rispetto alla dieta controllo 
in tutto il gruppo di soggetti, con concomitante aumento delle concentrazioni di folati 
e luteina, e diminuzione delle purine ossidate (-22,6%). Si è visto un effetto più 
consistente di tutela contro i danni del DNA in individui con genotipo GSTM1 nulli (-
27,6%) rispetto ai soggetti GSTM1 positivo (-13,1%) (p <0,05). L’attività di riparazione 
del DNA e i livelli di espressione di mRNA di OGG1, HO-1 e NUDT1 non differivano 
per tutto lo studio di intervento.  
Dodici volontari sono stati selezionati per lo studio a singolo pasto, 
raccogliendo i campioni di sangue prima del consumo di broccoli e dopo 3, 6, 8 e 24 
ore, valutando: resistenza del DNA contro stress ossidativo, biodisponibilità di folati, 
luteina, β-carotene e vitamina C e attività totale della GST. Il consumo del pasto di 
broccoli ha determinato un aumento dei valori plasmatici di folati, vitamina C e β-
carotene e attività della GST, e una riduzione del danno al DNA indotto ex-vivo in 
modo maggiore nei soggetti con genotipo GSTM1 positivo.  
In conclusione, questi due studi dimostrano che 10 giorni di consumo di broccoli cotti 
al vapore potrebbero migliorare la difesa contro i danni del DNA, ma non influenzano 
l'attività di riparazione del DNA in giovani fumatori sani. Inoltre, una singola porzione 
di broccoli al vapore è in grado di ridurre il danno al DNA e di modulare l'attività di 
GST. Anche se preliminari, i nostri dati suggeriscono una interazione "dieta/profilo 
genetico".  
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Delfinidina-3-glucoside (Dp-3-glc) e cianidina-3-glucoside (Cy-3-glc) sono due 
ACN in grado di inibire la proliferazione delle cellule tumorali.  
Uno studio in vitro è stato progettato per studiare l'effetto di Dp-3-glc e Cy-3-glc 
sull’angiogenesi e Dp-3-glc sull’attività procoagulante di cellule endoteliali 
microvascolari (HMEC-1). Le HMEC-1 sono state incubate per un massimo di 24 ore 
con terreni di coltura ± ACN (0,1, 1, 10, 100 µM) da sole o in combinazione con il 
VEGF, o endotossina batterica (LPS). L'angiogenesi è stata valutata mediante i saggi di 
formazione di strutture capillaro-simili in Matrigel e “wound healing”, mentre 
l'attività pro-coagulante è stata testata mediante il test di generazione di trombina (TG) 
e l’espressione del fattore tissutale (TF), come antigene, saggio di ricalcificazione e 
quantificazione dell’mRNA. I risultati mostrano che la Dp-3-glc ha inibito l'angiogenesi 
in condizioni basali e stimolate da VEGF a 100 µM; l'inibizione dello stimolo 
migratorio del VEGF è iniziato alla concentrazione di 1 µM. Nel test di TG, la Dp-3-glc 
ha significativamente contrastato lo stimolo pro-trombotico di LPS a partire dalla 
concentrazione 10 µM su monostrato intatto di HMEC-1 e l’espressione di TF a 100 
µM. Diversamente, la Cy-3-glc non ha mostrato alcun effetto sulla angiogenesi. 
In conclusione, la Dp-3-glc ha dimostrato proprietà anti-angiogeniche e anti-coagulanti 
che rendono questo composto un potenziale agente chemiopreventivo del cancro. 
Nel complesso i nostri risultati degli studi in vivo sull'uomo e in modelli in vitro 
in coltura cellulare sostengono benefici potenziali per la salute provenienti dal 
consumo di frutti (bacche colorate) e ortaggi (broccoli). 
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0. PREFACE 
 
Chronic diseases are one of the main causes of death world-wide. In particular, the 
increase of degenerative diseases, such as metabolic syndrome, cancer and 
cardiovascular disease, in our country seems to be related to a modification of lifestyle 
and dietary habits.  
The rise in chronic diseases reflects a significant change in diet habits, physical activity 
levels, and tobacco consumption world-wide as a result of industrialization, 
urbanization, economic development and food market globalization. People are 
consuming a more energy-dense, nutrient-poor diet and are less physically active. 
These are no longer only diseases of the developed world: about 80% of all 
cardiovascular disease (CVD) deaths world-wide took place in developing, low and 
middle-income countries, while these countries also accounted for 86% of the global 
CVD disease burden. In developing countries people are being exposed to these risk 
factors for longer periods and a high proportion of disease takes place in people of 
working age. As reported by the World Health Organization (WHO, 2003) chronic 
conditions, including cardiovascular diseases (CVD), diabetes, obesity, cancers and 
respiratory diseases, account for 59% of the 57 million deaths annually and 46% of the 
global burden of disease. Five out of the 10 leading global disease burden risk factors 
identified by World Health Report 2002 - high blood pressure, high cholesterol, 
obesity, physical inactivity and insufficient consumption of fruits and vegetables - are 
strongly related to diet and physical activity. Together with alcohol and tobacco use, 
these preventable risks play a key role in the development of chronic diseases, which 
frequently involve overlapping risk factors and chronic conditions. In particular, low 
fruit and vegetable intake accounts for 2.7 million deaths.  
There is good evidence that a change in dietary habits, physical activity and tobacco 
control can produce rapid changes in population risk factors and disease burden 
prevalence for these chronic diseases. Thus, the demonstration of functional effects of 
foods is crucial for the development of health promoting strategies. 
The healthy effect of fruit and vegetable seems to be related to their content in 
vitamins, minerals and non-nutrient components, like fibre and bioactive compounds, 
called phytochemicals. This is a collective term for a variety of plant components that 
often perform important functions in the plant, such as providing colour, flavour, or 
protection, but are not essential in the human diet. All of these compounds have been 
shown either in humans or in laboratory experiments to have potential benefit for 
health wellness when they are included in diets. However, the bioavailability of these 
compounds is variable and their ultimate health effects uncertain. 
The importance of diet and its relationship to disease prevention and maintenance of 
health has been the topic of numerous studies. Recently, the concept of the ability of 
some foods to carriers of bioactive compounds with possible effect on disease 
prevention, disease arrest or therapy has been under world-wide investigation. 
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Multidisciplinary approaches could allow demonstration of the importance of either 
whole diet or single food, starting from epidemiological relevance to the 
understanding of cellular and molecular mechanisms. 
In particular, attention has been given to study and development of functional foods. 
Functional foods are any healthy food declared to have an health-promoting or 
disease-preventing properties beyond the basic function of supplying nutrients (i.e. 
fermented foods with live cultures with probiotic benefits; fruit and vegetable with 
effects on cardiovascular disease or anti-tumor properties, etc.). 
Functional food products need to include health claims on their label describing their 
benefits. A nutrition claim states that a food has beneficial nutritional properties. An 
health claim is any statement on labels, advertising or other marketing products 
describing health benefits resulted from its consumption. Health claims must be 
supported by credible scientific evidence regarding a relationship between a substance 
(specific food or food component) and a disease or health-related condition. Both of 
these elements - a substance and a disease - must be present in the health claim. An 
example of an authorized health claim is: "Calcium may reduce the risk of 
osteoporosis". The European Commission has requested the European Food Safety 
Authority (EFSA) to provide relevant scientific advice for the setting of nutrient 
profiles (conditions concerning the nutrient content of foods) that foods or certain 
groups of foods must respect in order to bear nutrition and health claims. 
The Nutrition EFSA Scientific Panel on dietetic products, nutrition and allergies (NDA) 
of Europe’s food safety watchdog delivered in 2008 scientific advice to assist the 
European Commission and Member States in defining nutrient profile for foods 
bearing nutrition and health claims. The Panel has defined scientific criteria that could 
be utilised by EU policy makers in assessing which foods may carry nutrition and 
health claims. The Panel concluded that the main scientific consideration in 
establishing nutrient profiles is the potential of a food to adversely affect overall 
dietary balance, as defined by nutrient intake recommendations. The dietary role of 
different food groups must also be taken into account and the nutrient profiles should 
be consistent with food-based dietary guidelines established in EU Member States.  
Since now, only few products obtained health claim, as most of results in literature 
failed in the demonstration of a cause-effect relationship between the intake of food 
and the benefit claimed. 
Current research efforts are directed toward understanding the mechanisms and 
identifying both individual bioactive plant components and whole foods that may 
improve protection against chronic diseases. 
 
0.1 References 
World Health Organization (2003) Information sheet: Chronic disease - key risk factors 
include high cholesterol, high blood pressure, low fruit and vegetable intake 
3 
 
1. STATE OF THE ART 
 
Vegetables and fruits intake: an overview  
Nutrition science investigates the metabolic and physiological responses of the body to 
diet. With advances in the fields of molecular biology, biochemistry, and genetics, the 
study of nutrition is increasingly concerned with metabolism and metabolic pathways: 
the sequences of biochemical steps through which substances in living things change 
from one form to another. 
Vegetables and fruits are generally low in energy density (with a few exceptions) and, 
when consumed in different assortment, are sources of many vitamins, minerals, and 
other bioactive compounds (phytochemicals). Many non-starchy vegetables, including 
salad vegetables and fruits, may be eaten raw and may also be cooked. Legumes are 
high in protein. Traditional diets all over the world combine cereals (grains) with 
pulses (legumes) and, in this way, ensure sufficient protein of adequate quality, 
usually with small amounts of animal foods. Nuts and seeds are concentrated sources 
of numerous micronutrients and of essential fatty acids. All these foods are sources of 
dietary fibre. Many herbs and spices have potent pharmacological as well as culinary 
properties. Consumption of vegetables and fruits is very variable: high around the 
Mediterranean littoral and some tropical countries; low in many low-income countries, 
including some in which fruits are abundant. Consumption of legumes is also very 
variable: beans and chickpeas and their products are basic foods in a number of Latin 
American, Middle Eastern, and Asian countries, but pulses are insignificant in typical 
North American and most European diets. Consumption of nuts, seeds, herbs, and 
spices also varies. Traditional Middle Eastern and Indian cuisines use a great variety of 
herbs and spices; garlic, usually classified as a herb, is consumed in remarkable 
quantities in some countries (WCRF/AICR 2007). 
Vegetables and fruits (including berries), nuts and seeds, and herbs and spices, where 
they grow and can be cultivated, have always been part of human diets. Gatherer–
hunters and pastoral peoples probably consumed more than relatively impoverished 
urban dwellers: for them, vegetables were the main sources of many vitamins, and 
fruits were a main source of energy, from sugar (also found in wild honey). They are 
consumed abundantly as part of many long-established traditional cuisines, around 
the Mediterranean littoral, the Middle East, in many Asian countries, and the Pacific 
islands, where substantial amounts of meat, dairy products, and other animal foods 
are traditionally consumed only occasionally. In contrast, monotonous ‘poverty’ diets 
include few of these foods. Globally, consumption of these foods is lower than now 
generally recommended. Vegetables and fruits are sometimes seen as relatively 
expensive. Well stocked supermarkets usually now display a variety of local and 
imported fresh vegetables and fruits, although supplies in smaller stores are more 
variable. Consumption of fresh vegetables and fruits in many tropical countries in 
Africa and Latin America is low: on average people in Brazil, for example, consume 
roughly the same as people in Britain. The explanation may be that in Africa, many 
rural communities are obliged to grow cash crops that displace gardens, and that in 
4 
 
Latin America knowledge of the value — and pleasure — of many indigenous 
vegetables and fruits has been lost. Many programmes in tropical countries are now 
dedicated to regaining this knowledge (Burkitt & Trowell, 1977). 
Even before the discovery of vitamins as essential nutrients beginning in the early 20th 
century, vegetables and fruits have been recommended as ‘protective foods’. Early 
reports concerned with nutritional deficiencies paid less attention to pulses (legumes), 
nuts, and seeds, even though these plant foods contain protein, and nuts and seeds are 
nutrient- and also energy-dense, perhaps because they are not much consumed in the 
countries where most such reports were compiled. Instead, as already mentioned, 
priority was given to energy- and nutrient-dense foods of animal origin. By the 1980s, 
most reports concerned with prevention of chronic diseases recommended relatively 
high intakes of vegetables and fruits and sometimes also legumes, either because these 
foods were seen as nourishing substitutes for energy-dense fatty or sugary foods, or 
else because they were identified as positively protective against cardiovascular 
disease (Trowell & Burkitt, 1986). Evidence that vegetables and fruits might be 
protective against some cancers emerged in the 1990s (WHO 2003). 
 A common recommendation has been for at least five portions (or at least 400 g) of 
vegetables and fruits a day (WHO 1990). 
 
Nutritional characteristics of vegetables and fruits  
There are six major classes of nutrients: carbohydrates, fats, minerals, protein, 
vitamins, and water. These nutrient classes can be categorized as either macronutrients 
(needed in relatively large amounts) or micronutrients (needed in smaller quantities). 
The macronutrients include carbohydrates, fats, protein, and water. The 
micronutrients are minerals and vitamins. 
The macronutrients (excluding water) provide structural material (amino acids from 
which proteins are built, and lipids from which cell membranes and some signaling 
molecules are built), and energy. Vitamins, minerals, fiber, and water do not provide 
energy, but are required for other reasons. A third class of dietary material, fiber (i.e., 
non-digestible material such as cellulose), is also required, for both mechanical and 
biochemical reasons, although the exact reasons remain unclear. 
Other micronutrients include bioactive compounds, which are said to influence (or 
protect) some body systems. In particular plants contain a wide range of biologically 
active compounds, some of which are known as phytochemicals. There may be as 
many as 100,000 different compounds, which determine particular properties in plants, 
and in the fruits and vegetables they produce, such as flavour and colour. 
Phytochemicals are classified according to their chemical structure and functional 
characteristics, and include salicylates, phytosterols, saponins, glucosinolates, 
polyphenols, protease inhibitors, monoterpenes, phytoestrogens, sulphides, terpenes, 
and lectins. 
It is widely believed that the health benefits of diets high in fruits and vegetables are 
likely to be due partly to the presence of phytochemicals. For instance, several act as 
antioxidants, preventing oxidative damage to cells, proteins, and DNA. It is likely that 
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other bioactive compounds have yet to be identified, and those that are known may 
have additional properties in the body that are not yet understood. But it is thought 
that nutrients, phytochemicals, and other, as yet unknown, bioactive components act 
together to influence physiological responses. Although many of these substances are 
bioactive, they are not essential in the diet and there is no daily requirement, so they 
are not classed as nutrients. Humans have developed tastes for some phytochemicals, 
such as the hot flavours of mustard oil, bitter alkaloids, and irritating capsaicins. There 
is genetically inherited variation in sensitivity to some tastes, for example, the bitter 
taste of isothiocyanates in cruciferous vegetables such as cabbage. 
The composition of fruits and vegetables depends both on species and on subtype, as 
well as on the environmental, farming, production, and storage conditions. These 
include factors such as sun exposure, soil quality, agricultural practices, harvesting 
time, ripeness, length of time between harvest and consumption, and preservation and 
preparation methods. 
 
Functions of different classes of bioactive compounds and their food sources 
Vegetables, fruits, legumes, nuts, and seeds are sources of a wide variety of 
micronutrients and other bioactive compounds. Foods containing several of these 
constituents have been identified in the systematic literature reviews as being inversely 
associated with cancer risk. These are: carotenoids (including β-carotene and 
lycopene), folate, vitamin C, vitamin D, vitamin E, polyphenols (e.g. quercetin), 
pyridoxine, and selenium, explained below. However, it is not possible to ascribe the 
association between these foods and lower cancer risk to a causal effect of specific 
compounds with confidence, as each food contains a complex mixture of different 
constituents, all of which might also contribute to any observed effect. 
Carotenoids are found in varying concentrations in all vegetables, particularly those 
that are red or orange. They are a family of more than 600 fat-soluble red/orange 
pigments that comprise xanthophylls (such as lutein) and carotenes (such as α-and β-
carotene, and lycopene). Some carotenoids, most importantly β-carotene, can be 
converted by the body to retinol and are sometimes called pro-vitamin A carotenoids. 
These compounds tend to be the main dietary source of vitamin A in low-income 
countries. Only about half of the 50 or so carotenoids in human diets can be absorbed. 
They have antioxidant and other bioactivities. Sources of carotenoids include spinach, 
kale, butternut squash, pumpkin, red (bell) peppers, carrots, tomatoes, cantaloupe 
melon, and sweet potatoes. β-carotene is found in yellow, orange, and green fruits and 
green, leafy vegetables including carrots, spinach, lettuce, tomatoes, sweet potatoes, 
broccoli, cantaloupe melon, oranges, and winter squash (pumpkin). As a rule of 
thumb, the greater the intensity of the colour of the fruit or vegetable  the more β-
carotene it contains. The most concentrated source of lycopene is tomatoes, but it is 
also present in watermelon, red (bell) peppers, pink or red grapefruit, pink-fleshed 
guava, and persimmons (kaki). 
The B-vitamin folate is a family of compounds essential for human health. Folic acid, 
the synthetic form, is used to fortify manufactured cereal products, spreads, and, in 
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some countries, flour or grains. Folates are involved in a number of metabolic 
pathways, especially in the synthesis of purines and pyrimidines, which are important 
for DNA synthesis and cell replication. Sources of dietary folate include liver, beans, 
spinach, broccoli, romaine lettuce, chicory, oranges, and papaya. 
Vitamin C (ascorbic acid) is a water-soluble vitamin. Humans, like a small number of 
other animals, cannot synthesise vitamin C, so it is an essential part of diets. Vitamin C 
is essential for collagen synthesis and also has antioxidant activity. Severe deficiency 
causes scurvy. It is added to many foods, including bread and soft drinks, in small 
amounts as an antioxidant preservative. Natural dietary sources are vegetables,tubers, 
and fruits, including red/yellow (bell) peppers, kiwi fruits, broccoli, papaya, citrus 
fruits, strawberries, and potatoes, but it is destroyed by heat or contact with the air (for 
instance, when vegetables are chopped), or lost into cooking water. 
Vitamin E is a fat-soluble vitamin and a potent antioxidant that occurs as eight 
different forms: α- and γ-tocopherol are the most common. The most important dietary 
sources of vitamin E are vegetable oils such as palm, sunflower, corn, soya bean, and 
olive oils. Nuts, sunflower seeds, and wheat-germ are also sources. Whole-grains, fish, 
peanut butter, green, leafy vegetables, and fortified breakfast cereals also contain this 
vitamin. 
Pyridoxine is one of a group of water-soluble compounds collectively known as 
vitamin B6. This vitamin is involved in neurotransmitter synthesis, red blood cell 
formation and function, niacin (vitamin B3) formation, steroid hormone  function, and 
nucleic acid synthesis (Leklem, 1999). Food sources include bananas, fish, poultry, 
liver, potatoes eaten with the skin, green, leafy vegetables, beans, legumes, nuts, 
wholegrains, and fortified breakfast cereals . 
Selenium is a mineral element that occurs in different chemical forms. It is toxic in 
large amounts, but is essential in the diet at trace levels. It is present at varying 
concentrations in different soils; and since plants take up selenium from the soil, these 
levels determine the amount present in vegetables. Thus selenium deficiency is more 
prevalent in regions where the soil selenium content is low. Selenium is a component 
of the amino acids selenocysteine and selenomethionine, which are integrated into 
proteins to form selenoproteins. Selenoproteins include antioxidant enzymes such as 
glutathione peroxidases, thioredoxin reductase, which is important for DNA synthesis, 
and iodothyronine deiodinase, which is important for the synthesis of thyroid 
hormones (Geissler & Powers, 2005). Dietary sources of selenium include brazil nuts, 
fish, wholegrains, wheatgerm, and sunflower seeds. 
The polyphenols is a group of chemical substances found in plants, characterized by 
the presence of more than one phenol unit or building block per molecule, they are not 
essential dietary components. Polyphenols are generally divided into hydrolyzable 
tannins (gallic acid esters of glucose and other sugars) and phenylpropanoids, such as 
lignins, flavonoids, and condensed tannins. They are derived from secondary plant 
metabolism of the shikimate pathway, where they exert different functions. They 
possess antioxidant activity and are widely studied for the mechanisms involved in 
their health benefit effects. One of the most studied is quercetin, a flavonoid. Many 
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studies in cultured cells and animals suggest that quercetin has antioxidant activity, 
which could give rise to a range of biological activities, including reducing 
inflammation. Quercetin is found in apples, green and black tea, onions, raspberries, 
red wine, red grapes, citrus fruits, leafy, green vegetables, cherries, elderberries, 
broccoli, blueberries, cranberries, and bilberries. 
 
Different levels of scientific evidence 
Three different and consequent levels of scientific evidence occur to demonstrate the 
(protective) effect of a food on human health. Through epidemiological evidence nwe 
can study the relationship between the consumption of a certain food and its 
protective effect; by means of experimental study it is possible to investigate molecular 
and cellular mechanisms and bioavailability of most interesting compounds by in vitro 
and in vivo models. Finally intervention trials on humans will be necessary to confirm 
the relationship between the intake of foods and their protective effect and to help in 
the study of the mechanisms involved.  
A brief explanation of each one of these steps is given below. 
 
1. Epidemiological evidence: relationship food intake-protective effect. 
Epidemiological research describes and seeks to explain the distribution of health and 
disease within human populations. The methods used are based mainly on 
comparative observations made at the level of whole populations, special groups (such 
as migrants), or individuals within populations. This type of investigation is known as 
observational. By relating differences in circumstances and behavior to differences in 
the incidence of disease, associations are identified that may be causal. In 
epidemiological studies, an ‘exposure’ is a factor or condition that may increase or 
decrease the risk of disease.  
Descriptive studies give information about statistics on disease incidence or mortality. 
Descriptive epidemiology informs cancer surveillance programmes, and is a basic tool 
for determining patterns of cancer, relative rates of cancer and other diseases, and 
changes in patterns and trends over time. Remarkable changes in the incidence of 
cancers provide first lines of evidence pointing to causation due to corresponding 
changes in environmental circumstances. Like all types of study, descriptive 
epidemiology has limitations. Apparent trends in cancer incidence and mortality may 
be due in part to changes and developments in screening, diagnosis, or treatment. 
Ecological studies are designed to explore relationships between environmental 
factors and disease amongst populations rather than individuals. While ecological 
studies, like other observational studies, may suggest a relationship between a specific 
environmental factor (such as an aspect of food and nutrition) and disease, the actual 
causal relationship may be with a different ‘confounding’ factor, which may or may 
not be associated with the environmental factor being investigated. Ecological studies 
are often used to identify associations or trends that warrant further investigation. 
They have special strengths, particularly when conducted between populations, either 
internationally, or cross-culturally among different populations within a country. 
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Thus, the contrast in dietary intake between countries is often much larger than the 
contrast within countries. In addition, average national diets are likely to be more 
stable over time than the diets of communities, families, or individual people. For most 
countries, the changes in overall national dietary intakes over a decade or two are 
relatively small. Migrant studies compare cancer rates for migrants, and for their 
offspring, in their current country of residence, with rates in their country of origin. 
(Last, 2001). These studies show that populations migrating between areas with 
different cancer incidence rates acquire the rates characteristic of their new location for 
some cancers, often after only one or two generations. This shows that environmental, 
rather than inherited, factors are primarily responsible for the large differences in 
cancer rates in different regions and countries. Those diseases for which incidence 
shifts with migration, such as cancer, are diseases with evidently important 
environmental causes. 
In case-control studies, individuals diagnosed with a specific type of cancer (‘cases’) 
are compared with otherwise similar individuals who have not been diagnosed with 
cancer (‘controls’). The control group is a sample of the population from which the 
cases arose, and provides an estimate of how the exposures being studied are 
distributed in that population. Identifying and enrolling appropriate controls is a 
major challenge in case-control studies. 
In prospective cohort studies (usually simply called cohort studies), the diets, body 
compositions, and/or physical activity levels of a large group (cohort) of people who 
are assumed to be healthy are assessed, and the group is followed over a period of 
time. During the follow-up period, some members of the cohort will develop and be 
diagnosed with cancer, while others will not, and comparisons are then made between 
these two groups. Because measurements are made before any cancer diagnosis, cohort 
studies are not subject to recall bias. A single cohort study allows examination of the 
effects of diet and physical activity on multiple types of cancer and other diseases. 
Also, in cohort studies, blood and tissue samples are often collected and stored for 
future analysis. Finally, cohort studies provide the opportunity to obtain repeated 
assessments of participants’ diets at regular intervals, which may improve the dietary 
assessment. Cohort studies may need to be very large (up to tens or even hundreds of 
thousands of participants) to have sufficient statistical power to identify factors that 
may increase cancer risk by as little as 20 or 30 per cent. Also, meaningful comparisons 
between cases and non-cases can be made only for factors that vary sufficiently within 
the cohort. Cohort studies are expensive, so they have been conducted mostly in high-
income countries.  
Meta-analysis is a method used to combine the results of several studies addressing 
similar questions. Unless an epidemiological study is sufficiently large, modest but 
potentially important associations can be missed, simply because of the inadequate 
statistical power of the individual study. Meta-analysis is used to provide summaries 
of selected collections of studies. Study-level meta-analysis provides single estimates 
of effect using information from multiple studies of the same design. These summary 
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estimates can provide evidence regarding the presence or absence of an association, as 
well as examining possible dose-response relationships (WCRF/AICR 2007). 
 
Epidemiological evidence and relationship cancer-lifestyle 
The first evidence suggesting that cancer is a largely preventable disease has come 
from studies noting variations in cancer incidence across time and place. The most 
impressive initial evidence showing that patterns of cancer are altered by 
environmental factors, and are not mainly genetically determined, comes from studies 
describing changes in the rates of different cancers in genetically identical populations 
that migrate from their native countries to other countries. Such studies consistently 
show that changes in the rates of some of the most common cancers, including those of 
the stomach, colorectum, breast, and prostate, can be remarkable, even over one or two 
generations. Patterns of food and drink, of physical activity, and of body composition 
have changed remarkably throughout human history. With industrialization and 
urbanisation, food supplies usually become more secure, and more food is available 
for consumption. In general, diets become more energy dense, containing fewer 
starchy foods, more fats and oils, sugars, and additives, and often more alcoholic 
drinks. At the same time, patterns of physical activity change: populations become 
increasingly sedentary, their need for energy from food drops, and rates of overweight 
and obesity increase. These changes correlate with changes in the patterns of cancer 
throughout the world. Middleand low-income regions and countries within Africa, 
Asia, and Latin America have generally experienced comparatively high rates of 
cancers of the upper aerodigestive tract (of the mouth, pharynx, larynx, nasopharynx, 
and oesophagus), and of the stomach, liver (primary), and cervix. Rates of some 
cancers, especially stomach cancer, are now generally decreasing. In contrast, high-
income countries, and urbanized and industrialised areas of middle- and low-income 
regions and countries, have higher rates of colorectal cancer and of hormone-related 
cancers (of the breast, ovary, endometrium, and prostate). Lung cancer is now the most 
common type in the world because of the increase in tobacco smoking and exposure to 
environmental tobacco smoke. Rates of these cancers, some of which may have been 
historically rare, are increasing. Globally, the number of people with cancer is 
projected to double by the year 2030, with most of this increase likely to occur in 
middle- and lowincome countries. Such an increase would only partly be accounted 
for by the projected rise in the size and average age of the global population. This 
makes the task of cancer prevention all the more urgent and important. 
 
2. Experimental evidence: studies to investigate mechanisms of action 
Epidemiological studies all have strengths and limitations. So do laboratory and 
mechanistic studies; their main strength is control. The environment of these research 
studies is defined by chosen experimental conditions: precise manipulations can be 
made and relatively exact measures taken. Occasionally the test participant is a human 
volunteer, but usually these studies are conducted in animals (in vivo) or using human 
or animal cells grown in the laboratory (in vitro). Rodents (usually rats or mice) are the 
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most commonly used animals in laboratory experiments. Their relatively short lifespan 
provides comparatively fast results in cancer studies, and they offer a ‘whole body 
system’ suited to a wide variety of tests. Rodent studies can show how nutrients and 
other compounds might affect the cancer process. But it is known that some 
interventions that affect rodents do not affect humans, or do not affect them in the 
same ways or to the same degrees, and vice versa. Also, experiments on animals may 
be highly artificial, using special breeds of rodents initially given massive doses of 
carcinogenic agents, and then fed nutrients or other substances at levels far higher than 
humans would normally consume, or could ethically be given. Human or animal cells, 
sometimes derived from particular cancers, can be grown in vitro in the laboratory and 
used in experiments to help researchers understand mechanisms that may lead to the 
development of cancer. In vitro studies are conducted using cells or other test systems. 
Human cells, animal cells, mechanistic test systems, and bacterial systems can be used. 
Cell cultures can be primary, where tissue (such as a tumor biopsy) is taken directly 
from humans or animals and then cultured; or secondary, where the original cells are 
cultured a number of times. Such cell lines are commonly used in laboratory research, 
and can become immortal — cultured again and again. The cells or tissues are 
subjected to potential carcinogens, and then markers of damage are measured. 
Conducting studies in vitro has two main advantages. First, specific, well defined 
interventions can be tested; and second, intracellular mechanisms can be examined. 
However, these studies do not allow the study of integrated systems, such as how 
organs or the whole body responds to the interventions. Therefore extrapolation of 
results to humans is limited. 
When we consume a food or drink, the nutrients contained are released from the 
matrix, absorbed into the bloodstream and transported to their respective target tissues 
(EUFIC, 2010). However, not all nutrients can be utilized to the same extent. In other 
words, they differ in their bioavailability. Several definitions exist for nutrient 
bioavailability, but broadly it refers to the proportion of a nutrient that is absorbed 
from the diet and used for normal body functions (Aggett, 2010). The following 
components describe the different steps of the metabolic pathway where changes in 
nutrient bioavailability may occur (Aggett, 2010): 
• release of the nutrient from the physicochemical dietary matrix;  
• effects of digestive enzymes in the intestine;  
• binding and uptake by the intestinal mucosa;  
• transfer across the gut wall (passing through the cells, in-between them or 
both) to the blood or lymphatic circulation;  
• systemic distribution;  
• systemic deposition (stores);  
• metabolic and functional use;  
• excretion (via urine or faeces). 
As it is evident from this list, the bioavailability of a nutrient is governed by external 
and internal factors. The bioavailability of macronutrients – carbohydrates, proteins, 
fats – is usually very high at more than 90% of the amount ingested. On the other 
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hand, micronutrients, i.e. vitamins and minerals, and bioactive phytochemicals can 
vary widely in the extent they are absorbed and utilised. The first step in making a 
nutrient bioavailable is to liberate it from the food matrix and turn it into a chemical 
form that can bind to and enter the gut cells or pass between them. Collectively this is 
referred to as bioaccessibility (Holst & Williamson, 2008).
 
Nutrients are rendered 
bioaccessible by the processes of chewing (mastication) and initial enzymatic digestion 
of the food in the mouth, mixing with acid and further enzymes in the gastric juice 
upon swallowing, and finally release into the small intestine, the major site of nutrient 
absorption. Here, yet more enzymes, supplied by the pancreatic juice, continue 
breaking down the food matrix. In addition to the bodily means of mastication and 
enzyme action, the digestibility of food matrices, especially of plant foods, is aided by 
cooking or pureeing the food. Minerals and other nutrients exist in different chemical 
forms in the food and this can influence their bioavailability. Nutrients can interact 
with one another or with other dietary components at the site of absorption, resulting 
in either a change in bioavailability or – if enhancers and inhibitors cancel each other 
out – a nil effect. Enhancers can act in different ways such as keeping a nutrient soluble 
or protecting it from interaction with inhibitors. For example, since carotenoids are fat-
soluble, adding small quantities of fat or oil to the meal (3-5 g per meal) improves their 
bioavailability. Inhibitors may reduce nutrient bioavailability by: binding the nutrient 
in question in a form that is not recognized by the uptake systems on the surface of 
intestinal cells, rendering the nutrient insoluble and thus unavailable for absorption, or 
competing for the same uptake system. Systemic factors include deficiency of a certain 
nutrient or changes in physiologic state, e.g. pregnancy. In both cases, the body may 
respond by increasing the respective nutrient absorptive pathway or utilisation to meet 
the increased demand. Internal or host-related factors can be subdivided into 
gastrointestinal and systemic factors. Thus, the study of bioavailability of whole food 
or phytochemicals needs a scientific approach. Bioavailability studies can be assessed 
both on human and animals models. Compounds of interest or their metabolite are 
monitored during a certain time in blood, urine or faeces and target tissues (in 
particular for animal models), in order to obtain a quantification over the time of the 
presence of the constituent of interest within the body. Parameters of kinetics of a 
compound are: Cmax (the maximal concentration achieved in blood); T1/2 (halftime for 
reaching the half of Cmax in blood); AUC (area under the curve) in a curve 
concentration (y assis) and time (x assis) (Figure 1.1).  
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Figure 1.1 Bioavalability curve.  
 
3. Human intervention studies: the most important in vivo evidence 
A randomized controlled trial (RCT) is an experiment of design in which participants 
are randomly assigned to groups, often called intervention and control groups, to 
receive or not receive an experimental intervention. The main use of RCTs has 
generally been to test the efficacy of drugs and other medical treatments. In a ‘double 
blind’ RCT, neither the participants nor the investigators know to which group 
(intervention or control) the participant has been assigned. Blinding is used because 
the knowledge of group assignment might influence study results, but it is usually 
impossible to achieve with trials involving physical activity, or those investigating 
foods and drinks in their usual form. An effective use of RCTs is to test the effects of 
supplementation with specified doses of dietary micronutrients (as pills or by other 
means). However, pharmacological doses of supplements are often studied — doses 
much higher than can be derived from diets — and results may not be directly relevant 
to dietary intakes of that micronutrient. Such trials may yield powerful evidence of the 
effect of a specific dietary constituent. However, they are often conducted as a result of 
promising epidemiological studies that have shown protective effects of a particular 
group of foods, and there is always a possibility that the actual active agent or 
combination of agents in the foods has not been used in the trial. Dietary constituents 
that are or may be protective when contained within foods may have unexpected 
effects in isolation, especially at doses higher than those found in normal diets. RCTs 
are also used to test interventions designed to change behavior, including dietary 
intakes and physical activity. Such trials require a high level of commitment by 
participants, and learning how to conduct them well is a topic of active investigation. 
A unique and important strength of sufficiently large RCTs is that confounding 
variables, both known and unknown, will on average be distributed equally between 
the treatment and control groups, and will therefore not bias the study results. 
 
The research approaches in the evaluation of the protective role of diet 
Many scientists are studying dietary cancer prevention, yet often data are missing on 
how to translate much of the research generated into clear guidelines for the consumer. 
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For example, “broccoli may decrease risk for prostate cancer” sounds clear, but leaves 
both the consumer and the clinician interested in designing a robust clinical trial 
unsure of dose, frequency of inclusion into the diet, or whether variety or preparation 
method is important for gaining the health benefit, or even if a sulforaphane (SF) 
supplement could replace whole broccoli. As a result of this lack of information on 
foods that have health benefits, neither the clinician nor the consumer has any 
knowledge of an effective dose. This is of particular concern when considering cancer 
prevention, since there is no easy, short-term endpoint/health outcome in order to 
judge effectiveness, such as plasma cholesterol levels for cardiovascular health. 
Clinical trials carried out prior to filling these knowledge gaps may not be optimized 
for these parameters and may provide confusing, disappointing, and maybe even 
harmful results. Substantial data gaps must be filled, to provide the detailed, evidence-
based information necessary for the optimized design of these clinical trials: 
epidemiological data alone cannot provide the information necessary to design a 
robust clinical trial; in vitro data, even based on epidemiological studies, cannot 
provide the necessary detail or justification for designing a robust clinical trial; animal 
modeling of efficacy, bioavailability, and kinetics are essential for designing a robust 
clinical trial (Jeffery & Keck, 2008). 
Whereas epidemiological studies are an excellent source of material for hypothesis 
generation, basing marketing, or lifestyle guidelines on epidemiological data alone 
may not always prove useful. A recent report even suggested that epidemiological 
studies are considerably less than 50% reproducible (Tuma, 2007). This low 
reproducibility might be due to our lack of knowledge of different aspects of the food 
under study, such as changes in the content of bioactive components with plant variety 
or cooking method. Mechanistic evidence for bioactivity is often derived from in vitro 
studies of purified components isolated from foods, and has gone far to persuade 
scientists of the potential benefit of plant foods, even though cell culture studies do not 
address disposition. The effects of bioactive components on cellular physiology may 
change with both dose and cell type. It is well known that all compounds are toxic and 
that a safe and tolerable upper level needs to be determined, particularly when 
bioactive components are isolated from whole foods and provided as dietary 
supplements. Potential interactions with drugs, dietary supplements and other 
bioactive food components, positive or negative, may also be of concern. Many foods 
contain more than one bioactive component, and yet scientists have a tendency to 
identify a major bioactive and then equate effects of that individual component with 
the effect of the whole food. Cell culture studies can be very informative about 
mechanism, but it is not enough to know that a component has bioactivity in cell 
culture. Cell culture studies may use doses that cannot be achieved physiologically, 
and they cannot provide information on bioavailability. Additionally, they may miss 
interactions with additional components in the whole food. For these reasons, in vitro 
studies do not extrapolate directly to dietary effects. The greatest gap in our 
understanding of health effects of bioactive food components may be details on 
disposition: bioavailability from different products, distribution, and metabolism, the 
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effective dose and the tolerable upper level. Animal studies can provide information 
on many of these questions to permit moving forward to small clinical studies. Animal 
studies can compare the purified component(s) used in cell culture with the complex 
foods in our diet, confirming (or refuting) the mechanisms identified in cell culture. 
Although animal studies do not always reflect in vitro findings, it is imperative to 
compare similar doses, forms, and extent of exposure before rejecting in vitro findings. 
Animal studies can highlight or dismiss concerns over bioavailability, efficacy, and 
kinetics. Frequently only a fraction of a dietary dose is absorbed. Animal studies can 
provide information about digestion, kinetics, and metabolism that may, for example, 
suggest specific processing methods to optimize bioavailability. Once a metabolic 
pathway is identified in animals, detecting and confirming it in a small clinical study 
can be relatively straightforward. Once efficacy has been established in animal models, 
translation to humans requires measurement of exposure and disposition, as well as 
measurement of efficacy. Whereas animal studies do not always appear to translate 
successfully to clinical findings, this is often because of differences in dose, exposure 
route, duration and frequency of exposure, or genetic diversity within the human 
population under study (Jeffery & Keck, 2008).  
Availability of robust biomarkers of efficacy in healthy individuals is still extremely 
sparse. Whereas multiple biomarkers for effective maintenance of health have been 
developed in association with cardiac health, there remains a lack of biomarkers for 
determining successful prevention of cancers. As these are identified, it will be 
necessary to determine how new biomarkers can best be utilized to help the general 
public choose a diet that prevents cancer. Methods for the evaluation of safety and 
efficacy of drugs undergoing development typically start with in vitro screening 
assays, and all steps are well established, as outlined in Figure 1.2-A. For an optimal 
scientific approach to study the health benefits of foods it is essential to conduct 
detailed preclinical studies and small human studies before taking the step to fully 
randomized, double blind placebo-controlled human trials (Figure 1.2-B). 
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A: Drug development 
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B: An optimal scientific approach to the study of foods with health benefits 
 
 
 
 
  Pre-clinical   Clinical 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 A: A drug development; B: An optimal scientific approach to the study of foods with 
health benefits. A solid line represents common practice and dotted line represents less 
frequent occurrence (Jeffery & Keck, 2008). 
 
Biomarkers 
A biomarker is a characteristic that can be objectively measured and evaluated as an 
indicator of normal and disease processes or pharmacological responses (Biomarkers 
Definitions Working Group (2001)). 
A biomarker has been described as “a biological molecule that can be modified by an 
environmental or endogenous factor; the variation in the molecule can be quantified”. 
In case of oxidative processes that often occur in the organism as the result of a high 
production of reactive species (ROS and RNS), a biomarker can be considered as “a 
biological molecule that has arisen from attack by reactive oxygen, nitrogen or halide 
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species.” Reactive species originate from a range of cellular processes, external factors 
and/or disease states (Ferguson et al., 2006). Reactive species can cause damage to 
lipids, proteins and DNA. Therefore, biomarkers used in intervention studies regard 
lipids, proteins and DNA, as well as plasma antioxidant status as several molecules 
(such as phytochemicals) could act as antioxidants counteracting oxidant species.  
 
The cancer process  
Carcinogenesis is characterized by a complex process that involves a series of 
individual steps. Tumor development has been generally considered to consist in three 
distinct steps: initiation, promotion and progression (Figure 1.3). 
 
 
 
Figure 1.3 Carcinogenic process. Multistage process, which simplified, comprises initiation (attack by 
ROS, carcinogen), accumulation of carcinogenic mutations, progresses trough preneoplastic 
stages by the acquisition of more mutations, promotion by a tumor promoter, progression 
and development of angiogenic potential leading to expression of tumor (Trueba et al., 2004) 
 
Initiation is an irreversible event that begins when cells in normal tissues are exposed 
to a carcinogen and their genomic DNA undergoes damage that remains unrepaired or 
misrepaired. In case of chemically-induced carcinogenesi, initiation involves uptake of 
a given carcinogenic agent with subsequent distribution and transport to organs and 
tissues where metabolism occurs, the interaction of a reactive metabolite with cellular 
DNA with subsequent structural alterations in the DNA molecule, and final fixation of 
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the genotoxic damage to cause mutation. The resulting somatic mutation in a damaged 
cell can be reproduced during mitosis, which gives rise to a clone of mutated cells. 
Promotion is the expansion of the damaged cells to form an actively proliferating 
multi-cellular premalignant tumor cell population. Progression is the irreversible 
process which produces a new clone of tumor cells with increased proliferative 
capacity, invasiveness and metastatic potential (Fimognari et al., 2008). 
Food and nutrition modify the risk of cancers at a large number of sites. This means 
that some foods and drinks, dietary constituents (or their balance in diets), and 
methods of food production, processing, preservation, and preparation influence the 
development of some cancers. More recently, evidence has accumulated about the 
effects of physical activity and body composition on the risk of a number of cancers, 
suggesting that bioenergetics is another factor determining cancer risk and tumor 
behavior (WCRF/AICR 2007). Since the mid-1990s, great progress has been made in 
understanding the cancer process, and which internal and external factors modify 
cancer risk. Mapping of the human genome has enabled the establishment and 
development of new disciplines devoted to understanding biological processes at the 
most basic level, including those that prevent cancer, those that cause cancer, and those 
that modify its behavior. Evolution in living organisms depends on the accumulation 
of adaptations as a result of changes in the expression of the genetic information 
carried in DNA. Even with no changes in the DNA, alterations in how the message in 
the genetic code is translated can lead to functional changes. More importantly, the 
DNA itself is susceptible to mutation — changes in the genetic code itself — as a result 
of damage from external causes such as radiation or simply due to the process of 
metabolism. Such mutations are the essential basis for human evolution, by producing 
adaptations that are beneficial in particular environmental circumstances. At the same 
time, some mutations can contribute to the harmful changes in cells that eventually 
lead to cancer. The integrity of the genetic information is protected by many systems 
that prevent DNA damage, or remove or repair damaged DNA if it occurs. 
Imperfections in these systems limit the ability to block all damage and allow both 
helpful and harmful mutations to occur. Cancers result when sufficient mutations have 
accumulated, most presenting at an age that was rarely reached in the evolutionary 
past of human beings. The development of cancer may be seen as a corollary of the 
ability of humans to evolve and adapt. Ultimately it is both the genetic information 
(genotype) and its expression that control the characteristics (or phenotype) of an 
individual. Any exposure during the life course that affects the genotype or its 
expression may also have an effect on the phenotype. At any point in time, the 
phenotype is related not only to the genotype but also to a host of environmental 
factors, including nutritional exposures. This accumulated metabolic experience may 
begin during maternal and early life, and proceed throughout a person’s lifetime 
(WCRF/AICR 2007).  
 
In the introduction of each topic of this PhD thesis detailed information will be given 
regard the mechanisms studied in the different research models. 
18 
 
 
 Cancer 
Cancer is a group of more than 100 diseases characterized by uncontrolled cellular 
growth as a result of changes in the genetic information of cells. Cells and tissues are 
complex systems with critical stages and checkpoints to ensure normal growth, 
development, and function. Normally the division, differentiation, and death of cells 
are carefully regulated. All cancers start as a single cell that has lost control of its 
normal growth and replication processes. Human adults are made up of around 1013 
(or 10 000 000 000 000) cells, which are renewed and replaced constantly. About 5–10 
per cent of cancers result directly from inheriting genes associated with cancer, but the 
majority involve alterations or damage accumulated over time to the genetic material 
within cells. The causes of damage are both endogenous (internal) and exogenous 
(environmental). Food, nutrition, and physical activity are important environmental 
factors in the development of cancer. Each type of cancer has different characteristics, 
but one feature of all these diseases is unregulated cell growth and/or cell death. Apart 
from haematological cancers such as leukaemias, this results in a tumour or mass, and 
cancerous cells often invade the surrounding tissue. Spread of cancer cells from the 
primary site to other parts of the body is called metastasis. Benign tumours do not 
invade or metastasise. Malignant tumours do not remain localised but can invade 
and/or metastasise. 
 Genetic material 
The genetic material of mammalian cells is composed of double-stranded DNA made 
from four organic bases — cytosine, guanine, adenine, and thymine — within a helical 
spine comprising deoxyribose (a sugar) and phosphate. The combination of a base 
with phosphate and deoxyribose is called a nucleotide. Humans have 3 billion base 
pairs in the DNA code that encode approximately 30 000 different genes. The nucleus 
of a cell contains DNA, and the information in the code is ‘read’ to generate proteins in 
the cytoplasm of the cell. This is achieved by transcribing the DNA into RNA, and then 
translating the information in RNA to synthesise protein. For transcription, the two 
DNA strands separate and an intermediary, complementary copy of the DNA is made 
from mRNA (which differs slightly in structure from DNA and is single stranded). For 
translation, the RNA leaves the nucleus and binds to an organelle in the cytoplasm 
called the ribosome. The RNA nucleotides encode for 21 different amino acids, with 
the ribosome moving along the RNA molecule and translating the genetic code into a 
sequence of amino acids that build into a protein. The normal metabolic processes in 
cells are controlled by proteins, each of which is a product of a single gene from the 
DNA in the nucleus. Although each cell in the body contains exactly the same genes, 
cells from different organs have different structures and functions because there is a 
process of regulation that determines which genes are expressed; that is, which genes 
are turned on and which are not. This differential gene expression varies not only from 
tissue to tissue but also from time to time over the course of a person’s life, from 
embryonic and fetal stages onwards. 
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Gene expression is regulated by promoter regions of genes in the DNA, as well as by 
epigenetic factors — those that alter gene expression without changing the nucleotide 
sequence. The availability of nutrients within the immediate environment influences 
these processes (Figure 1.4). 
 
 
Figure 1.4 The basis for the study of food, nutrition, bioactive food components and the cancer 
process. The genetic message in the DNA code is translated into RNA, and then into 
protein synthesis, and so determines the metabolic process. Research methods called “-
omics” address these different stages.  
 
An integrated framework that simultaneously examines genetics and associated 
polymorphisms with diet-related diseases (nutrigenetics), nutrient induced changes in 
DNA methylation and chromatin alterations (nutritional epigenomics), nutrient 
induced changes in gene expression (nutritional transcriptomics), and altered 
formation and/or bioactivation of proteins (proteomics) will allow for a greater 
understanding of the interrelationships between diet and cancer risk and tumor 
behavior. Since the response to a bioactive food component may be subtle, careful 
attention will need to be given to characterizing how the quantity and timing of 
exposure influence small molecular weight cellular constituents (metabolomics). 
 Nutrigenomics and cancer 
Unraveling links between diet and cancer is complex, as thousands of dietary 
components are consumed each day; a typical diet may provide more than 25000 
bioactive food constituents (Craig, 1997). Assessing intakes of some constituents is 
difficult due to wide variations in the amounts of bioactive components within a 
particular food (McNaughton & Marks, 2003; Finley, 2006).  Dietary constituents 
modify a multitude of processes in both normal and cancer cells (Milner, 2004; Finley, 
2005). The response is further complicated since a single, bioactive food constituent can 
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modify multiple steps in the cancer process. Likewise, many of these processes can be 
influenced by several food components. Normal and cancer cells also differ in their 
responses to bioactive food components in terms of the dose (quantity), timing, and 
duration of exposure required to bring about effects. To unravel the contribution of 
nutrition to cancer, the biological processes underpinning cancer development need to 
be understood. Extensive evidence exists for nutritional factors in several processes 
related to cancer development (Figure 1.5). 
 
 
Figure 1.5 Bioactive food components may modify simultaneously more than one cancer process 
including such diverse events as carcinogen metabolism, hormonal balance, cell 
signalling, cell-cycle control, apoptosis, and angiogenesis. (Trujillo et al., 2006) 
 
However, because of the complexity of the process, it is not possible to conclude that 
modifying any one, or more, of these processes influences cancer risk. The recent 
expansion of knowledge in molecular biology has allowed new techniques to be 
developed to explain these mechanisms. Nutrigenomics is a new field with profound 
implications in cancer prevention and therapy, since it seeks to clarify the impact of 
nutrition in the maintenance of genome stability, and to dissect out the influence of 
genotype in determining our response to diet. Nutrigenomics is the study of 
nutritional influences on the phenotypic variability of individuals based on genomic 
diversity (Figure 1.4). This determines the sequence and functions of genes, and 
studies single nucleotide polymorphisms (SNPs), and amplifications and deletions 
within the DNA sequence as modifiers of the response to foods and beverages and 
their constituents. Nutritional epigenomics is another key determinant of gene 
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expression patterns. It includes non-coding modification of genes (such as methylation, 
changes in histone homeostasis, miRNA, and DNA stability) in response to nutrition. 
Nutritional transcriptomics is the study of gene expression patterns at the RNA level, 
and it can identify common nutritional response elements in gene promoters that can 
be modulated by diet. Proteomics studies the proteins that can be expressed by a cell, 
many of which can be influenced by nutrition. Metabolomics studies the range of 
metabolic processes in a cell and metabolic regulation in cells or tissues, which again 
are heavily influenced by food, nutrition, and physical activity. 
 Cellular processes 
The role of nutrition in cancer depends on how it impacts on fundamental cellular 
processes including the cell cycle. To understand cancer biology, it is important first to 
understand normal cellular processes. The integrity of tissues and organs depends on a 
regulated balance between cell proliferation and death, and appropriate cell 
differentiation. This regulation is controlled by several types of genes including 
oncogenes and tumor suppressor genes, and factors in the cellular environment that 
influence their expression. Maintenance of the DNA sequence and structure as cells 
divide is essential: several cellular mechanisms exist to ensure this is achieved. 
Cell signalling 
Cells detect and respond to external stimuli and send messages to other cells through a 
molecular mechanism known as cell signalling. Cells within a tissue normally 
communicate with each other through a network of locally produced chemicals called 
cytokines (including some growth factors). Cell proliferation is a tightly controlled and 
coordinated process, and is stimulated by growth factors. These soluble proteins can 
be produced locally, either from the same cell (autocrine), or from different cells 
(paracrine), or as hormones (endocrine) produced by a distant tissue and transported 
in the blood. Growth factors bind to specific receptors on the cell surface and transmit 
a signal into the cell, which is relayed to the nucleus. In the nucleus, genes are 
switched on to produce the proteins necessary for cell division. Getting the growth 
signal from the outside of the cell to the nucleus requires a series of steps. The shape of 
the receptor changes when the growth factor binds to it, which causes part of the 
receptor to become activated, usually by a process called phosphorylation. A regulated 
process of phosphorylation and dephosphorylation is necessary for the appropriate 
initiation, transmission, and cessation of signals. 
Gene expression 
Gene expression is the process by which the information within a gene is ‘turned on’ or 
‘turned off’. The information is used to create the associated proteins and modify the 
amounts produced. Also see Figure 1.3. Transcription factors are proteins involved in 
the regulation of gene expression and carry the signal from the cytoplasm to the 
nucleus. They bind to the promoter regions of genes and have the effect of either 
switching gene expression on or off. There are also nuclear receptors, such as retinoic 
acid receptors, that function as transcription factors by binding directly to specific 
DNA sequences. Some so-called ‘housekeeping’ genes are expressed by almost all cell 
types. These genes generally encode proteins that participate in basic cell functions 
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such as metabolic pathways and synthesis, and processing of DNA, RNA, or proteins. 
Other genes have more restricted expression, and are expressed only in specific cell 
types, and/or stages of development. Gene expression can also be influenced by 
changes outside the DNA of genes. DNA is closely organised and tightly packaged in 
the nucleus of cells. To achieve this, DNA is spooled around proteins called histones. 
Histone structure can be modified either, like DNA itself, by methylation, or more 
commonly by acetylation (addition of an acetyl group). Acetylation and deacetylation 
(removal) are mediated by the enzymes histone acetyl transferase (HAT) and histone 
deacetylase (HDAC), respectively. HATs relax the packaged DNA structure, which is 
associated with enhanced transcription, whereas HDACs stabilise the structure with 
higher levels of packaging, and so suppress transcription. Butyrate, produced in the 
colon by bacterial fermentation of non-starch polysaccharide (dietary fibre), diallyl 
disulphide from garlic and other allium vegetables, and sulphoraphane, a 
glucosinolate from cruciferous vegetables, can behave as histone deacetylase inhibitors 
(Dashwood et al., 2006), and act to maintain DNA stability or enhance transcription. 
Micro RNAs (miRNAs) are RNA molecules that do not encode proteins; instead they 
function as negative regulators of gene expression. Some mutations in miRNAs have 
been associated with human cancers, and they can function as oncogenes or tumour 
suppressor genes. miRNAs are short, single-stranded RNA molecules of 
approximately 22 nucleotides. For instance, to silence (turn off) genes, they may bind 
to complementary mRNA sequences and degrade them before they have been 
translated. Profiling miRNA signatures within cancer cells may aid the diagnosis, 
classification, and treatment of cancer. For example, a certain miRNA that is down-
regulated in lung cancer is associated with decreased survival (Esquela-Kerscher & 
Slack, 2006). Research on the interactions between nutrition and non-coding RNA 
molecules is at an early stage but is potentially relevant to cancer. 
 DNA damage and repair 
Each time a cell divides into two new daughter cells, there is potential for an error in 
replication of the DNA. These mutations result in non-functioning genes or in proteins 
with altered amino acid sequences that can change cell function. DNA is continuously 
exposed to damage from products of normal intracellular metabolism, including 
reactive oxygen species, hydroxyl radicals, and hydrogen peroxide; and also to 
damage from external factors such as ultra-violet (UV) light, as well as other 
environmental factors including food, nutrition, and physical activity. There are 
several mechanisms for DNA repair, a vital defense in maintaining cellular integrity 
and preventing a cell being transformed from normal to cancerous (see also chapter 
3.1). Various studies suggest that nutritional status and/or certain food constituents 
may influence DNA repair. Data from observational studies suggest that severe 
malnutrition can impair DNA repair (Gonzalez et al., 2002). Although the processes of 
cell development, signalling, and DNA repair are tightly controlled, errors will occur 
during the trillions of cell divisions that occur over a lifetime. This may result in 
inappropriate proliferation or failure of damaged cells to die. These changes could 
provide the altered cell with a growth advantage over the normal cells in the tissue. If 
23 
 
additional alterations occur, this can result in a cell with the potential to become 
cancerous. 
 Causes of cancer 
A number of different types of exogenous (environmental) factors are known causes of 
cancer. These include some aspects of food and nutrition that are established as 
carcinogenic by the International Agency for Research on Cancer, although it is 
difficult to estimate the proportion of cancers directly attributable to these. Known 
causes of cancer include: tobacco smoking and its use, infectious agents, medication, 
radiation, and industrial chemicals, and also carcinogenic agents in food and drink. 
 
1. Endogenous causes 
Inherited germ line mutations 
As mentioned, only a minority (5–10 per cent) of cancers are linked to single inherited 
genes. Such inherited alterations are termed germ line mutations, and are passed on 
from egg or sperm DNA. Individuals with inherited germ line mutations will not 
definitely get cancer but have an increased risk of developing cancer compared with 
the general population. Often mutations in tumor suppressor genes increase the 
chance of developing cancer at a young age.  
The other type of genetic mutation — somatic gene changes — develops during the life 
course. Such somatic mutations are not passed on to offspring. This DNA damage is 
caused by exposure to external factors such as radiation or carcinogens, or harmful 
products of normal aerobic metabolism. 
Oxidative stress 
Reactive oxygen species generated through normal oxidative metabolism have the 
potential to cause extensive DNA damage. The body has several mechanisms, which 
can scavenge reactive oxygen species to prevent such damage occurring, or block the 
effects. Reactive oxygen species cause oxidative damage to DNA. During repair, the 
damaged, oxidized bases are excreted in the urine. Levels of urinary 8-hydroxy-2'-
deoxyguanosine, an oxidative DNA damage adduct, can be used as an indicator of 
oxidative DNA damage in humans and rodents. Antioxidants can scavenge reactive 
oxygen species. Vitamins C and E can donate electrons to free radicals and block their 
damaging activity. Dietary constituents such as ITCs and polyphenols can also activate 
the signaling pathways that lead to activation of the antioxidant response element, and 
up-regulation of the expression of detoxifying enzymes. 
Inflammation 
Inflammation is a physiological response to infection, foreign bodies, trauma, or 
chemical or other irritation, and in the acute phase can be helpful. However, chronic 
inflammation can result in DNA damage and cancer promotion. Chronically inflamed 
tissue is infiltrated with a variety of inflammatory cells that produce a wide variety of 
bioactive chemicals. These include cytokines, growth factors, reactive oxygen and 
nitrogen species, cyclooxygenase, and lipoxygenase products. A chronic inflammatory 
environment can increase proliferation and differentiation, inhibit apoptosis 
(programmed cell death), and induce angiogenesis (generation of new blood vessels).  
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Epidemiological and experimental evidence has demonstrated that long-term use of 
non-steroidal  anti-inflammatory drugs can inhibit cancer development in a number of 
tissues including colon, oesophagus, and breast (Coussens & Werb, 2002; Hawkes, 
2005). Cancer induced by inflammation may be susceptible to nutritional influences. 
Thus, dietary constituents could be involved in generation of reactive oxygen species, 
could influence antioxidant defenses, or could suppress the inflammatory process. For 
example, the glucocorticoid receptor pathway and the vitamin D receptor are capable 
of suppressing inflammation. 
The immune system can be divided into innate and adaptive responses. Innate 
immunity provides initial defenses. Adaptive immunity develops later and involves 
activation of lymphocytes and their differentiation into effector and memory cells. The 
‘immune surveillance’ hypothesis proposes that both the innate and adaptive immune 
systems constantly survey for and eliminate newly formed cancer cells, and that onset 
and progression of cancer are kept under control by the immune system (Smyth et al., 
2006). Immuno-surveillance requires that the immune system recognizes something 
different about cancer cells compared with normal cells within the same tissue – often 
different proteins (termed tumor antigens) that are expressed on the surface of a cancer 
cell. This recognition of ‘altered self’ allows the immune system to generate a response 
to these tumor antigens. They can be proteins that are only expressed by cancer cells, 
and newly expressed during cancer development; or proteins that have become 
mutated during the cancer process and so are different from the non-mutated protein; 
or proteins expressed due to differentiation of cancer cells (termed differentiation 
antigens); or proteins that are normally expressed by cells but that are expressed at 
much higher levels by cancer cells. Evasion of immune-surveillance is sometimes 
referred to as a further hallmark of cancer(Zitvogel et al., 2006), although the evidence 
remains speculative. Specialized mucosal cells form the interface between the inside 
and outside of the body (Miura et al., 1998). These are normally an efficient barrier 
against pathogens. The gut barrier consists of gut-associated lymphoid cells that can 
sense pathogens, and participate in innate and adaptive responses (Tlaskalova-
Hogenova et al., 2002). The function of these cells is dependent on nutrition.  For 
example, n- 3 PUFAs can enhance immunity, whereas high concentrations of n-6 
unsaturated fatty acids can have a suppressive effect (Gleeson et al., 2004). Various 
factors have been shown to modulate both inflammation and immunity, including 
vitamins A and E, copper, selenium, zinc, PUFAs, and epigallocatechin-3-gallate 
(EGCG) from green tea (Kubena & McMurray, 1996).  
The cytokine IL-6 can act as a pro- or anti-inflammatory cytokine. In cancer, IL-6 can 
either stimulate proliferation or exert anti-tumor effects by enhancing both innate and 
adaptive immunity (Trikha et al., 2003). Dietary phytoestrogens, such as soy 
isoflavones, downregulate IL-6 gene expression and thus potentially influence the 
development of hormone-related cancers (Dijsselbloem et al., 2004).  
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2. Exogenous causes 
Tobacco use 
Tobacco causes an estimated 20 per cent of all cancer deaths, and an estimated total of 
1.2 million in 2002 World Health Organization and International Agency for Research 
on Cancer (World Cancer Report 2003). Smokers have increased risk of a number of 
different cancers. Worldwide, around 80 per cent of lung cancer cases in men and 50 
per cent in women are caused by tobacco smoking (Mackay et al., 2006). In 2002, out of 
all new cases of cancer in low-income countries, over 1 in 5 in men and almost 4 per 
cent in women were attributable to tobacco. In high-income countries, one third of all 
new cancer cases in men and just over 1 in 8 in women were attributed to tobacco 
smoking. Cigarette smoke contains at least 80 known mutagenic carcinogens, 
including arsenic, cadmium, ammonia, formaldehyde, and benzopyrene. Each will 
have a separate mechanism for causing cancer. For example, following metabolic 
activation, the activated derivative of benzopyrene, benzo(a)pyrenediol epoxide, can 
form DNA adducts in lung epithelial cells (Nishikawa et al., 2004). Cigarette smoke is a 
powerful carcinogen and also a source of oxidative stress. Compared with non-
smokers, active smokers have lower circulating concentrations of several antioxidant 
micronutrients including α-carotene, β-carotene, cryptoxanthin, and ascorbic acid 
(Alberg, 2002). 
Carcinogenic agents in food 
Food may be contaminated with natural or man-made carcinogenic toxicants. Moulds 
and the toxins produced by some moulds cause DNA adducts and are carcinogenic. 
Aflatoxin B, a product of the Aspergillus fungus and a common contaminant of cereals 
(grains) and peanuts, is an established cause of liver cancer. Fumonisin B, a toxin 
produced by the fungus Fusarium verticillioides, may be found on maize and may be 
carcinogenic, although epidemiological studies are lacking. Some carcinogenic 
compounds are formed during food preparation. Heterocyclic amines are formed by 
cooking meat at high temperatures, and polycyclic aromatic hydrocarbons can be 
produced in meat and fish that has been grilled (broiled) or barbecued (charbroiled) 
over a direct flame. High environmental concentrations of polycyclic aromatic 
hydrocarbons, which also come from pollution caused by traffic and industry, can 
contaminate other foods such as cereals, vegetables, and fruits. Some N-nitroso 
compounds are carcinogens, and are formed in foods containing added nitrates or 
nitrites; examples include fish and meat preserved with salting or preservatives, and 
smoking or drying. These carcinogens can also be generated from ingested foods 
containing nitrate or nitrite. N-nitroso compounds are also produced endogenously in 
the stomach and colon of people who eat large amounts of red meat or take nitrite 
supplements.  
 
Nutrition and cancer 
The majority of cancers are not inherited. Cancer is, however, a disease of altered gene 
expression that originates in changes to DNA, the carrier of genetic information. For a 
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cell to be transformed from normal to cancerous, it has to acquire different phenotypic 
characteristics that result from alterations to the genotype. Most cancers develop to the 
stage of being clinically identifiable only years or decades after the initial DNA 
damage. Cancer development, or carcinogenesis, requires a series of cellular changes. 
No single gene causes cancer. It is a multistep process caused by accumulated errors in 
the genes that control cellular processes. One genetic mutation may allow a single trait 
(such as increased survival) to be acquired by a lineage of cells, and descendants of 
these cells may then acquire additional genetic mutations. However, cancer only 
develops when several genes are altered that confer growth and survival advantages 
over neighbouring normal cells. The capacity of a cell to achieve effective cancer 
prevention or repair is dependent on the extracellular microenvironment, including 
the availability of energy and the presence of appropriate macro- and micronutrients. 
Tumors are not simply masses of cancer cells. Rather, they are heterogeneous 
collections of cancer cells with many other cell types — so-called stromal cells; cancer 
cells communicate with stromal cells within the tumor. The tumor microenvironment 
comprises many cell types including infiltrating immune cells such as lymphocytes 
and macrophages, endothelial cells, nerve cells, and fibroblasts. All these cell types can 
produce growth factors, inflammatory mediators, and cytokines, which can support 
malignant transformation and tumor growth, and attenuate host responses. In 
addition, factors produced by the cancer cells themselves modulate the activity and 
behavior of the tumor stroma. Initiation is the exposure of a cell or tissue to an agent 
that results in the first genetic mutation. This can be an inherited mutation or an 
exogenous or endogenous (produced through oxidative metabolism) factor. Even 
without external oxidative stress, hundreds of sites within DNA are damaged each day 
but are normally repaired or eliminated. Exposure to the carcinogen initiates DNA 
damage, usually via the formation of DNA adducts. If left uncorrected, these adducts 
can be transferred to daughter cells during division and confer the potential for 
neoplastic (new and abnormal) growth. Initiation alone is insufficient for cancer to 
develop. An initiated cell must go through a process of clonal expansion during 
promotion to become neoplastic; the larger the number of initiated cells, the greater the 
risk of progressing to cancer. Promotion involves exposure of the initiated cell to a 
promoting agent. This may allow alterations in the rate of proliferation or additional 
DNA damage to occur, leading to further mutations within the same cell, which alter 
gene expression and cellular proliferation. Finally, these initiated and promoted cells 
grow and expand to form a tumor mass. DNA damage continues at this stage and 
cancer cells often contain multiple copies of chromosomes. This clear, sequential 
process is typical of experimentally induced cancers but may be less clear in sporadic 
cancers in humans. At the end of the multistage process of carcinogenesis, the cell will 
bear some or all of the hallmarks of cancer (Hanahan & Weinberg, 2000). Several genes 
can contribute to each hallmark and one gene (for example p53) can contribute to 
several of the hallmarks. These hallmarks or traits are shared by most, if not all, cancer 
cells. The six hallmarks of cancer cells are (Hanahan & Weinberg, 2000): 
1) self-sufficiency in growth signals;  
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2) insensitivity to antigrowth signals;  
3) limitless replicative potential;  
4) evasion of apoptosis;  
5) sustained angiogenesis;  
6) tissue evasion and metastasis. 
Food, nutrition, and physical activity-related factors influence cellular processes and 
lead to cells accumulating these traits. 
1) Growth signal autonomy 
Unlike normal cells, cancer cells are not dependent on external growth factors to 
stimulate their division. Instead, they can generate their own signals or respond to 
lower concentrations of external signals. This frees cancer cells from the growth 
constraints of normal cells. 
2) Insensitivity to antigrowth signals 
Normal cells also receive growth inhibitory signals. Indeed, most cells of the body are 
quiescent and not actively dividing. Cells respond to negative environmental signals 
such as contact with other cells. Cancer cells have acquired mutations that interfere 
with these pathways and so do not respond to growth inhibitory signals. 
3) Limitless replicative potential 
Normal cells can divide a finite number of times. Once they have replicated 60 or 70 
times they stop — a process termed senescence, which is thought to constitute a 
protective mechanism against unlimited proliferation. This preordained number of cell 
doublings is controlled by telomeres. Telomeres are segments of DNA on the ends of 
chromosomes, which are shortened during each round of DNA replication. Eventually 
when the telomeres are too short, the cell can no longer divide and it undergoes 
apoptosis. By contrast, cancer cells have acquired the ability to maintain the length of 
their telomeres, which means they can replicate endlessly. Recent work has suggested 
that senescence can be induced prematurely, particularly in premalignant cells, by 
activation of the normal, non-mutated forms of genes such as p53 and Rb (Hanahan & 
Weinberg, 2000). This senescence is a normal active process involving genetic and 
phenotypic changes that may protect against cancer development; for example, it may 
be one mechanism preventing benign moles from progressing to malignant melanoma. 
However, in malignant melanoma, cell markers of senescence are lost (Sharpless & 
DePinho, 2005). In experimental conditions, many constituents of food such as retinol, 
calcium, allyl sulphide, n-3 fatty acids, and genistein are known to influence 
progression of cells through the cell cycle. These studies, when conducted in cells in 
culture, need to be assessed cautiously because they may not always adequately reflect 
events in vivo. However, they can and do provide evidence additional to that gained 
from epidemiological studies.  
Specific dietary components have effects on cell cycle progression and proliferation in 
experimental settings. Some known or hypothesized benefits of some dietary 
constituents are summarized here. 
Vitamin A (in the form of retinol) can lead to cell cycle arrest (Bohnsack & Hirschi, 
2004). Retinoids and carotenoids inhibit proliferation by binding retinoid receptors on 
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the cell surface. Reduced expression of retinoid receptors occurs during development 
of lung cancer (Lotan, 1999); retinoic acid receptor silencing is also common in other 
malignancies. Retinoic acid, a metabolite of vitamin A, has been used as a 
chemopreventive and therapeutic agent in cervical cancer (Palan et al., 1998). Retinoids 
can inhibit proliferation of initiated cells by inducing apoptosis or inducing 
differentiation of abnormal cells back to normal (Butterworth et al., 1982). Retinoids 
may also cause regression of precancerous lesions in the cervix (Abu et al., 2005). 
Butyrate and diallyl disulphide can act as histone deacetylase inhibitors (Dashwood et 
al., 2006) , and arrest the cell cycle. Folate is a necessary cofactor for DNA synthesis, 
and deficiency can reduce cell proliferation due to decreased DNA synthesis. Phenolic 
compounds, including genistein and EGCG, can inhibit some cyclins and cyclin-
dependent kinases (Chen & Kong, 2005). Specifically, in people with oral leukoplakia, 
green tea (which contains EGCG) has been associated with significant decreases in the 
size of cancers and of micronuclei formation in exfoliated oral cells (Li et al., 1999). 
Phytoestrogens are found in high concentrations in soya beans, and have been shown 
in vitro to exhibit a plethora of different anti-cancer effects, including inhibiting 
proliferation (Strauss et al., 1998; Adlercreutz, 2002).  Only about one third of people 
have the types of microbial flora in their gut that are capable of metabolising the 
dietary isoflavone daidzein to equol. Compared with Western populations, Asian 
populations are more likely to produce equol, and this affects the expression of genes 
involved in cell signalling and differentiation, and cell division. Equol can also 
modulate oestrogenresponsive oestrogenresponsive genes (Niculescu et al., 2007). 
Glucosinolates from cruciferous vegetables are converted in the liver to ITCs, which 
can arrest cell cycle progression, as well as induce phase II enzymes, which can 
promote carcinogen excretion. In a variety of animal studies, certain dietary 
components have shown reductions in experimentally induced cancers. Allyl 
sulphides in garlic inhibit experimentally induced colon tumor formation. Although 
this is not completely understood, experiments with diallyl disulphide suggest a block 
in the G2/M phase in the progression of the cell cycle, and induction of apoptosis 
(Knowles & Milner, 2001). Fish oil supplements decrease the number of tumors in 
experimental models of colorectal cancer (Rao et al., 2001). Long-chain n-3 PUFAs in 
fish oils can limit tumor cell proliferation (Nkondjock et al., 2003; Roynette et al., 2004) 
by modifying signaling pathways, (Gupta et al., 2000; Price et al., 2000; Novak et al., 
2003) for example, by decreasing signaling of activated oncogenes (Collett et al., 2001). 
Animals that receive a diet supplemented with n-3 fatty acids have fewer colonic 
tumors than those fed a diet supplemented with corn oil (Chapkin et al., 1998), due to 
dietary fibre-altering, fatty acid-binding, protein expression in colonocytes during 
tumor development.  
Various growth factors and hormones involved in normal cell processes can be used or 
produced by cancer cells to maintain or augment uncontrolled cell proliferation. The 
receptor for IGF-1 is over-expressed on many cancer cells. IGF-1 can enhance the 
growth of a variety of cancer cell lines (LeRoith et al., 1995) by stimulating progression 
of the cell cycle from G1 to S phase (Calle & Kaaks, 2004). Insulin itself can also act as a 
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growth factor for tumor cell proliferation, both by binding to the insulin receptor on 
cancer cells and by stimulating increased IGF-1 production by the liver (Calle & Kaaks, 
2004; Yakar et al., 2005). Insulin resistance increases with body fatness, in particular 
abdominal fatness, and the pancreas compensates by increasing insulin production. 
This hyperinsulinaemia is associated with a risk of cancers of the colon and 
endometrium, and possibly of the pancreas and kidney(Calle & Kaaks, 2004). Leptin, a 
hormone produced by fat cells, can also stimulate proliferation of many premalignant 
and malignant cell types (Fenton et al., 2005), as can a number of sex steroid hormones. 
Physical activity improves insulin sensitivity and decreases levels of insulin (Grimm, 
1999). However, exercise has little or no long-term effects on circulating IGF-1 levels 
(Schmitz et al., 2002; McTiernan et al., 2005). IGF binding activity may increase with 
physical activity, and thus overall IGF-1 bioavailability and activity may decrease. 
Physical activity decreases serum estrogen and androgens in postmenopausal women. 
In premenopausal women, it decreases circulating estrogens, increases cycle length, 
and decreases ovulation, all of which provide a protective effect for breast and 
endometrial cancers.  
In experimental animals, energy restriction leads to a reduction in cell proliferation 
(Hursting et al., 2003) . At the molecular level, dietary energy restriction affects levels 
of cell cycle control proteins (decreased cyclins, increased levels of cyclindependent 
kinase inhibitors, and decreased cyclin-dependent kinases), leading to reduced Rb 
phosphorylation and inhibited cell cycle progression (Thompson et al., 2003). This, in 
turn, may directly inhibit tumor growth and/or indirectly reduce cancer development 
by reducing the number of cell divisions, thus reducing the chances for incorrect DNA 
replication or preventing damaged DNA from being replicated. 
4) Evasion of apoptosis 
Apoptosis is the tightly regulated process of cell death that controls cell numbers, 
removes damaged cells, and prevents damaged cells being replicated, thereby 
maintaining tissue integrity and protecting against cancer. Ultimately, cells break into 
small membrane-surrounded fragments (apoptotic bodies) that are phagocytosed 
without inducing inflammation. Triggers for apoptosis in normal cells include DNA 
damage, disruption of the cell cycle, hypoxia, reactive oxygen species, and physical or 
chemical insult. Two nonexclusive pathways, the intrinsic (mitochondrial) pathway or 
the extrinsic (death-receptor) pathway, can be activated. Both involve activation of 
caspases, a family of protease enzymes that cleave intracellular proteins (Fischer & 
Schulze-Osthoff, 2005). In apoptosis, p53 functions as a transcriptional activator of 
genes encoding apoptosis effectors. p53 can also exert a direct apoptotic effect by 
damaging mitochondria (Mihara et al., 2003). Cancer cells have acquired mutations in 
genes regulating apoptosis and therefore can evade apoptotic signals. Defects in 
apoptosis are often observed in established cancers. In cancer cells, many signals that 
normally induce apoptosis, such as damaged DNA or expression of activated 
oncogenes, are present but apoptosis is not induced. This avoidance of apoptosis 
allows further opportunity for additional mutations to develop. In cancer cells with 
mutations in p53 or other members of this family, apoptosis may not occur. 
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Additionally, mutations in genes that would normally activate p53 or regulate its 
activity, or in genes that should be switched on as a result of p53 activation, can have 
the same effect. Cancer cells with upregulated expression of IGF-1R and increased 
responses to IGF-1 have decreased apoptosis (Yakar et al., 2005). In experimental 
settings, energy restriction creates a proapoptotic environment, adjacent to 
premalignant and malignant breast pathologies (Thompson et al., 2004). Long-chain n-
3 PUFAs in fish oils limit tumor cell proliferation, increasing apoptotic potential along 
the crypt axis, promoting differentiation and limiting angiogenesis (Rao et al., 2001; 
Nkondjock et al., 2003; Roynette et al., 2004). Reactive oxygen species can induce 
apoptosis, but it is also possible that scavenging of reactive oxygen species by dietary 
antioxidants can delay or inhibit apoptosis, and thus favor survival of premalignant 
cells. Indeed, this could explain why dietary antioxidant intervention trials have 
produced mixed results (Salganik et al., 2000; Albright et al., 2004). 
Many dietary components have been shown to induce apoptosis in cultured cancer 
cells and in experimental models of cancer (Watson et al., 2000).These include EGCG, 
curcumin, genistein, indole-3-carbinol, resveratrol, ITCs, lycopene, capsaicin, and 
organosulphur compounds (Khan et al., 2007). In premalignant cells, retinoids, 
polyphenols, and vanilloids stimulate apoptosis (Sun et al., 2004). Alpha-tocopherol (a 
form of vitamin E) has been shown both to induce (Gunawardena et al., 2000) and to 
protect against apoptosis (Takahashi et al., 1998). 
5) Sustained angiogenesis 
Angiogenesis, the formation of new blood vessels, is essential for the supply of 
nutrients and oxygen to any growing tissue, including tumors. Most cells within 
tissues reside within 100 mm of a capillary blood vessel. The generation of blood 
vessels in adults is fairly constant and tightly controlled by a balance of angiogenesis 
inducers and inhibitors. For a cancer to progress to a larger size, it must acquire the 
ability to induce angiogenesis. Currently about 35 proteins have been identified as 
angiogenesis activators or inhibitors (Folkman, 2003; Folkman, 2006). In experimental 
settings, one of the first dietary components for which a beneficial anti-angiogenic 
effect was clearly demonstrated was EGCG from green tea (Cao & Cao, 1999). Now 
some 20 different compounds consisting mainly of flavonoids and isoflavones 
(including genistein) are documented as being able to modulate the angiogenic 
process. Diets high in n-6 fatty acids are associated with poor prognosis in breast 
cancer patients, whereas those high in n-3 fatty acids appear to suppress angiogenesis 
(Rose & Connolly, 2000). Curcumin, quercetin, and resveratrol have all been shown to 
inhibit the angiogenic factor, vascular endothelial growth factor (VEGF), in cultured 
cancer cells. Garlic extract may inhibit experimentally induced angiogenesis, as it can 
suppress endothelial cell motility, proliferation, and tube formation (Matsuura et al., 
2006). Phytoestrogens found in high concentrations in soya beans have also been 
shown to inhibit angiogenesis (Strauss et al., 1998). Energy restriction reduces blood 
vessel density in premalignant and malignant breast pathologies (Thompson et al., 
2004). Exercise increases the levels of a circulating endogenous VEGF inhibitor in 
healthy people, which could decrease plasma levels of VEGF (Bailey et al., 2006). 
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6) Tissue invasion and metastasis 
Normal cells in solid tissues maintain their position in the body and generally do not 
migrate. As a cancer increases, it eventually reaches the membrane encapsulating the 
organ. Tumor cells secrete enzymes such as matrix metalloproteases (MMPs), which 
digest the membrane and allow the cancer to invade adjacent tissue. Once through the 
membrane, cancer cells can access other sites via the blood and lymphatic systems. 
This migration of cancer cells, or metastasis, is a common characteristic of most cancer 
deaths. There is limited evidence for dietary components to influence these late stages 
of cancer, although in vitro, EGCG, resveratrol, quercetin, curcumin, and genistein can 
inhibit one or more MMPs. Vitamin C can inhibit MMP production by a number of 
human cancer cell lines and prevent invasion of these lines in vitro (Roomi et al., 2006). 
Vitamin E can inhibit metastasis of pre-established tumors in mouse models of breast 
cancer (Hahn et al., 2006). 
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2. AIMS OF THE STUDY 
 
The intake of several foods rich in bioactive constituents has been identified in the 
literature reviews as being associated with lower chronic-degenerative disease risk 
(Liu, 2004). The bioactivity of these compounds is in part related to their antioxidant 
properties which are important to decrease the risk of the onset development of many 
of the chronic degenerative diseases (Espin et al., 2007).  
Despite of this consideration, more studies are needed to demonstrate the protective 
role of specific food and the mechanisms of action of bioactive compounds. 
This PhD research project will be divided in two parts.  
1) The first part will concern to the evaluation of the impact of bioactive 
compounds in Cruciferae, on humans with different genetic polymorphisms of 
enzymes, involved in endogenous biotransformation systems. Particularly, two types 
of study will be designed analyzing: the bioavailability of protective compounds from 
broccoli and their role in the protection against biomarkers of oxidative stress, taking 
into account individual genetic susceptibility. The response of different biomarkers to 
both single meal and regular consumption of broccoli will be investigated. DNA 
damage will be evaluated as resistance to exogenous damage, endogenous DNA 
damage and OGG1 repair ability; while OGG1, HO-1 and NUDT1 mRNA levels will 
be considered as markers of repair and defence systems.  
Recently, the inverse relationship found between cruciferous vegetable intake and 
cancer risk increased interest among scientists involved in cancer prevention studies. 
Dietary or environmental carcinogens must be activated to induce cancer. The ability 
of dietary constituents in cruciferous vegetables to inhibit phase I activation and to 
induce phase II enzymes are of primary importance to their cancer chemopreventive 
effects (Fimognari et al., 2008). In particular, phase II enzymes decrease carcinogenicity 
by blocking carcinogen metabolic activation and enhancing carcinogen detoxification. 
Glutathione-S-Transferase (GST), is included in the phase II family enzymes activated 
by Cruciferae consumption (Jeffery & Keck, 2008). Moreover  its genetic polymorphism 
is related to cancer risk (Qiu et al., 2010; Wan et al., 2010). Thus, we will evaluate the 
different susceptibility to risk of different GST polymorphisms in relation to broccoli 
consumption. Controversial data are found in literature, and human intervention 
studies have not clearly demonstrated the relationship between GST polymorphisms 
and protective effect of broccoli. It is hypothesized that GST genotypes associated with 
lower protection against carcinogens benefit most from cruciferous vegetable 
consumption. 
The first part of this PhD research project will be carried out at the Dipartimento di 
Scienze e Tecnologie Alimentari e Microbiologiche (DiSTAM)-sezione Nutrizione 
(Università degli Studi di Milano), under the direction of Prof. Marisa Porrini and Dr. 
Patrizia Riso. 
2) The second part will be focused on the study of mechanisms of action 
involved at cellular level induced by single compounds. Since most cancers are 
dependent on the growth of tumor blood vessels, angiogenesis may thus provide an 
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efficient strategy to delay or block tumor growth. Migration and proliferation of 
endothelial cells are critical steps in angiogenesis since these events allow cells to 
disseminate from pre-existing vessels to form new capillary structures (Folkman, 
2006). Moreover, blood coagulation and cancer biology are strictly related (ten Cate & 
Falanga, 2008). 
Capillary-like formation assay is a reliable approach able to test pro- or anti-angiogenic 
properties of a chemical compound. After a review of the literature two anthocyanins, 
i.e. Delphinidin-3-glucoside (Dp-3-glc) and Cyanidin-3-glucoside (Cy-3-glc), will be 
selected for this type of studies. These two compounds are able to inhibit tumor cell 
proliferation (Katsube et al., 2003; Fimognari et al., 2004; Olsson et al., 2004), but it is not 
known whether they can also act on pro-angiogenic and the pro-thrombotic properties 
of endothelial cells.  Models of angiogenesis on human microvascular endothelial cells 
will be used to test the role of Dp-3-glc and Cy-3-glc in capillary network formation 
and wound healing assay in resting and VEGF-stimulated conditions. The same cell 
line will be used to test the protective role of Dp-3-glc in pro-coagulant activity both in 
resting and LPS-stimulated conditions. The results will enhance our knowledge of the 
intricate roles and functions that ACNs act at both cellular and molecular level. 
This part of research will be performed at the Hemostasis and Thrombosis Center, 
Ospedali Riuniti di Bergamo, Italy, supervised by Dr. Anna Falanga and Dr. Marina 
Marchetti. 
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3. RESULTS AND DISCUSSION 
 
3.1 TOPIC I: Role of broccoli intake, a glucosinolate-rich source, on biomarkers 
of oxidative stress in young smokers  
 
Abstract 
Scientific evidences support the protective role of diets rich in fruit and vegetables 
against chronic diseases, like cancer and cardiovascular disease (WCRF/AICR 2007). 
Fruits and vegetables compounds, able to reduce the risk of chronic diseases, include 
vitamins, minerals and numerous phytochemicals. The latter are bioactive compounds 
that have been shown to exert a wide range of biological activities. Since they are 
ingested regularly and in significant amounts as part of the diet, they may have a 
noticeable long-term beneficial effect. 
Cruciferae and especially Brassica genus contain high concentration of constituents 
with antioxidant properties (e.g. carotenoids, vitamin C, folate) as well as glucosinolate 
precursors of isothiocyanates (ITCs) and indoles that modulate xenobiotic 
biotransformation enzymes, such as Glutathione S-Transferase (GST). Different GST 
polymorphisms seem to be related to altered protective effect against xenobiotics. The 
protective effect of broccoli (Brassica oleracea L. var. italica) was tested through two 
different study protocols performed at DiSTAM-sezione Nutrizione (Università degli 
Studi di Milano): a regular-intake intervention study with daily consumption of one 
serving of steamed broccoli for 10 days and a single-meal study (i.e. with one serving 
of broccoli). Broccoli were chemically characterized for the content in antioxidant 
compounds (carotenoids, vitamin C) and glucosinolates as isothiocyanates (ITCs). One 
portion of 250g of steamed broccoli provided: 2.75 mg of lutein, 1.50 mg of β-carotene, 
172 mg of vitamin C and 160 µmol of phenethyl- isothiocyanate (PEITC) equivalents of 
ITCs. 
Subjects involved in the study were young male smokers recruited on the basis of 
anthropometric characteristics, food habits and their GSTM1 genotype. 
Thirty subjects were enrolled for the regular-intake study. A single blind randomized 
cross-over experimental design was scheduled: 15 volunteers followed the sequence 
broccoli diet/wash-out/control diet; while the others followed the opposite sequence. 
Broccoli and control diet were 10 days long and they were spaced out from 20 days of 
free diet. One serving consisted of 250 g of steamed broccoli. Fasting blood samples 
were collected at the beginning and at the end of each treatment period (0, 10, 30, 40 
days). Plasma, serum and lymphocytes were separated and stored for specific 
analyses. Concentration of carotenoids, lutein, β-carotene and folate was assessed in 
plasma and serum samples. Lymphocytes were separated and used immediately for 
the determination of cell resistance against oxidative stress (H2O2-induced DNA 
strands breaks) through the COMET assay. Additionally, lymphocytes were isolated 
and appropriately stored at -80°C for the subsequent determination of biomarkers of 
oxidative stress: endogenous DNA damage (i.e. oxidized purines), in vitro DNA repair 
activity and mRNA expression of OGG1, NUDT1 and HO-1 levels. Twenty-seven male 
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smokers of the 30 enrolled completed the regular-intake study (age 22.1±2.5 y; BMI 
23.0±2.7 kg/m2). Cell protection against H2O2-induced DNA damage was higher after 
broccoli diet with respect to control diet in the whole group of subjects. Folate and 
lutein concentrations increased significantly after broccoli diet. By analyzing data 
considering genotype as independent factor, broccoli intake caused a more consistent 
and significant effect of protection against DNA damage in GSTM1 null (-27.6%) 
compared to GSTM1 positive (-13.1%) subjects (p<0.05). Oxidatively damaged purine 
bases decreased significantly (p<0.05) after broccoli intake (-22.6%), while no effect of 
polymorphism was observed. DNA repair activity and OGG1, HO-1 and NUDT1 
mRNA expression levels did not differ throughout the intervention study. 
Twelve volunteers were selected for the single-meal study. One serving of 250 g of 
steamed broccoli with 70 g of pasta was consumed as first meal. Fasting blood samples 
were collected before broccoli consumption and at 3, 6, 8 and 24 h after broccoli intake. 
Plasma, serum and lymphocytes were separated and stored for specific analyses.  
Cell resistance to oxidative stress (H2O2-induced DNA strands breaks) was determined 
through the COMET assay. Additionally lymphocytes were isolated and appropriately 
stored at -80°C for the subsequent determination of concentration of bioactive 
compounds (folate, lutein, β-carotene and vitamin C) and total GST activity. Total GST 
activity in plasma and lymphocytes was calculated by measuring the conjugation of 1-
chloro-2,4-dinitrobenzene (CDNB) with reduced glutathione, and normalized by the 
amount of proteins found in each sample. All the 12 selected volunteers (age 20.8±1.6 
y; BMI 22.5±2.1 kg/m2) completed the single meal study. Serum folate, plasma vitamin 
C and β-carotene concentrations increased significantly after 3h for the first two, and at 
6h for β-carotene; while antioxidant content in lymphocytes did not show any increase 
after broccoli meal. In general, individuals with positive GSTM1 genotype showed a 
greater plasma and lymphocyte GST activity compared to individuals with GSTM1 
null genotype. After broccoli consumption, plasma GST activity increased significantly 
(p<0.05) in individuals with GSTM1 positive genotype at 6 h with respect to 3 h and 24 
h but not compared to baseline. No significant difference was observed in lymphocyte 
GST activity. A significant reduction of ex-vivo induced DNA damage (p<0.05) after 24 
h from broccoli consumption intake with respect to time 0, 3 and 6 h was observed. 
Broccoli under controlled dietary conditions modulated GST activity even if it seems to 
be more evident in individuals with GSTM1 positive genotype, who showed also a 
greater protection against DNA damage. 
In conclusion, these two studies demonstrated that 10 days of consumption of steamed 
broccoli could improve defence against DNA damage but did not affect repair activity 
in young healthy smokers. Our data are in accordance with shown protective effects of 
cruciferous vegetables, including Brussel sprouts, broccoli and watercress, on 
biomarkers of oxidative damage to DNA in human intervention studies. Also a single 
portion of steamed broccoli was able to decrease DNA damage and to modulate GST 
activity. Even if preliminary, our data suggest a “diet/genetic” interaction. In particular 
we supported the hypothesis that GSTM1 null genotype subjects might have particular 
benefit from regular brassica vegetable intake. 
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Introduction 
As reported in detail in the State of the Art (chapter 1) the onset of several chronic 
diseases is linked to oxidative stress. In fact, oxidative DNA damage formed during 
oxidative stress and DNA repair may mediate several cellular processes, like 
replication and transcription, mutagenesis and apoptosis and thus may be for the 
organism development as well as its pathogenesis, including cancer. Diet seems to 
play a significant role in these mechanisms and the aetiology of several cancers. The 
evidence of the protective role  for diets rich in fruit and vegetable is convincing and, 
associated with an healthy lifestyle, provides low incidence of cancer (WCRF/AICR 
2007). In this regard, a class of specific vegetable food with hypothesized health 
benefits is Cruciferae vegetable. Despite many in vitro and animal studies, only little 
evidence is present in dietary controlled human intervention studies. 
 
Intake and health benefits of Cruciferae 
Specific groups of vegetables seem to offer enhanced sources of protective 
phytochemicals, notably Cruciferae and especially Brassica genus (Moreno et al., 
2006), which contain many putative protective agents. Cruciferae include 20 species in 
the Brassica genus (Table 3.1.1). 
 
Table 3.1.1  Cruciferous vegatables (adapted from Thomson and Green 2003): species and common 
names of different plants 
Genus Species Plant 
Brassica oleracea Broccoli, brussel sprouts, cabbage, savoy cabbage, red cabbage, 
cauliflower, collards, kale, Chinese kale, Italian broccoli, asparagous 
broccoli, sea kale, wild cabbage, kohlrabi 
Brassica rapa Chinese cabbage, celery ,cabbage, spinaci mustard, turnip, turnip tops, 
turnip broccoli, toria 
Brassica napus Rape, colza, Siberian kale, rutabaga 
Brassica japonica wasabi 
Brassica juncea Chinese mustards, mustard greens, curled mustard, pak choi, bok 
celery, brown mustard 
Brassica alba White mustard 
Brassica nigra Black mustard oil, black mustard seeds 
Sisymbrium officinale Hedge mustard 
Nasturtium amoracea Horseradish 
Nasturtium officinale Watercress 
 
Bioactive compounds contained in Brassica include glucosinolates (GLS), phenolic 
compounds and antioxidants such as carotenoids (lutein and β-carotene) and vitamins 
(C, K1 and folate). The single active compounds responsible for chemopreventive 
properties probably do not exist since the protective activity results from the 
synergistic action of many different compounds, but glucosinolates are indeed the 
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most distinguishing compounds of these vegetables, and more than 120 GLS have been 
characterized so far (Halkier & Gershenzon, 2006; Sonderby et al., 2010). 
Table 3.1.2 shows a list of epidemiological studies which pointed out an effect on 
cancer prevention, related to cruciferous vegetables consumption. 
 
Table 3.1.2 Epidemiological studies on cruciferous vegetables consumption 
Cruciferous vegetable Study population References 
Mustard green and Kale Singapore (MacLennan et al., 1977) 
Cabbage, Cauliflower, Rutabaga Norway (Kvale et al., 1983) 
Broccoli Massachusset (Colditz et al., 1985) 
Cruciferous vegetables Greece (Katsouyanni et al., 1986) 
Broccoli Texas (Bond et al., 1987) 
Broccoli Louisiana (Fontham et al., 1988) 
Brassica vegetables Hawaii (Le Marchand et al., 1989) 
Broccoli Hawaii (Goodman et al., 1992) 
Brassica vegetables Shanghai (Zhang et al., 1992) 
Cabbage Japan (Gao et al., 1993) 
Cabbage and Cauliflower India (Sankaranarayanan et al., 1994) 
Brassica vegetables The Netherlands (Voorrips et al., 2000) 
Brassica vegetables USA (Slattery et al., 2000) 
Brassica vegetables Sweden (Terry et al., 2001) 
 
The chemical structure of glucosinolate consists of a β-D-glucopyranose residue linked 
via a sulfur atom to a N-hydroximinosulfate ester, plus a variable R group derived 
from one of eight amino acids (Halkier & Gershenzon, 2006). 
Biosynthesis of glucosinolates in vegetables can be conveniently divided into three 
separate phases (Figure 3.1.1): 
1. certain aliphatic and aromatic amino acids (e.g. methionine and 
phenylalanine for aromatic glucosinolates and tryptophan for indoles) are elongated 
by inserting methylene groups into their side chains; 
2. the amino acid moiety itself, whether elongated or not, is metabolically 
reconfigured to give the core structure of glucosinolates; 
3. the initially formed glucosinolates are modified by various secondary 
transformations which consist in the de-saturation and hydroxylation of the chain 
(Halkier & Gershenzon, 2006). 
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Figure 3.1.1 Biosynthesis of glucosinolates (Fahey et al., 2001) 
 
 
Figure 3.1.2 Formation of isothiocyanates, nitriles and thiocyanates from glucosinolates by 
myrosinase-catalyzed degradation (Thornalley, 2002) 
Glucosinolates are sulfur-rich, anionic natural products that following hydrolysis by 
myrosinases (endogenous thioglucosidases) produce several different products (for 
example isothiocyanates, thiocyanates, and nitriles) (Figure 3.1.2). 
Isothiocyanates are absorbed in the intestinal cells by passive diffusion and 
transported to liver by serum albumine. They are electrophilic and thus react with 
nucleophilic agents including thiols. The main reactive group in the cell is glutathione. 
The reaction between isothiocyanate and glutathione is spontaneous but can also be 
catalyzed by glutathione S-transferase (GST). The first product of this reaction is a 
dithiocarbamate, which can be further metabolized to the cysteine conjugate and then 
N-acetylated to form the corresponding mercapturic acid which is readily excreted in 
urine (Ye et al., 2002). 
Sulforaphane (1-isothiocyanato-4-methylsulfinyl butane) is the major isothiocyanate 
derived from the 4-methylsulfinylbutyl glucosinolate that is accumulated in broccoli 
florets.  
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Table 3.1.3 Mechanisms of chemoprevention associated to isothiocyanates adapted from 
(Fimognari et al., 2008) and (Thomson and Green 2003) 
Chemo-preventive 
mechanism 
Cruciferous/constituent References 
Apoptosis and regulation of 
cell cycle 
Indole-3-carbinol 
Sulforaphane 
(Chung et al., 2000) 
(Chiao et al., 2000) 
Inhibition of phase I enzymes Dithiolthione (Steinkellner et al., 2001) 
 Ascorbigen  
Phenethyliothiocyanate 
(Hecht, 2000) 
Induction of phase II enzymes 
 
Dithiolthione 
Indole-3-carbinol 
Isothiocyanates  
Sulforaphane  
Indole 
(Brooks et al., 2001)  
(Morimitsu et al., 2000) 
(Hecht, 2000) 
(Steinkellner et al., 2001) 
Inhibition of alpha 
hydroxilation of nitrosamine 
Indoles 
Isothiocyanates 
(Steinkellner et al., 2001) 
(Hecht, 2000) 
Radical and electrophil 
scavenging 
Indole-3-carbinol 
Ascorbigen 
(Shertzer & Senft, 2000) 
 
It is a potent inducer of phase II detoxification enzymes, inhibits phase I enzymes and 
can induce cell cycle arrest and apoptosis (Traka et al., 2005). However, there are many 
other natural bioactive constituents which may be responsible of chemopreventive 
mechanisms: indole-3-carbinol, benzyl isothiocyanate and phentyl isothiocyanate 
(Visanji et al., 2004). They have been extensively studied in experimental in vitro and in 
vivo carcinogenesis models. Numerous studies have consistently shown that 
chemoprotective agents influence carcinogenesis during the initiation and promotion 
phases of cancer development. In Table 3.1.3 the mechanisms for chemoprevention by 
constituents of cruciferous vegetables are reported. 
Cancer protective mechanisms of sulforaphane have been widely studied with several 
in vitro studies as reported in Table 3.1.4. 
In recent years, the inverse relationship found between cruciferous vegetable intake 
and cancer risk increased interest among scientists involved in cancer prevention 
studies.  
Dietary or environmental carcinogens must be activated to induce cancer. The ability 
of dietary constituents in cruciferous vegetables to inhibit phase I enzymes activation 
are of primary importance to their cancer chemopreventive effects. The ability of 
cruciferous vegetables to activate phase II drug-metabolizing enzymes was 
demonstrated in 1979. Phase II enzymes decrease carcinogenicity by blocking 
carcinogen metabolic activation and enhancing carcinogen detoxification.  
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Table 3.1.4 Mechanisms of chemoprevention associated to sulforaphane adapted from (Fimognari 
et al., 2008; Jeffery & Keck, 2008) 
Endpoints SF dose (µM) Cancer cell type References 
Induction of phase II 
detoxification 
enzyme 
0.4-0.8 Liver (mouse) (Zhang et al., 1992) 
2-5 Liver (human) (Bacon et al., 2007) 
5-10 Colon (human) (Bacon et al., 2007) 
0.5-5 Prostate (human) (Brooks et al., 2001) 
0.2 Liver (mouse) (Posner et al., 1994) 
Inhibition of histone 
deacetylation 
15 Prostate (human) (Myzak et al., 2006) 
5-25 Breast (human) (Pledgie-Tracy et al., 2007) 
Cell cycle arrest 15 Colon (human) (Gamet-Payrastre et al., 2000) 
25-50 Colon (human) (Jakubikova et al., 2005) 
10-40 Prostate (human) (Herman-Antosiewicz et al., 2007) 
15 Breast (human) (Jackson & Singletary, 2004) 
30 T-cells (human) (Fimognari et al., 2002) 
Apoptosis 15 Colon (human) (Gamet-Payrastre et al., 2000) 
 10-20 Prostate (human) (Choi et al., 2007; Herman-
Antosiewicz et al., 2007) 
 30 T-cells (human) (Fimognari et al., 2002) 
Inhibit cell growth 27 Bladder (human) (Shan et al., 2006) 
 40 Ovarian (human) (Chaudhuri et al., 2007) 
 8-10 Breast (human) (Pledgie-Tracy et al., 2007) 
 15 Breast (human) (Jackson & Singletary, 2004) 
 10-30 T-cells (human) (Fimognari et al., 2002) 
 12 Bladder (human) (Tang et al., 2006) 
 
In Phase I reactions, a small polar group (containing both positive and negative 
charges) is either exposed on the toxicant or added to the toxicant. The three main 
Phase I reactions are oxidation, reduction, and hydrolysis. The most common 
enzymatic process is through the addition of  oxygen catalyzed by cytochrome P450 
enzymes. Some of the intermediates  formed in this process may be elecrophiles, which 
can react with nucleophilic sites in critical macromolecules such as DNA, RNA and 
protein and form a covalent binding product called adducts. DNA adducts that persist 
unrepaired can cause miscoding and thus produce mutations in critical genes.  
A xenobiotic that has undergone a Phase I reaction is now a new intermediate 
metabolite that contains a reactive chemical group, e.g., hydroxyl (-OH), amino (-NH2), 
and carboxyl (-COOH). Many of these intermediate metabolites do not possess 
sufficient hydrophilicity to permit elimination from the body. These metabolites must 
undergo additional biotransformation as a Phase II reaction.  
Phase II reactions are conjugation reactions, that is, a molecule normally present in the 
body is added to the reactive site of the Phase I metabolite. The result is a conjugated 
metabolite that is more water-soluble than the original xenobiotic or Phase I 
metabolite. Usually the Phase II metabolite is quite hydrophilic and can be readily 
eliminated from the body. Some of the Phase II ezymes are quinone reductase, 
glutathione-S-transferase, UDP-glucurunosyl tranferase and sulfotransferase.  
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Blocking carcinogen metabolic activation by Phase I enzymes and enhancing 
carcinogen detoxification by Phase II enzymes are two ways to decrease carcinogenity 
(Fimognari et al., 2008). 
 
Figure 3.1.3 The glutathione-S-transferase supergene family, (adapted from (Strange et al., 2001) 
 On the basis of sequence homology and immunologic cross-reactivity, human cytosolic 
GSTs have been grouped into seven families, designated GST-α, -μ, π, σ, ω, θ, and ζ. 
The GST-μ family is encoded by a 100-kb gene cluster at 1p13.3 arranged as 5′-
GSTM4-GSTM2-GSTM1-GSTM5-GSTM3–3’. Deletion of the GSTM1 gene, 
GSTM1*0, frequently affects both alleles, resulting in the so-called null genotype, 
GSTM1−/− (Roodi et al., 2004). 
 
In recent years, evidence has accumulated to support hypothesis that genetic 
polymorphisms in carcinogen-metabolizing enzymes may be of importance in 
determining individual susceptibility to cancer. The Glutathione S-transferases (GSTs), 
a family of multifunctional enzymes (Figure 3.1.3), metabolize a variety of xenobiotics 
with a large overlap in substrate specificity. Individuals who are homozygous for the 
null GSTM1 or null GSTT1 alleles lack the respective enzyme functions. The null 
GSTM1 genotype appears to be common in both Asians and Caucasians, whereas the 
null GSTT1 genotype exhibits population frequencies that depend on ethnicity. The 
GSTM1 and GSTT1 defects seem to be associated with increased risk of certain cancers; 
however, conflicting data have been observed (Chen et al., 1996; Qiu et al., 2010; Wan et 
al., 2010). This may reflect the fact that certain GSTs may be more efficient in 
detoxifying certain carcinogens, but others may result in a higher risk for some types 
of exposure, which has been especially demonstrated with GSTT1 (Huang et al., 2000; 
Agalliu et al., 2006; Lampe, 2007). 
 
DNA repair and defence systems 
Mammals have five types of DNA repair system (Hoeijmakers, 2001; Larsen et al., 
2005):  
1. Direct reversal (DR) corrects rather than removes damaged DNA bases;  
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2. Base-excision repair (BER) corrects DNA damage caused by reactive oxygen 
species, deamination, and hydroxylation arising from cellular metabolism and 
spontaneous depurination.  
3. Nucleotide-excision repair (NER) removes lesions that distort the structure of 
the DNA helix, such as pyrimidine dimers and DNA adducts.  
4. Recombinational repair (RER). Homologous recombination and non-
homologous endjoining repair double-strand breaks. Homologous 
recombination is used when a second identical DNA copy is available, for 
example after replication; non-homologous end-joining re-links the ‘broken’ 
ends of a double-strand break. 
5. DNA mismatch repair (MMR) detects and repairs copying errors made during 
replication. 
One protective mechanism of action of Brassica vegetables is thought to involve 
reduction of free radical-related molecular damage and this could be particularly 
important in subjects with high exposure to oxidative stress. Cigarette smoke contains 
a large amount of reactive oxygen species (ROS) as well as other substances which 
generate ROS (Frei et al., 1991). ROS can cause oxidative damage to DNA such as 
oxidized bases and strand breaks. These DNA lesions, including the promutagenic 8-
oxo-7,8-dihydro-2’-deoxyguaninosine (8-oxodG) could be implicated in early steps of 
cancer development (Evans et al., 2004; Cooke et al., 2006). Fortunately, mammalian 
cells have a large array of repair systems for the removal of oxidized DNA lesions; the 
most important pathway for oxidized bases is considered to be base excision repair 
(BER), whereas the nucleotide excision repair enzymes most likely functions as a back-
up system. The repair of 8-oxodG by the BER system is initiated by the enzyme 8-
oxoguanine DNA glycosylase (OGG1), which cleaves the N-glycosidic bond leaving 
behind a free base and an AP-site (apurinic/apyrimidinic site), as shown in Figure 3.1.4 
(Moller et al., 2003; Loft & Moller, 2006; Tudek et al., 2006).  
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Figure 3.1.4 OGG1 cleaves the glycosylic bond between 8-oxoG and the deoxyribose, thereby 
releasing the damaged base from DNA. The remaining abasic site is then cleaved 5’ to 
the lesion by an AP endonuclease, APE, also called HAP1, or by the lyase activity of 
OGG1. The dRPase (deoxyribose phosphate lyase) activity of DNA polymerase b 
cleaves 3’ to the lesion, and the missing nucleotide is inserted by DNA polymerase β, 
followed by ligation. Additional repair proteins are involved in this process. 
 
Nucleotide pool modification is an important source of nucleic acids damage. 
Intracellular free nucleotides play essential roles as precursors in the synthesis of DNA 
and RNA, and as molecules for energy storage, cofactors of metabolic pathways and 
regulators of signal transduction. Free nucleotides can, however, undergo various 
chemical modifications by endogenous and exogenous reactive molecules, some of 
which are inevitably produced in living cells (Iyama et al., 2010). 
In the nucleotide pool, dGTP can be oxidized to 8-oxo-2’-deoxyguanosine 5’-
triphosphate (8-oxo-dGTP), which may give rise to 8-oxodG in DNA if the oxidized 
nucleotide is incorporated during replication or repair. 8-OxodGTP is removed from 
the nucleotide pool by the nucleoside diphosphate linked moiety X-type motif 1 
(NUDT1) enzyme (Loft & Moller, 2006), as described in Figure 3.1.5. Misincorporation 
of oxidized nucleoside triphosphates into DNA/RNA during replication and 
transcription can cause mutations that may result in carcinogenesis or 
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neurodegeneration. The protein encoded by this gene is an enzyme that hydrolyzes 
oxidized purine nucleoside triphosphates, such as 8-oxo-dGTP, 8-oxo-dATP, 2-
hydroxy-dATP, and 2-hydroxy rATP, to monophosphates, thereby preventing 
misincorporation. The encoded protein is localized mainly in the cytoplasm, with some 
in the mitochondria, suggesting that it is involved in the sanitization of nucleotide 
pools both for nuclear and mitochondrial genomes. 
 
 
Figure 3.1.5 Oxidation of guanine in DNA and the nucleotide pool with consequences in terms of 
potential mutations as well as the involved repair pathways. NER, nucleotide excision 
repair; TCR, transcription coupled repair. Bold G indicates oxidized guanine (Loft & 
Moller, 2006). 
 
Heme oxigenase-1 (HO-1) is responsible of the degradation of heme to biliverdin and 
is a well known stress response protein inducible  by various agents able to generate 
ROS and thereby causing  oxidative stress (e.g. U.V., X-ray radiation, oxidants such as 
H2O2, heavy metals, pro-inflammatory mediators). OH-1 is found over-expressed  in 
various tissues affected by diseases such as atherosclerosis, hypertension, lung injury 
and cancer. Thus the level of HO-1 mRNA can be considered an important oxidative 
stress response and defence enzyme (Risom et al., 2003). 
 
3.2 Materials and methods 
3.2.1 Characteristics and analyses of the product 
“Marathon” broccoli (Brassica oleracea L. Var italica) was used for this intervention 
study. It was a kind gift from Di Stasi Company, Italy. The company guaranteed that 
the whole amount of vegetables used were from a single batch of production (same 
condition of growth). The vegetables arrived at the DiSTAM laboratory one day after 
the harvest and were immediately processed at the Experimental Institute of 
Agricultural Products and Technologies (IVTPA, Milan). Broccoli florets were handled 
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gently, excised from the main stem, immediately blanched (high temperature steaming 
of vegetables to deactivate enzymes) and, after cooling at room temperature for some 
minutes, frozen at -25°C. Aliquots of broccoli (raw and steamed) were lyophilized and 
finely ground before their analytical characterization. 
Analysis of Carotenoids 
Lyophilized broccoli (50 mg) were extracted at least four times (until colourless) in an 
ultrasonic bath with 5 mL tetrahydrofuran (THF), vortexed for 3 min and centrifuged 
at 1300 x g for 10 minutes. 
The supernatants were combined, dried under nitrogen and stored at -80°C until 
HPLC analysis. The residue was dissolved in 100 µL eluent (MetOH:THF, 95:5) and 
put into dark vials for HPLC analysis. The HPLC system (Waters- Alliance and DAD) 
was equipped with a Vydac 201TP54 (250 x 4.6 mm) column. The elution was carried 
out by linear gradient using MetOT and THF as eluents, the gradient was: MetOH 
100% for 5 min; MetOH:THF (95:5) for 15 min and MetOH:THF (85:15) for 10 min. The 
flow rate was 1.2 mL/min. Lutein, zeaxanthin, β-cryptoxanthin, α-carotene and β-
carotene were acquired at 445 nm wavelenght. Lycopene was acquired at 472 nm. The 
standars were from SIGMA (Taufkirchen, Germany) and Roche (Basel, Switzerland). 
Analysis of Vitamin C 
About 5 g of freshly steamed broccoli ready to eat were gently chopped with a fork, 
and the vitamin quickly stabilized with metaphosphoric acid (MPA 10%) and vortexed 
for about 5 min. The final volume was 50 mL; the supernatant was centrifuged for 5 
min at 2000 x g and immediately injected into HPLC system. Samples were compared 
with an external calibration curve (5-20 µg/mL; 14-114 µmol/L) of ascorbic acid (Sigma) 
freshly prepared with MPA 10%. 
HPLC quantification was performed by injecting 50 µL into the HPLC system: pump 
Waters 510; detector UV-Vis Waters mod 486MS set at 245 nm; column C18 Atlantis 5 
µm 250 x 4.6 mm Waters; eluent 0.1% formic acid flow 1.4 mL/min. 
Analysis of Isothiocyanates (ITCs) derived glucosinolates 
Broccoli samples were analyzed for content in non-indolyl glucosinolates measuring 
related isothiocyanates through the cyclocondensation reaction according to (Conaway 
et al., 2000). Indole glucosinalates were not measured as, with this method, their 
hydrolysis  products decompose spontaneously (Shapiro et al., 1998). 
Samples of lyophilized powder (0.2 g) were weighed in 10 mL glass tubes and 
extracted with 3.5 mL MetOH:water (70:30, v/v). Samples were heated in a heating 
bath at 70°C for 10 min. The mixture was centrifuged (1500 x g; 10 min, 4°C), 
supernatant was removed and pellets were re-extracted twice: the first one with 
MetOH:water 70:30 and the last one with only water. All supernatants were combined 
and made up to a final volume of 10 mL. This extract underwent the 
cyclocondensation reaction and ITCs were quantified after myrosinase treatment. One 
mL of extract was incubated with 1 mL myrosinase (Sigma T4528), 0.35 U/mL in 0.1 
mol/L potassium phosphate buffer pH 6.6 at 37°C for 2 h, 100 µL of mixture were used 
for the cyclocondensation reaction. The cyclocondensation reaction was performed in 5 
mL tubes, 0.1 mL of supernatant was added to 0.4 mL distilled water, 0.5 mL of 100 
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mmol/L potassium phosphate buffer pH 8.5 and 1 mL of 20 nmol/L 1,2 benzenedithiole 
(SIGMA 27086) in acetonitrile; the mixture was incubated for 2 h at 65°C. Once 
derivatized, samples were immediately loaded into an auto-sampler and injected, after 
filtration with 0.45 µm PTFE filters. 1,3 benzenedithiole-2-thione peak was eluted 
isocratically with 80% MetOH and 20% water (flow rate 1.8 mL/min) on a Whatman 
Partisil 10 ODS-2 reverse-phase (4.6 x 250 mm) column equipped with Whatman guard 
cartridges RP. The HPLC system was an Alliance Waters 2996 coupled with DAD 
photodiode array detector 2996; the acquisition was performed at 365 nm wavelenght. 
The peak of 1,3 benzenedithiole-2-thione was identified on the basis of retention time 
and UV spectra. Samples were compared with an external standard curve by using 
concentrations of 100 ng/mL (0.61 µmol/L), 250 ng/mL (1.53 µmol/L), 500 ng/mL (3.06 
µmol/L), 1000 ng/mL (6.13 µmol/L) of PEITC (phenethyl isothiocyanate, Sigma 253731) 
in acetonitrile that was treated with  cyclocondensation reaction as the samples. 
Results were expressed as µmol/L PEITC equivalents. 
 
3.2.2 Regular-intake dietary intervention study 
Subjects 
Healthy males were recruited from the student population of the Università degli 
Studi di Milano and enrolled on the basis of their food habits, evaluated by means of a 
food frequency questionnaire (APPENDIX 3), and GSTM1 genotype. Subjects with 
high (>5 portions/day) or low (<2 portions/day) intake of fruit vegetables and those 
who followed macrobiotic or other alternative diets and who took supplements were 
excluded. Smoker males were included in the study if they smoked more than 10 
cigarettes/day.  The study was proved by the Local Ethical Committee and was in 
accordance with the Declaration of Helsinki. Informed consent was signed by each 
participant, who received a fee for the participation to the intervention study. 
 
Polymorphisms analysis/GSTM1 genotyping 
A PCR method was used to detect the presence or absence of the GSTM1 gene in 
genomic DNA samples obtained from blood samples through DNeasy® Blood and 
Tissue kit (QIAGEN) as reported on handbook. 
Then genomic DNA was amplified in a total reaction volume of 25 µl containing 4 µl of 
DNA, 1,5 mM dNTPs, 1.5 mM MgCl2, 5 pmol of each oligonucleotide primer and 0.12 
µl (5U/µl) TaqGOLD. DNA samples were amplified using the following primers: for 
GSTM1 forward 5’-GGG CTCA AAT ATA CGG TGG A and reverse 5’- GGA GGA 
ACT CCC TGA AAA GC; for albumine forward 5’- AAA GCC AGA GCT GGA AGT 
CA and reverse 5’- CAG CTT TGG GAA ATC TCT GG; with a PCR product of 233 and 
349 bp respectively. 
PCR was performed with: TaqGOLD activation for 5 min at 95°C, the temperature 
profile repeated for the first two cycles was: denaturing 30 sec at 95°C, annealing 15 sec 
at 60°C and extension 30 sec at 72°C; for other 2 cycles: denaturing 30 sec at 95°C, 
annealing 15 sec at 58°C and extension 30 sec at 72°C; for other 2 cycles: denaturing 30 
sec at 95°C, annealing 15 sec at 56°C and extension 30 sec at 72°C; and 29 cycles with 
53 
 
denaturing 30 sec at 95°C, annealing 15 sec at 54°C and extension 30 sec at 72°C; final 
extension for 5 min at 72°C and storage at 4°C. The amplified products were 
electrophoresed through 2% agarose gel and visualized by ethidium bromide staining. 
 
Experimental design 
A single blind randomized cross-over dietary intervention study was scheduled as 
represented in Figure 3.2.2.1. Thirty subjects were randomly divided into two groups 
of 15 subjects each: group 1 was assigned to the sequence broccoli diet/wash-
out/control diet, whereas group 2 followed the sequence control diet/wash-out/broccoli 
diet. In this way each participant was his own control, which excluded confounding by 
factors that are stable within an individual over time but vary among subjects. Broccoli 
and control diet were 10 d long and they were spaced out from a 20 d wash-out period 
between dietary treatments. During the control diet subjects could consume their 
habitual diet avoiding the intake of cruciferous vegetables. A list of not allowed 
vegetables was given and a dietary daily diary was demanded during both the broccoli 
and control diet periods (APPENDIX 3). 
 
  day 0  day 10   day 30   day 40 
Group 1 
(n=15) 
  broccoli diet  wash-out  control diet 
 
  day 0  day 10   day 30   day 40 
Group 2 
(n=15) 
  control diet  wash-out  broccoli diet 
 
Figure 3.2.2.1 Scheme of cross-over dietary intervention trial 
 
Diet 
During the period of supplementation with broccoli, subjects received a daily portion 
(250 g) of “Marathon” broccoli (Brassica oleracea L. var. italica) frozen as previously 
described. During the trial, every day a defined amount of broccoli was steam-cooked 
for 15 min and portioned into appropriate food containers. On Friday subjects were 
given with two portions to eat during the weekend.  
Blood samples 
Blood samples were collected at the beginning and at the end of each treatment period 
(0, 10, 30, 40 d), early in the morning after overnight fasting. Samples were drawn into 
microtubes with heparin as the anticoagulant. Lymphocytes were separated by density 
gradient centrifugation of 100 µL whole blood with Histopaque 1077 (Sigma Chemicals 
Co, St Louis, MO, USA). The lymphocyte layer was removed from the gradient, 
washed with Phosphate Buffer Saline (PBS, Sigma), centrifuged and used immediately 
for the determination of cell resistance to an oxidative stress (H2O2-induced DNA 
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strand breaks). Additional lymphocytes were isolated, diluted into a solution 
containing 50% fetal bovine serum (FBS, Gibco, Gaithersburg, MD, U.S.A.), 40% 
culture medium (RPMI 1640, Gibco) and 10% dimethylsulfoxide (DMSO, Sigma) and 
stored at -80°C for the subsequent determination of: oxidized bases (i.e. 
formamidopyrimidine DNA glycosilase (FPG) sensitive sites), OGG1 DNA repair 
activity and mRNA expression levels of OGG1, HO-1 and NUDT1.  
 
Detection of Biomarkers of Oxidative Stress 
Hydrogen peroxide sensitivity estimation by the Comet assay 
The resistance of lymphocytes to DNA oxidative stress was evaluated by means of the 
Comet assay, already applied in previous studies (Riso et al., 1999; Riso et al., 2004).  
The measurement of H2O2-induced DNA strand breaks is considered to be a biomarker 
of the cellular resistance to oxidative stress because H2O2 generates DNA damage 
through oxidative attack. 
Separated lymphocytes were fixed with agarose on fully frosted slides (Richardson 
Supply Co, London, U.K.). Two slides for each subject were prepared. One slide was 
subjected to a H2O2 treatment (submerging in a solution of H2O2 500 µmol/l in PBS for 
5 min in the dark) while the other one acted as a control (submerging in PBS for 5 min). 
Slides were put in lysis buffer (0.1 M Na2EDTA; 10 mM TRIS; 2.5 M NaCl; 1 % 
sarcosine; pH 10 with NaOH; 1% triton X-100 and 1% DMSO added just before use) for 
1 h at 4°C and then were left for 40 min in electrophoresis buffer alkaline solution (10 
M NaOH, 0.2 M Na2EDTA, pH>13) in a horizontal electrophoresis tank, prior to 
electrophoresis in the same solution at 25 V, 300 mA for 20 min in the dark. Slides were 
successively neutralized to pH 7, stained with ethidium bromide (2 µg/ml), washed in 
PBS, drained, and lastly covered with coverslips. One hundred cells for each slide were 
electronically captured using an epifluorescence microscope (Olympus CX 41, 
Olympus Italia) attached to a high-sensitivity CCD video-camera (CFW 1808M, Scion 
Corporation, Germany) and to a computer provided with an image analysis system 
(Cometa 1.5, Comet Program developed and improved on Image Pro Plus 5.1; 
Immagini e Computer, Bareggio, Milan, Italy). Levels of strand breaks were calculated 
as percentage DNA in tail. For each subject, the percentage DNA in tail of control cells 
(not treated with H2O2, i.e. background strand breaks, SBs in PBS) was subtracted from 
the percentage DNA in tail of treated cells. 
FPG-sensitive sites estimation by the Comet assay 
Detection of oxidative endogenous DNA base damage was performed by means of the 
enzyme FPG, which introduces breaks at sites of oxidized purines such as 8-oxo-2'-
deoxyguanosine (8-oxodG, the major purine oxidation product), as well as other 
altered purines. The European Comet assay Validation Group demonstrated that the 
intra-assay variation of the comet assay is very low and we could detect dose-
dependent increase in FPG sites in coded samples (Forchhammer et al., 2010). 
The concentration of FPG enzyme was selected after a dose-finding test through the 
Comet assay. Cryo-preserved lymphocytes were thawed and washed with fresh RPMI 
and cold PBS and then fixed with agarose on fully frosted slides to perform the Comet 
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assay as above described. After the lysis phase, slides were immersed in Endo Buffer 
(EB, 40 mM HEPES; 0.1 M KCl; 0.5 mM EDTA; 0.2 mg/ml bovine serum albumine 
(BSA); pH 8.0 with KOH, used also for the enzyme dilution) for 5 min for 3 times and 
then added with 50 µL of a diluted solution of FPG (100 ng/mL) or with buffer alone 
(control) and incubated at 37°C for 45 minutes. The FPG enzyme was a gift from Prof 
Andrew Collins (University of Oslo, Norway). FPG added to the DNA in gel converts 
altered purines into DNA breaks (Collins et al., 1996). Alkaline treatment and 
electrophoresis then followed. Net enzyme-sensitive sites, calculated by subtracting % 
DNA in the tail after incubation with buffer alone (EB, background SBs) from the % 
DNA in the tail with enzyme, indicated the extent of base oxidation. 
DNA repair activity  
The DNA repair activity was determined in cryo-preserved lymphocytes. Assessment 
of DNA repair incisions was analysed by a new version of theComet assay as 
described by (Guarnieri et al., 2008). 
The repair activity was measured as the incision activity of substrate DNA treated with 
a photosentisiser/white light, which generates 8-oxoG (Collins et al., 2001a; Collins & 
Horvathova, 2001; Collins, 2004; Guarnieri et al., 2008). Oxidized bases were 
introduced into A549 lung epithelial cells substrate nuclei by irradiating cells with 
white light in PBS solution with 1 µM Ro 19-8022 at 0°C (the photosentisiser was a gift 
from Hoffman-LaRoche, Basel, Switzerland). The cells were washed and re-suspended 
in freezing medium (50% FBS, 40% RPMI 1640 and 10 % DMSO) to a concentration of 
3x106 cells/mL and frozen at –80°C. 
For the preparation of human lymphocytes  extracts, the cryo-preserved cells were 
centrifuged (300 g, 5 min, 4°C), and the pellet was re-suspended in buffer A (45 mM 
HEPES, 0.4 M KCl, 1 mM EDTA, 0.1 mM dithiothreitol, 10% glycerol, pH 7.8) at a 
volume of 20 µL per 106 cells. The re-suspended cells were divided in aliquots of 50 µL 
to which 12 µL 1% Triton X-100 was added. The lysate was centrifuged (700 g, 5 min, 
4°C) and the supernatant was mixed with 200 µL buffer B (40 mM HEPES, 0.1 M KCl, 
0.5 mM Na2EDTA, 0.2 mM BSA, pH 8). Approximately 3x104 substrate cells were 
embedded in agarose and applied on 85×100 mm GelBond® films and lysed as 
described for the Comet assay. After 3 times washing (5 min each) in buffer B, repair 
incisions were detected by incubation of the agarose-embedded nuclei with 60 µL 
lymphocytes extract or buffer B for 20 min at 37°C. The subsequent alkaline treatment 
and electrophoresis were identical to the conditions used to determine DNA damage 
using the Comet assay. An assay control (a sample for FPG sentitive-sites evaluation) 
was included in each electrophoresis run. 
After neutralisation with 0.4 M Tris-HCl (pH 7.5) cells were placed in 96% ethanol for 
1.5h or overnight. Nuclei were visualized as previously described for strand breaks 
and FPG-sensitive sites estimation after staining with 40 µl ethidium bromide (4 
µg/ml) in PBS solution. The repair activity of the lymphocytes extract was determined 
as the difference in %DNA in the tail between parallel gels incubated with extract and 
control solution. 
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Quantification of OGG1, HO-1 and NUDT1 mRNA expression in lymphocytes by real 
time RT-PCR 
Lymphocytes samples were stored in freezing medium as above described. 
Approximately 0.4 µg RNA was used for cDNA synthesis in a reaction volume of 20 
µL using the TaqMan GeneAmp RT-PCR kit as recommended by Applied Biosystems 
(Nærum, Denmark). Quantative PCR reactions were carried out in ABI PRISM 7900HT 
(Applied Biosystems), using primers and cDNA-specific probes purchased from 
Applied Biosystems. We used as the reference gene 18S rRNA, which is commercially 
available as a probe and primer solution (Eukaryotic 18S rRNA Endogenous Control, 
4352930E; Applied Biosystems). Below are probes and primers for the genes. Sequence 
accession ID numbers are from GenBank (http://www.ncbi.nlm.nih. gov/Genbank/; 
accessed 12 February 2007): hHO-1: forward primer: 5´-CAT GAG GAA CTT TCA 
GAA GGG C-3´; reverse primer: GAT GTG GTA CAG GGA GGC CAT-3; TaqMan 
probe: 5´-6-FAM-TGA CCC GAG ACG GCT TCA AGC AGC TG-TAMRA-3´ 
(NM_002133). hOGG1: forward primer: 5´-AAA TTC CAA GGT GTG CGA CTG-3´; 
reverse primer: 5´-GCG ATG TTG TTG TTG GAG GA-3´; TaqMan probe: 5´-6-FAM-
CAA GAC CCC ATC GAA TGC CTT TTC TCT TTTAMRA- 3´ (U96710). hNUDT1: 
forward primer: 5´-CAT CGAGGA TGG GGC TAG -3´; reverse primer: CAG AAG 
ACA TGC ACG TCC ATG A-3´; TaqMan probe: 5´-6-FAM-TCG CCC ACG AAC TCA 
AAC ACG ATC T-TAMRA-3´ (D16581). We performed the PCR reactions in triplicate 
using TaqMan Fast Universal PCR Master Mix (Applied Biosystems) according to the 
manufacturer’s protocol. For the PCR reaction the following protocol was used: 
activation of TAQ polymerase for 20 sec at 95°C, followed by a total of 45 temperature 
cycles for 0.01 sec at 95°C and 20 sec at 60°C. In each run a standard was included and 
verified on the efficiency plot, and the variation coefficients of the repeated 
measurements were 2.98% (Brauner et al., 2007). 
Determination of carotenoids (lutein and β-carotene) in plasma 
Fasting blood samples were drawn into Vacuntainers™ containing heparine as 
anticoagulant. Plasma was obtained by centrifugation at 250 g for 15 min at 4°C. After 
centrifugation the samples were stored at -80°C in aliquots for no longer than 2 
months. Carotenoids were extracted from plasma using the method developed by 
(Porrini et al., 1998). Briefly, the compounds were extracted from 100 µL of plasma 
with hexane after a first step of deproteinization with absolute ethanol containing 
echineone as internal standard. After extraction, the solvent was evaporated under N2 
and samples stored at -80°C until HPLC analysis. HPLC conditions were the same as 
used for the determination of carotenoids in broccoli samples. Recoveries were 
between 80 and 100%; coefficients of variation were lower than 8% for both the 
carotenoids. 
Determination of folate in serum 
Fasting blood samples were drawn into Vacuntainers TM containing silicone. Samples 
were allowed to clot for 30 minutes before centrifugation for 15 min at 250 g at 4°C. 
Serum was immediately moved, aliquoted and stored at -80°C.Analysis of folate in 
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serum was performed using AIA-PACK FOLATE enzyme immunoassay kit (Tosoh 
Bioscience; Inc; Grova City U.S.A.). 
 
Statistical analysis 
An analysis of variance (ANOVA) with sequence (broccoli intake vs control diet or vice 
versa) as independent factor was used in order to evaluate the presence of a carry-over 
effect. As it was not detected (always p>0.05), data from the two groups of subjects 
were consider independently from the sequence of treatment and analyzed together 
using ANOVA for repeated-measure design. This analysis with type of treatment and 
time as independent factors was used to investigate the effect of broccoli consumption 
on: cell resistance against induced DNA oxidative stress, levels of FPG-sensitive sites, 
OGG1 DNA repair activity, OGG1, HO-1 and NUDT1 mRNA expressions. 
Data were also stratified by considering polymorphisms in GSTM1 gene as 
independent factor to evaluate the genetic susceptibility of these variables. 
Post-hoc analyses of differences between mean values of treatments or genotypes were 
further assessed by Fisher Least Significant Difference (LSD) test. Differences were 
considered significant at p<0.05. Regression analysis was applied to verify correlation 
between % changes in plasma carotenoids and serum folate concentrations registered 
in the four points of experimentation and the % changes in the end point of DNA 
damage considered. Statistical analyses were performed by means of STATISTICA 5.0 
software (Statsoft Inc, Tulsa, OK). 
 
3.2.3 Single-meal study 
Experimental design 
Twelve volunteers were selected for the “single-meal” study. Volunteers were divided 
into 4 groups of 3 subjects. Each group was analyzed the same day, as reported in 
Figure 3.2.1.1. 
 
t=0 broccoli  3h 6h 8h   24h 
  meal   
 
 
Figure 3.2.3.1 Scheme of single-meal intervention study for each group of 3 subjects. 
 
Diet 
For the experimentation “Marathon” broccoli (Brassica oleracea L. var. italica)  were 
steamed under standardized condition (10 min), portioned and served to the 
volunteers, together with 70 g pasta (“Penne Rigate”, Barilla, Foggia, Italy). One 
serving was consumed as first meal at 9.30 in the morning. 
Throughout the experimental period, subjects were instructed to observe some rules 
and to avoid smoking 30 min before blood collection. 
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Blood samples 
Fasting blood samples were collected before broccoli and pasta consumption and then 
at 3, 6, 8 and 24h after broccoli intake in VacuntainersTM containing heparine as 
anticoagulant. Lymphocytes were isolated as described in paragraph 3.2.2 for detection 
of Oxidative DNA damage with the Comet assay. Additional lymphocytes samples 
were stored at -80°C in PBS and used for GST activity quantification after three cycles 
of freezing/thawing. Plasma was obtained by centrifugation at 250 x g for 15 minutes at 
4°C of whole blood samples. After centrifugation the samples were stored at -80°C in 
aliquots for no longer than 2 months. 
Determination of carotenoids (lutein and β-carotene) in plasma and folate in serum 
As reported for “regular-intake” intervention trial. 
Determination of vitamin C in plasma and lymphocytes 
One hundred microliter MPA (10%) solution were added to 100 µL plasma in 
duplicate; the samples were vortexed, centrifuged at 2200 x g for 2 minutes in order to 
separate the supernatant and injected. Lymphocyte pellets were suspended in 150 µL 
PBS. From each sample four aliquots were obtained. Two aliquots of 40 µL were added 
with 40 µL MPA (10%) solution and vortexed, while two aliquots of 35 µL were used 
for protein quantification. All the samples were kept at -80°C until HPLC analysis. 
Vitamin C concentrations in lymphocytes were expressed adjusting the results for 
protein concentrations. Then the prepared samples were injected as reported for the 
analysis of vitamin C in broccoli (paragraph 3.2.1). 
Detection of Oxidative DNA damage in lymphocytes with the Comet assay 
Hydrogen peroxide sensitivity estimation was performed on freshly lymphocytes as 
described in paragraph 3.2.2 for “regular-intake” study. 
GST activity in plasma and lymphocytes 
Plasma and lymphocytes were separated as previously described for the “regular-
intake” study.  
GST analysis was performed by TECAN spectrophotometer Infinite F200 a microplate 
reader and a 96-well plate (Greiner 96 wells, crystal clear, 500x346x176mm). 
Total GST activity in plasma and lymphocyte was calculated by measuring the 
conjugation of 1-chloro-2.4-dinitrobenzene (CDNB) with reduced glutathione. The 
reaction is accompanied by an increase of absorbance at 340nm. CDNB solution (20 
mM CDNB in EtOH 95%) and GSH solution (20 mM GSH distilled water)were diluited 
1:16 with buffer solution (0.1 M KH2PO4, 1mM EDTA in distilled water; pH 6.5). In 
each well 88 µL CDNB and 88 µL GSH solutions were gently mixed and added with 50 
µL of plasma or lymphocytes samples or buffer solution. Reaction was monitored for 5 
min at 340 nm. GST activity obtained was standardized to mg protein plasma or 
lymphocytes content.  
Protein quantification 
Proteins were analyzed by BCA™ Protein Assay Kit (Pierce, rockford, IL). The assay is 
a detergent-compatible formulation based on bicinchoninic acid (BCA) for the 
colorimetric detection and quantification of total protein. This method combined the 
well-known reduction of Cu+2 to Cu+1 by protein in alkaline medium with the highly 
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sensitive and selective colorimetric detection of the cuprous cation (Cu+1) using a 
reagent containing BCA. 
Statistical analysis 
An analysis of variance (ANOVA) was performed with time as independent factor was 
used to investigate the effect of broccoli consumption on: cell resistance against 
induced DNA oxidative stress, GST activity, antioxidant compound concentrations. 
Data were also stratified by considering polymorphisms in GSTM1 gene as 
independent factor to evaluate the genetic susceptibility of these variables. 
Post-hoc analyses of differences between mean values of treatments or genotypes were 
further assessed by Fisher Least Significant Difference (LSD) test. Differences were 
considered significant at p<0.05. Statistical analyses were performed by means of 
STATISTICA 5.0 software (Statsoft Inc, Tulsa, OK). 
3.3 Results and discussion TOPIC I 
3.3.1 Characteristic and analysis of the product 
In table 3.3.1.1 the content of vitamins and protective compounds in steamed broccoli 
are summarized. We chose the portion of 250 g of broccoli after the quantification of 
glucosinolates as non-indolyl ITCs to provide 160 µmol of ITCs. One serving of 
steamed broccoli provided very low amount of carotenoids in particular lutein and 
beta-carotene, high amount of vitamin C (three time the italian raccomanded daily 
intake) and a discreet amount of isothiocyanates by considering data in literature (200 
µmol). 
Table 3.3.1.1 Lutein, β-carotene, vitamin C and isothyocianates content in one portion of steamed 
broccoli (mean ± SD). (*) Data are expressed as μmol PEITC (phenethyl 
isothiocyanate) equivalents. 
Steamed broccoli mg/portion 
Lutein 2.75±0.10 
β-Carotene 1.50±0.03 
Vitamin C 172.00±3.25 
Isothiocyanates 160.00±0.05* 
 
3.3.2 Regular-intake dietary intervention study 
Characteristics of subjects 
Twenty-seven male smokers of the 30 enrolled completed the “regular-intake” study 
(age 22.1±2.5 y; BMI 23.0±2.7 kg/m2); while 3 volunteers dropped out during the 
experimental period. Fourteen were GSTM1 positive and 13 were GSTM1 null 
genotype (Figure 3.3.2.1). 
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Figure 3.3.2.1  Example of image of gel electrophoresis of PCR for GSTM1 determination.  
M: DNA molecular marker 
Number of subjects 
b: blank, no template sample 
 
No side effects were observed in the whole group of subjects. 
In table 3.3.2.2 characteristic of subjects at recruitment are summarized. 
 
Table 3.3.2.2 Characteristics of subjects at recruitment (mean value ± SD) 
Characteristics Number of subjects Results 
Age (years) 27 22.1±2.5 
BMI (kg*m-2) 27 23.0±2.7 
H2O2- induced DNA strand breaks (% DNA in tail) 27 62.9±8.8 
Oxidized purines (% DNA in tail) 19 14.0±6.3 
OGG1 repair activity 11 1.9±2.3 
NUDT1/18S mRNA (*10-6) 17 0.5±1.3 
OGG1/18S mRNA (*10-6) 17 4.6±5.8 
HO-1/18S mRNA (*10-5) 17 1.6±3.0 
BMI: body max index; 
NUDT1: human nucleoside diphosphate linked moiety X-type motif 1; 
OGG1: human 7,8-dihydro-8-oxoguanine-DNA glycosilase; 
HO-1: human heme oxigenase 1; 
18S: reference gene 18S rRNA. 
 
Oxidative lymphocyte DNA damage 
The level of H2O2-induced DNA strand breaks in lymphocytes decreased by 23% [95% 
CI: +13%, +34%] in the period of broccoli intake as compared to the control diet. This 
difference was driven by a reduction in the level of H2O2-induced DNA strand breaks 
after the broccoli intake period (-22%, [95% CI: -13%, -31%]), whereas no difference 
was detected after the control diet. (-0.4%, [95% CI: -10%, +9.4%]). The levels of FPG-
sensitive sites and H2O2-induced strand breaks are reported in Table 3.2.4.3. The 
subjects had 41% [95% CI: +10%, +72%] lower level of FPG-sensitive sites after 10 days 
of broccoli consumption with respect to the control diet. The difference was driven by 
decreased level of FPG sites in the period of broccoli intake (-34%, [95% CI: -53%, 
ALBUMIN  
349 bp 
GSTM1  
233 bp 
M 32 37 38 39 40 41 42 43 44 45 46 b 
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+15%]); whereas it was unaltered during the control diet period (+4%, [95% CI: -20%, 
+28%]). Analysis of effect-modification by the GSTM1 genotype revealed significant 
single-factor effects of the genotype (p<0.05) and diet (p<0.01) on H2O2-induced DNA 
strand breaks, whereas the interaction was not statistically significant (p>0.05). The 
subjects with GSTM1 null genotype had higher baseline levels of H2O2-induced strand 
breaks (Table 3.3.2.3), however at the end of the 10 days broccoli diet there was no 
difference in the resistance to ex vivo generation of strand breaks depending on the 
genotype. Consequently, the effect on resistance towards ex vivo generation of strand 
breaks following broccoli intake (% changes) was most pronounced in GSTM1 null 
subjects (-27%, [95% CI: -37.9%, -17.4%]), whereas the subjects with GSTM1 positive 
genotype had lower effect on the level of resistance (-13%, [95% CI: -27.3%, +1.1%]).  
 
Table 3.3.2.3 Results of “regular intake” study (Mean value±SD). 
 Bbd Abd Bcd Acd 
Background SBs in PBS (% DNA in tail) 
All subjects (n=27) 
 
7.5±2.6 
 
7.7±2.3 
 
7.4±2.8 
 
7.4±2.6 
H2O2-induced DNA SBs (% DNA in tail)     
All subjects (n=27) 61.4±11.1 47.9±11.4c 55.4±13.3 55.2±9.6 
GSTM1 positive (n=14) 57.6±11.8 48.8±12.1a 52.4±12.7 54.0±9.4 
GSTM1null (n=13) 65.4±9.1 46.9±11.1c 58.7±13.7 56.5±10.1 
Background SBs in EB (% DNA in tail) 
All subjects (n=19) 
 
23.0±8.0 
 
21.3±6.5 
 
21.8±8.8 
 
19.8±8.0 
Oxidized purines (%DNA in tail)     
All subjects (n=19) 16.5±7.7 11.0±5.4b 13.2±9.8 13.8±7.5 
GSTM1 positive (n=9) 17.3±7.2 11.1±5.2a 17.1±12.0 16.1±9.4 
GSTM1 null (n=10) 15.9±8.4 10.9±5.9a 9.8±6.0 11.6±4.8 
DNA repair activity (%DNA in tail)     
All subjects (n=11) 3.7±3.0 3.6±2.5 3.0±3.0 4.4±3.1 
OGG1/18S mRNA (*10-6)     
All subjects (n=17) 6.4±12.4 5.4±6.3 4.2±3.9 6.2±5.5 
HO-1/18S mRNA (*10-5)     
All subjects (n=17) 3.3±9.0 2.2±4.5 1.5±2.7 1.8±1.6 
NUDT1/18S mRNA (*10-6)     
All subjects (n=17) 1.6±5.5 0.8±2.0 0.6±1.3 0.5±0.7 
Bbd: before broccoli diet, Abd: after broccoli diet, Bcd: before control diet, Acd: after control diet. 
SBs: DNA strand breaks. NUDT1: human nucleoside diphosphate linked moiety X-type motif 1; OGG1: human 7,8-
dihydro-8-oxoguanine-DNA glycosilase; HO-1: human heme oxigenase 1; 18S: reference gene 18S rRNA. 
Significant difference between “before” and “after” each treatment: a: p<0.05; b: p<0.005; c: p<0.001. 
 
In contrast, the effect of broccoli consumption on the level of FPG sensitive sites was 
not statistically related to GSTM1 polymorphism. DNA repair activity was analyzed 
on lymphocyte samples of 11 subjects (with 7 GSTM1 positive and 4 GSTM1 null 
genotypes): it did not differ throughout the intervention study. OGG1, HO-1 and 
NUDT1 mRNA expression evaluated on 17 samples (with 8 GSTM1 positive and 9 
GSTM1null genotypes) were not significantly modulated (Table 3.3.2.3). 
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Carotenoids and folate concentrations in blood 
The circulating levels of folate and lutein significantly increased after broccoli 
consumption (+17.1% and +39.3% respectively), while no significant effect on  β-
carotene concentration was observed (Table 3.3.2.4). 
Regression analysis showed an inverse and significant correlation between changes in 
serum folate concentrations and changes in H2O2-induced strand breaks (R2=0.23; 
p<0.001).  
 
Table 3.3.2.4 Concentrations of folate (in serum), lutein and β -carotene (in plasma) before and after 
broccoli and control diet. Data are expressed as mean value ±SD. 
Bbd: before broccoli diet, Abd: after broccoli diet, Bcd: before control diet, Acd: after control diet. 
Significant difference between “before” and “after” each treatment: * p <0.001; ** p <0.01. 
 
3.3.2.1 Discussion of regular-intake study 
The present dietary intervention study showed that 10 days of consumption  of 
steamed broccoli (200g/day) by young smokers decreased the level of endogenous 
oxidized DNA bases and H2O2-induced DNA strand breaks in lymphocytes. Whereas, 
OGG1 repair activity and mRNA expression levels of OGG1, NUDT1 and HO-1 in the 
same cells were unaltered, at least in the sub-sample of data analyzed. Moreover 
broccoli diet induced also an increase in folate and lutein concentrations in blood. 
These data are in accordance with the fairly consistently shown protective effects of 
cruciferous vegetables, including Brussels sprouts, broccoli and watercress, on 
biomarkers of oxidative damage to DNA in human intervention studies (Verhagen et 
al., 1995; Verhagen et al., 1997; Gill et al., 2004; Murashima et al., 2004; Gill et al., 2007; 
Hoelzl et al., 2008; Riso et al., 2009b). 
Verhagen and colleagues investigated on the effect of consumption of 300g/day of 
Brussel sprouts in non-smokers healthy volunteers measuring 8-oxodG in 24h urine 
after 3 weeks in the first study and 1 week in the second one of intake.  They found a 
decrease of 28% in urine 8-oxodG in the first study performed on male subjects 
(Verhagen et al., 1995); and in the following trial the same effect was determined only 
in the male volunteers and not in females (Verhagen et al., 1997). Gill et al (2004) 
designed a dietary intervention trial where 18 subjects (male and female, non-smokers, 
subdivided into the control and treatment groups) consumed 113g of Crouciferous and 
Leguminous Sprouts (CLSs, composed of equal mix of sprouts of broccoli, radish, 
alphaaplha and clover) daily for 14 days. A significant anti-genotoxic effect against 
H2O2-induced DNA damage was shown in peripheral blood lymphocytes of the 
supplemented diet group respect to the control group; whereas no significant 
 Bbd Abd Bcd Acd 
Folate (nmol/L) (n=27) 11.3±3.9 13.2±3.3** 12.0±5.9 12.1±4.7 
Lutein (µmol/L) (n=27) 0.31±0.13 0.43±0.21* 0.30±0.14 0.29±0.13 
β-carotene (µmol/L) (n=27) 0.28±0.25 0.31±0.22 0.28±0.24 0.29±0.29 
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induction in detoxifying enzymes (GST, GPX and SOD) was observed during the 
study, neither plasma antioxidant levels or activity were altered (Gill et al., 2004).  
Murashima and colleagues the same year investigated the effect of broccoli sprouts on 
the induction of various biochemical oxidative stress markers. Twelve healthy subjects 
(6 males and 6 females) consumed fresh broccoli sprouts (100 g/day) for 1 week. With 
treatment, total cholesterol and LDL cholesterol decreased, and HDL cholesterol 
increased significantly. Plasma cystine decreased significantly. All subjects showed 
reduced serum phosphatidylcholine hydroperoxide, urinary 8-isoprostane and 8-
oxodG, and increased serum coenzyme CoQ(10)H(2)/CoQ(10) ratio (Murashima et al., 
2004). In a more recent intervention trial, Hoezl and colleagues (2008) found a 
protective effect of Brussel sprouts consumption (300g/day for 6 days) on peripheral 
human lymphocytes against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) 
and oxidative DNA-damage (measured as H(2)O(2)-induced DNA strand breaks and 
FPG and EndoIII sensitive sites) (Hoelzl et al., 2008).  
Such effects may be particularly important in subjects exposed to high levels of ROS, 
e.g. from cigarette smoke. Moreover smoking is strongly associated with lung cancer 
risk and smokers tend to consume fewer vegetables and fruits than non-smokers 
(Subar et al., 1990; McPhillips et al., 1994; Cranganu & Camporeale, 2009). Tang and 
colleagues (2010) observed significant linear inverse associations between intake of 
fruits, total vegetables, and cruciferous vegetables and risk of lung cancer in a case-
control study conducted in the US. Increasing cruciferous vegetable intake was 
significantly associated with reduction of lung cancer risk among smokers. The 
authors concluded that a diet high in cruciferous vegetables, particularly when 
consumed as raw, may reduce the risk of lung cancer among smokers (Tang et al., 
2010). Similar results were found recently by Lam and colleagues (2010) with a nested 
case-control study matched on cigarette smoking. The authors found an inverse 
association between cruciferous vegetables intake and lung cancer risk more 
significant for former and current smokers (Lam et al., 2010), confirming results of a 
previous systematic review (Lam et al., 2009).  
Indeed, moving to dietary intervention trials, Gill et al (2007) showed that smokers had 
larger reduction in basal and H2O2-induced DNA strand breaks in lymphocytes than 
non-smokers following an intervention with 85 g of raw watercress daily for 8 weeks 
(30 smokers and 30 non-smokers) (Gill et al., 2007). Similarly, Riso and colleagues 
(2009) found that FPG sites in lymphocytes decreased only in smokers, whereas the 
level of H2O2-induced DNA strand breaks decreased significantly both in smokers 
(n=10) and non-smokers (n=10) consuming 200 g of broccoli daily for 10 days (Riso et 
al., 2009b).  
A lowered level of FPG-sensitive sites in lymphocytes can in principle be caused by a 
decreased rate of guanine oxidation in DNA or in the nucleotide pool or an increased 
rate of repair (Loft & Moller, 2006). It has previously been observed that consumption 
of kiwi fruits increased the DNA repair activity and lowered the level of FPG sites in 
lymphocytes (Collins et al., 2003). In addition, Guarnieri et al (2008) investigated the 
repair activity towards oxidized DNA in human mononuclear blood cells in two 
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placebo-controlled antioxidant intervention studies, one with well-nourished subjects 
who consumed 600g/day of fruits and vegetables or tablets containing the same 
amount of vitamins and minerals for 24 days and another one with poorly nourished 
male smokers who consumed 500 mg/day vitamin C as slow- or plain- release 
formulations together with 182 mg/day vitamin E for 4 weeks (Guarnieri et al., 2008). 
Only male smokers supplemented with slow-release vitamin C tablets had increased 
DNA repair activity by about 27%, while there was no significant change in subjects 
supplemented with tablets with plain-release formulation of vitamin C and in subjects 
who consumed fruits and vegetables. In the present study, with a reduced level of FPG 
sites after broccoli intake no change in repair activity towards oxidatively damaged 
guanine in DNA in extracts from the same pool of lymphocytes was found. Similarly, 
there was no change in the mRNA expression of OGG1 and NUDT1 levels, the 
protein of which is responsible for repair of oxidised guanine in DNA and the 
nucleotide pool, respectively. A possible limitation of the present study is the number 
of missing data (due to samples storage problems) in the analysis of DNA repair 
activity and the mRNA expression. Still, it should be emphasized that neither the 
OGG1 expression nor the repair activity pointed in the direction of increased level after 
broccoli intake, indicating that we would not find beneficial effects with even a 
substantially larger number of subjects in the study. 
An increased resistance toward H2O2–induced DNA strand breaks was detected in 
lymphocytes. Thus, these data point mainly to increased resistance to oxidative stress 
in lymphocytes after a broccoli rich diet. This phenomena induced by cruciferous 
vegetables could be related to up-regulation of antioxidant, phase II and other 
defence enzymes and/or increased levels of scavengers of ROS. No change in the 
expression of HO-1 was found; HO-1 is highly susceptible to oxidative stress and also 
a part of the nrf2- dependent gene battery of phase II enzymes frequently ascribed 
protective effects of cruciferous vegetables (AICR 2004). Moreover, in a previous study 
with a similar broccoli intervention no modulation of GST activity in plasma was 
detected (Riso et al., 2009a). Similarly, in the watercress consumption study described 
above by Gill et al (2007) no change in mRNA levels of CAT, GPX1, GSTA4, GSTP1, 
SOD2 or UGT1A1 was found in lymphocytes despite considerable decreases in basal 
and oxidatively induced DNA damage (Hofmann et al., 2009). In the same study the 
activity of SOD and GPX in red cells was not significantly changed overall, although 
there seemed to be an increase among subjects with the GSTM1 null genotype 
(Hofmann et al., 2009). In another study, the activity of SOD and GPX were unchanged 
after Brussels sprouts intake despite reduction of oxidatively induced DNA damage in 
lymphocytes as previously reported (Hoelzl et al., 2008). Moreover, in a 3-phase 
crossover dietary intervention trial (standard broccoli, high glucosinolate broccoli, and 
water), the intake of standard broccoli changed the expression of only one gene tested 
in a very large battery of xenobiotic metabolism genes, through microarray and real-
time RT-PCR analyses, in gastric mucosal tissue 6h after the consumption. On the 
contrary, high glucosinolate broccoli up-regulated the expression of more and different 
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genes, including thioredoxin reductase, aldoketoreductases, and glutamate cysteine 
ligase modifier subunit (Gasper et al., 2007).  
In the present study differences in the level of background DNA strand breaks after 
the broccoli supplementation were not detected. This is in keeping with the conclusion 
from a literature review showing that only very few publications have reported effect 
on background DNA strand breaks in leukocytes (or subsets of leukocytes such as 
lymphocytes or mononuclear blood cells), whereas there is a larger proportion of 
publications that have reported an effect of antioxidant supplementation in terms of 
FPG sensitive sites or 8-oxodG in leukocytes (Moller & Loft, 2006). The null effect in 
terms of background DNA strand breaks in this study is further strengthened by the 
fact that it was determined in both the analyses of H2O2-sensitivity (with PBS) and FPG 
sensitive sites (with Endo Buffer, EB). The level of background DNA strand breaks 
analyzed was higher in the estimation of oxidized purines than the analysis of H2O2-
sensitivity. The difference in the level of DNA strand breaks between the two 
measurements may be due to methodological differences because the determination of 
H2O2-induced strand breaks was carried out on fresh lymphocytes separated from 
blood samples, whereas the level of FPG-sensitive sites was determined on 
cryopreserved samples. It should be noted that the higher level of strand breaks in the 
determination of FPG sensitive sites does not affect the validity of the analysis of 
oxidatively damaged DNA. In fact the level of FPG-sensitive sites measured is similar 
to the levels reported in other studies (Moller, 2006). However, inter-individual and 
intra-individual variation in the levels of oxidized purines and sensitivity to H2O2-
induced DNA strand breaks were observed. In addition, there is large effect of broccoli 
intake in some subjects, whereas other subjects appear to have no benefit. We cannot 
determine whether this heterogeneity is because some subjects are non-responders, 
since this trait would only be revealed if the person participated in several 
independent intervention trials. Nevertheless, it should be emphasized that this cross-
over study was not completely controlled in regard to habits of the subjects. 
Environmental and occupational exposures could affect the level of DNA damage and 
sensitivity to H2O2-induced DNA strand breaks, such as sunlight, air pollution, 
exhaustive exercise or therapeutics (Moller et al., 2000). In addition, it is also possible 
that some subjects entering a trial on beneficial effects of dietary products change 
toward a healthier lifestyle. In the present study this might be displayed as decreased 
levels of FPG-sites and increased resistance toward H2O2-induced DNA strand breaks. 
Still, the reduction of DNA damage, as found in this study, may be due to direct or 
indirect antioxidant scavenger functions of compounds in cruciferous vegetables, 
including vitamin C, carotenoids, polyphenols, folates and/or some ICTs. Indeed, the 
previous intervention trial (Riso et al., 2009a) showed that the broccoli consumption 
regime used in the present study increased the plasma concentrations of lutein and β-
carotene in smokers respectively by about 45% and 33% as well as folate (about 16%) 
and non-indolyl ITCs (about 86%). The present study confirmed an increase of folate 
and lutein concentrations after broccoli diet, while, differently from the previous 
study, β-carotene levels were not significantly increased after the intervention 
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(probably because of the higher individual variability). A significant inverse 
correlation between the % changes in folate levels and those of H2O2-induced DNA 
damage was detected; this finding supported the contribution of the vitamin to the 
DNA protection against ex-vivo induced damage and/or repair. Despite the lack of 
correlation for single carotenoids a role of carotenoids in the DNA protection was not 
excluded because the effect of these antioxidants might depend on the synergy of 
multiple bioactive substances contained in whole food rather than single compounds.  
The broccoli used in the present study had lower concentration of ITCs compared to 
the broccoli used the previous study (about 160 µmol vs. 200 µmol ITCs per portion 
provided), whereas there was the same level of protection against ex vivo generation 
of DNA strand breaks and endogenous levels of FPG-sites in lymphocytes from 
smokers (Riso et al., 2009b). Thus the mechanisms for reduction of oxidative damage to 
DNA do not seem to involve specifically the ITCs with enzyme inducing properties. 
This further supports the notion that whole foods can exert a protective effect in virtue 
of the numerous compounds present able to act in synergy.  
Data from epidemiological studies show that selected sub-groups of population have 
more evident protective effect by the consumption of Brassica gender vegetables. In 
particular GST genetic polymorphysms seem to play an important role at this regard. 
Some cross-sectional studies on air pollution exposure and diet do suggest that 
subjects with the GSTM1 null and positive genotype differ in respect to levels and 
response of FPG-sensitive sites and H2O2-induced strand breaks in leukocytes 
(Dusinska et al., 2001; Avogbe et al., 2005; Dusinska & Collins, 2008).  
However, in intervention trials, the relationship between GST genetic polymorphysms 
and the protective role of Brassica gender vegetables is more difficult to evaluate. 
A review by Steck & Herbert (2009), summarizes the results of feeding studies in 
humans that examine effects of polymorphisms in GSTs on ITC metabolite excretion, 
evaluates the evidence for modulation of Heterocyclic aromatic amines (HAA) 
mutagenicity by ITCs, and discusses the need for feeding studies examining potential 
interactions among polymorphic genes encoding phase I and phase II metabolizing 
enzymes, meat intake, and Brassica intake to elucidate their role in cancer etiology 
(Steck & Hebert, 2009). 
We registered a higher baseline level of DNA SBs in GSTM1 null genotype subjects 
respect to the positive ones. The GSTM1 null genotype individuals may have a lower 
cell protection against oxidative stress and a lower ability to detoxify xenobiotics. Since 
GST is involved in the biotrasformation of tobacco smoke carcinogens, such as 
polycyclic aromatic hydrocarbons, individuals that lack some of the enzyme isoforms 
and are subjected to smoke oxidative stress may have an increased risk of developing 
cancer. In this study broccoli consumption induced an increased resistance to H2O2–
induced DNA strand breaks in GSTM1 null subjects as compared to the positive ones.  
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3.3.3 Single-meal study 
Characteristics of subjects 
All the 12 selected volunteers completed the study, in Table 3.3.3.1 the characteristics 
of subjects at recruitment were summarized. Six were GSTM1 positive and 6 were 
GSTM1 null genotype. Results were analyzed in 9 subjects (4 GSTM1 positive 
genotype and 5 GSTM1 null genotype) because data of 3 subjects were outliers 
possibly due to analytical problems. 
 
Table 3.3.3.1 Characteristics of subjects at recruitment (mean ± SD) 
Characteristics Results 
Age (years) 20.8±1.6 
BMI (kg*m-2) 22.5±2.1 
H2O2-induced strand breaks (% DNA in tail) 53.3±9.3 
GST activity in lymphocytes (nmol/min/mg*pr) 39.7±11.4 
GST activity in plasma (pmol/min/mg*pr) 65.7±19.3 
BMI: body max index 
 
Carotenoids, folate and vitamin C levels 
Plasma carotenoid concentrations measured at baseline and up to 24 h after 
consumption of broccoli (Table 3.3.3.2). Plasma lutein did not change along the time 
after broccoli consumption. Only slight modification for β-carotene was detected. In 
particular despite the low concentration provided by the portion of broccoli, β-
carotene increased significantly (p<0.05) at 6h by about 0.04 µmol/L (+11%) respect to 
baseline, after its intake. Lymphocyte carotenoid concentrations measured from 
baseline and up to 24 h after consumption of broccoli meal, are represented in table 
3.3.3.2: no significant difference was found at any time considered. 
Plasma and lymphocyte vitamin C concentrations measured at baseline and up to 24 h 
after the consumption of broccoli, are represented in table 3.2.4.6. Plasma vitamin C 
concentrations increased significantly (p<0.0001) 3h after broccoli consumption by 
about 21.6 µmol/L (+35%). The increase was also present at 6 and 24 h with respect to 
baseline (p<0.001). The average increase corresponded to about 17.7 µmol/L (+28.6%) 
and 5.2 µmol/L (+8.5%) respectively. Vitamin C concentrations did not increase in 
lymphocytes following the broccoli intake. 
Serum folate concentrations measured at baseline and up to 24 h after consumption of 
broccoli, are represented in table 3.2.4.6. Folate concentrations increased significantly 
(p<0.0001) 3 h after broccoli intake by about 8.3 nmol/L (+70%). The increase was also 
significantly different (p<0.05) after 6 h and 24h respect to baseline 4.8 nmol/L (+41%) 
and 1.1 nmol/L (+9.6%) respectively. 
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Table 3.3.3.2 Carotenoids, vitamin C, folate levels in plasma, lymphocytes and serum samples (mean 
± SD). Data with different letters are significantly different (p<0.05) on the same row. 
Time  0 3 h 6 h 24 h 
β-carotene in plasma (µmol/L) 0.38 ± 0.20ab 0.39 ± 0.22ac 0.41 ± 028bc 0.40 ± 0.22ac 
Lutein in plasma (µmol/L) 0.40 ± 0.16 0.39 ± 0.13 0.38 ± 0.13 0.41 ± 0.11 
β-carotene in lymphocytes (nmol*mg p) 0.08 ± 0.05 0.06 ± 0.04 0.07 ± 0.04 0.07 ± 0.04 
Lutein in lymphocytes (nmol*mg p) 0.14 ± 0.04 0.12 ± 0.05 0.12 ± 0.05 0.12 ± 0.05 
Vitamin C in plasma (µmol/L) 61.7± 19.5a 83.3 ± 20.6b 79.4 ± 21.5c 66.9 ± 18.1d 
Vitamin C in lymphocytes (nmol*mg p) 17.5 ± 2.2 15.2 ± 2.9 16.6 ± 3.8 17.5 ± 3.8 
Folate in serum (nmol/L) 11.8 ± 3.6a 20.1 ± 4.2b 16.7 ± 4.2c 13.0 ± 4.3d 
  
Oxidative lymphocyte DNA damage 
A significant reduction of ex-vivo induced DNA damage (p<0.05) after 24 h from 
broccoli consumption intake with respect to time 0, 3 and 6 h was observed.  
One-way ANOVA showed a significant reduction of ex-vivo induced DNA damage 
(p<0.05) after 24 h from broccoli consumption intake with respect to 0 h, 3 h and 6 h.  
A further analysis by considering the different GST polymorphism as independent 
factor, showed that individuals GSTM1 positive polymorphism had lower DNA 
damage (p<0.05) at 24h with respect to 0, 3, and 6h; while no significant difference was 
registered in individuals with GSTM1 null genotype. Individuals with GSTM1 positive 
genotype showed a greater protection against DNA damage (Table 3.3.3.3). 
 
Table 3.3.3.3 Results of H2O2-induced DNA strand breaks single-dose study (Mean±SD). Data with 
different letters are significantly different (p<0.05) on the same row. 
Time  0 3 h 6 h 24 h 
H2O2-induced DNA strand breaks (% DNA in tail)     
All subjects (n=9) 53.3±9.3 54.7±7.8 58.1±12.5 43.4±16.4a 
GSTM1 positive (n=4) 54.6±10.3 56.0±5.6 66.0±7.3 33.2±13.1a 
GSTM1 null (n=5) 52.2±9.5 53.6±9.8 51.8±12.7 51.5±15.0 
 
GST activity in plasma and lymphocytes 
GST activity in plasma and lymphocytes analyzed in 9 subjects is reported in Table 
3.3.3.4. In general, individuals with positive GSTM1 genotype showed a greater 
plasma and lymphocyte GST activity compared to individuals with GSTM1 null 
genotype. However lymphocyte GST activity resulted significantly different (p<0.05) 
between individuals with GSTM1 positive and GSTM1 null genotype. After broccoli 
consumption, plasma GST activity significantly increased (p<0.05) in individuals with 
GSTM1 positive genotype at 6 h with respect to 3 h and 24 h but not with respect to 
baseline. No significant difference was observed in lymphocytes GST activity (Table 
3.3.3.4).  
 
 
 
69 
 
Table 3.3.3.4 Results of GST activity in plasma and lymphocytes of single-dose study (Mean±SD). 
Data with different letters are significantly different (p<0.05) on the same row. 
Time  0 3 h 6 h 24 h 
GST activity (n=9)     
Plasma (pmol/min/mg*pr)     
All subjects 65.7±19.3 58.1±24.5 74.5±30.0 58.9±13.3 
GSTM1 positive (n=5) 76.2±17.3a 68.6±29.4ab 87.5±35.2b 64.5±15.3a 
GSTM1 null (n=4) 52.6±13.4 45.0±5.9 58.1±10.8 51.9±6.3 
Lymphocytes(nmol/min/mg*pr)     
All subjects 39.7±11.4 36.6±21.3 35.1±27.3 35.8±12.9 
GSTM1 positive (n=5) 45.9±10.8 49.2±20.9 50.4±24.6 41.5±13.7 
GSTM1 null (n=4) 31.8±6.9 21.0±6.8 16.1±17.8 28.7±8.2 
 
3.3.3.1 Discussion of single-meal study 
A single portion of steamed broccoli was able to decrease DNA damage and to 
modulate plasma GST activity. Broccoli protective effect has been related to multiple 
substances such as carotenoids, vitamin C, isothiocyanates and polyphenols. They 
display complementary and overlapping mechanisms of action, including the 
induction of detoxification enzymes and antioxidant effects. 
In the present study, we have monitored the plasma concentrations of carotenoids, 
vitamin C and folate along the time after the intake of one portion of broccoli. The 
portion of broccoli (250 g) provided about 2.8 mg lutein, 1.5 mg β-carotene, 172 mg 
vitamin C and 160 µmol ITCs. 
The consumption of broccoli significantly increased some of the compounds such as 
vitamin C, folate and β-carotene in plasma. A significant increase of vitamin C plasma 
concentration was found 3 h after the consumption of broccoli and the levels were 
maintained significantly high until 24 h  with respect to baseline. Few studies have 
shown similar effect after the consumption of vegetables and fruit. In fact in a recent 
study, in which seven healthy, non-smoking female volunteers assumed a single 
portion (300 ml) of orange juice providing 150 mg vitamin C, the concentration of 
vitamin C increased significantly 1 h after the drink reaching a peak at 2-4 h, however 
at 24 h plasma concentrations were comparable to baseline values (Guarnieri et al., 
2007). One possible reason to explain the differences between studies could be related 
to differences among food matrices. Orange juice is a simple food matrix, thus vitamin 
C could be more quickly absorbed with respect to broccoli. Also in a recent 
intervention trial, where smokers and no smokers consumed broccoli for 10 days, no 
differences in vitamin C concentration in plasma after intake was found (Riso et al., 
2009a), even if the amount of vitamin C provided was high (from 60 to 150 mg per 
portion).  
Concerning carotenoids, no significant differences were observed for their 
concentration in plasma, except for β-carotene. The levels of β-carotene increased 
significantly following consumption of broccoli (+ 13% respect to baseline). However, 
limited studies have shown similar increase. In the study of Riso and colleagues 
(2009a), with 200 g of broccoli for 10 days, plasma lutein and β-carotene increased by 
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about 45% and 33% respectively. Similar results were found after 4 days of broccoli 
intake with an increase of 133% and about 28% for lutein and β-carotene plasma levels 
respectively (van het Hof et al., 1999). Also Bohn and co-authors (2010), in a 8-week 
randomized controlled clinical trial of male smokers, found a significant increase in 
carotenoid concentrations in plasma in the two intervention groups (diet with various 
antioxidant-rich foods and kiwifruit diet) compared to the control group; in particular 
lutein and β-carotene increased by about 37% and 50% respectively after the 
antioxidant-rich diet; while after kiwifruit diet the increase of lutein plasma 
concentration was of 37% (Bohn et al., 2010). Brown and colleagues (1989) did not find 
significant differences in plasma β-carotene concentrations after one portion of broccoli 
(600 g providing 6 mg β-carotene) (Brown et al., 1989). Similarly, the intake for one 
week of 200 g of broccoli induced a significant increase in lutein and not in β-carotene 
concentrations in plasma (Granado et al., 2006). 
We have found similar results for lutein concentration, in fact no significant difference 
was observed after broccoli intake. Three possible reasons can be hypothesized to 
explain the lack of increase of lutein. The first one could be related to the low amount 
present in broccoli. The second one could be due to the fact that lutein peak in plasma 
could have been occurred between 8 and 24 h after broccoli intake. In fact, in 
accordance with data reported in literature, each carotenoid shows its own pattern of 
absorption, clearance and metabolism. In a human study in which single equimolar 
doses (0.5 µmol/kg body weight) of lutein and β-carotene in oil solution were given to 
eight adults subjects, the mean serum concentration of lutein had a single maximum at 
16 h, β-carotene had a first peak at 6 h and then a second at 32 h (Brown et al., 1989). 
The third hypothesis could be related to an effect of competition between β-carotene 
and lutein for absorption. Kostic and colleagues showed that simultaneous ingestion of 
purified lutein and β-carotene decreased the bioavailability of lutein and consequently 
of the absorption (Kostic et al., 1995). 
From our results no significant difference in the concentration of the carotenoids and 
vitamin C in lymphocytes was observed. Probably, one portion of broccoli was not 
sufficient to increase the antioxidant content of such cells.  
Broccoli is also a good source of folate (generally the concentration vary from 90-100 
µg per 100 g of broccoli). Folate play an important role in nucleotide biosynthesis, 
DNA methylation and methionine biosynthesis (Blakley & Cocco, 1984). A sub-optimal 
status of folate is often associated to increased risk of cardiovascular disease (Boushey 
et al., 1995) and cancer (Kim, 1999). A high intake of folate, on the contrary, may hide a 
vitamin B12 deficiency, thus fortification may be at risk for some population groups 
(e.g. elderly people), while the intake of naturally rich vegetables should be advised.   
In a short intervention study, no significant increase was found after 4 day 
consumption of 300 g broccoli providing 260 µg folate (van het Hof et al., 1999). In the 
study by Riso et al (2009a), a significant increase of serum folate (about 15%) was 
registered after 10 days of broccoli consumption (200g), afterwards values decreased to 
basal levels after crouciferous free diet (Riso et al., 2009a). Even if in the present study 
it was not possible to determine folate in broccoli, a significant increase in serum 
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concentration was shown. In particular, the concentration of folate increased by 70% 
after 3 h the broccoli intake. The levels were maintained significantly high until 24 h 
with respect to baseline. 
Apart from antioxidants and vitamins, broccoli are a very important source of 
glucosinolates whose bioactive derivate are isothiocyanates (ITCs). Studies in 
literature demonstrated that ITCs are rapidly absorbed, cleared from blood and 
eliminated almost exclusively in urine (Shapiro et al., 1998). In fact after absorption, 
ITCs react with glutathione; the reaction is spontaneous but can also be catalyzed by 
glutathione-S-transferase (GST), a family of iso-enzyme involved in the detoxification 
of carcinogens. In the present study we evaluated whether one portion of broccoli 
could modulate GST activity; moreover we further try to verify whether differences 
between subjects with different GST polymorphisms could be revealed. After broccoli 
intake, plasma GST activity significantly increased at 6 h. This increment was partly 
due a fluctuation at 3 h but it may be also due to an effect of the absorption of ITCs. An 
increase of ITCs at 6 h was in fact demonstrated by Conaway after 200 g steamed 
broccoli intake and was found in a pilot study performed in our laboratory (Conaway 
et al., 2000). It was recently demonstrated that a regular intake of broccoli can increase 
the basal circulating levels of ITCs, in fact after 10 days of broccoli consumption (200g), 
ITCs levels doubled (Riso et al., 2009a). 
In general, individuals with positive GSTM1 genotype showed a greater plasma and 
lymphocyte GST activity with respect to  individuals with GSTM1 null genotype 
(Lampe & Peterson, 2002). This suggests that individuals with GSTM1 null genotype 
may had, in the whole, a low GST activity and consequently a lower ability to excrete 
ITCs with respect to GSTM1 positive subjects. In lymphocytes of GSTM1 null genotype 
subjects we found GST activity significantly lower than GSTM1 positive individuals. 
After broccoli intake the increase of GST activity at 6 h was present only in individuals 
with GSTM1 positive genotype. This suggests that GSTM1 could be involved in the 
metabolism of ITCs, which seem able to increase the activity in individuals with 
GSTM1 positive genotype. However considering the small number of individuals and 
the heterogeneous results obtained, more studies are necessary to support the role of 
ITCs in the modulation of GST activity. Data in literature illustrated that cruciferous 
vegetable diets could modulate GST iso-enzymes level or activity, and the modulation 
effects were differently affected by GSTM1 genotype. Individuals with GSTM1 null 
genotype showed a reduction of lymphocyte activity between response to basal and 
vegetable-supplemented diets (Lampe et al., 2000); instead Pool-Zobel showed that the 
induction of GSTM1 activity was more pronounced in individuals with positive 
genotype (Pool-Zobel et al., 2005). Gasper et al (2005) suggest that GSTM1 null subjects 
can excrete essentially all SFN metabolites via the mercapturic acid pathway after 
broccoli consumption; on the contrary only 70% of the ingested SFN could be excreted 
by GSTM1 positive subjects consuming the same amount of broccoli. The authors 
speculated that, in contrast to GSTM1 null genotype subjects, in GSTM1 positive ones  
a proportion of SFN could be retained within the body and this may mediate the 
anticarcinogenic activity of broccoli (Gasper et al., 2005). This hypothesis was sustained 
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by recent results obtained by Steck et al (2007) (Steck et al., 2007). However the regular 
consumption of broccoli (200g) for 10 days did not affect total GST activity, evaluated 
using CDNB as substrate (Riso et al., 2009a). The same results were found in another 
study for GST(CDNB) activity, while GSTM1 null genotypes had an increased serum 
GST-α level and GST(NBD-CI) activity (Lampe & Peterson, 2002). Considering these 
findings, it may be that the effect on GST activity could be examined with other 
substrates than CDNB or with specific GST evaluation. 
Another aim of the study was also to evaluate the effect of the portion of broccoli on 
lymphocyte protection from an ex vivo induced DNA oxidative damage. As a 
consequence of broccoli intake the cell resistance to DNA damage increased 
significantly at 24 h. A further analysis showed that only GSTM1 positive individuals 
increased significantly their protection ability at 24 h. This result, together with the 
observation that GST activity increased at 6 h from broccoli intake in GSTM1 positive 
individuals, could support the hypothesis of a lower disease risk of such subjects and a 
higher response to broccoli intake with respect to GSTM1 null individuals. As 
previously reported, Gasper et al., (2005) found a lower concentration of sulforaphane 
metabolites excreted in the urine of GSTM1-positive persons than in null ones (Gasper 
et al., 2005). Researchers speculated that SFN could be stored from tissues or have 
different metabolic pathway. This could explain why GSTM1-positive genotype had 
more protection from a small amount of broccoli. However researchers suggest that 
GSTM1 null individuals may compensate their genotype increasing the frequency of 
broccoli consumption in order to obtain effects similar to that observed in GSTM1 
positive subjects (Gasper et al., 2005).  
One of the hypothesis tested in the present study is that an increase of plasma and cell 
levels of antioxidants could determine a modulation of biomarkers such as 
lymphocytes resistance to oxidative stress and cell enzyme activity. For example 
studies showed an increase of the resistance to DNA oxidatively-induced damage, but 
no effect on endogenous DNA damage, in concomitance with an increase of plasma 
vitamin C concentration after the consumption of 0.5 L of a kiwifruit drink (Collins et 
al., 2001b). Similar results were also shown by Panayotidis & Collins (1997) in a human 
study, in which a single large dose of antioxidants (vitamin C, vitamin E and β-
carotene) was introduced (Panayiotidis & Collins, 1997). Also Guarnieri and colleagues 
(2007) found a protective effect of a single dose of Blood Orange Juice with a decrease 
of DNA damage after 3h (18%), maintained constant until 24 h (16%) (Guarnieri et al., 
2007). However Moller et al (2003) did not find an effect on DNA damage biomarkers 
after the intake of a 600 g fruit and vegetable diet or a supplementation containing the 
same amount of minerals and vitamins for 24 days (Moller et al., 2003). In a very recent 
dietary intervention trial 10 servings/day for 2 weeks of botanically defined fruit and 
vegetable did not affect endogenous DNA damage and repair measures in 
lymphocytes (Chang et al., 2010). In a similar study, where two groups of individuals 
consumed antagonistic diets, a protective effect of the diet rich in organic products, 
integral grains, fruit and vegetable and poor in industrialized products was found 
against oxidative DNA damage and DNA damage induced by H2O2 (Prado et al., 2010). 
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However in the present study we have demonstrated that the protection against DNA 
damage was not correlated with plasma concentration of vitamin C, folate or 
carotenoids at 24 h. This result supports some hypothesis reported in literature by 
which the antioxidant protection is not exerted by single compounds but by their 
synergy. This may require long time or, as in this case, be apparent already after 24 h 
of the intake of a food portion.  
 
3.4 Conclusions TOPIC I 
Many epidemiological studies suggest that a diet rich in fruits and vegetables, in 
particular vegetables of the Brassicaceae family, is associated with a decreased risk and 
incidence of many degenerative diseases such as cancer. 
Up to now, “regular-intake” study is the first published work reporting the possible 
relationship between GSTM1 polymorphism and modulation of DNA damage 
following broccoli intake (Riso et al., 2010). We found that individuals with GSTM1 
null genotype could benefit more than subjects with GSTM1 positive genotype from 
Brassica vegetables intake for 10 days. Differently, in the “single-meal” study, one 
portion of broccoli was able to affect more GSTM1 positive genotype subjects respect 
to the GSTM1 null genotypes, compared to the protection against DNA damage and 
modulation of GST activity. Broccoli seems to be a good bioavailable source of vitamin 
C, folate and carotenoids in both studies.  
Is the protective effect due to the action of ITCs? It seems that ITCs have a slower 
excretion in those individuals that lack GST enzyme. Moreover ITCs induce the 
expression of the same enzyme, increasing their own metabolism. So the amount of 
broccoli ingested, the accumulating exposure given by a regular consumption can 
make the difference. If these results will be confirmed in future studies where a larger 
group of subjects is recruited, it will be possible to verify whether higher amounts of 
broccoli or longer time of consumption could increase GST activity and protection 
against DNA damage also in null genotype subjects. 
It has been demonstrated that altered metabolism leads to a higher bioavailability of 
sulphoraphane or total ITCs, as shown in studies with administration of a single 
broccoli meal, although differences were small and the interpretation is debated 
(Gasper et al., 2005; Steck et al., 2007; Lampe, 2009). 
The impact of GSTM1 on possible cancer protective effects of cruciferous vegetables is 
also debated with effect mainly shown with the GSTM1 and GSTT1 double null 
genotype in Chinese and European populations (Kim & Park, 2009), whereas the 
GSTM1 positive genotype might convey beneficial effects in subjects from North 
America (Gasper et al., 2005). Intake of cruciferous vegetables, including broccoli, is 
most popular in the latter region, whereas other Brassica vegetables in the former 
region as well as multiple other dietary, life style and genetic differences can play roles 
in these apparent discrepancies. Even within a single family of vegetables, such as the 
crucifers and a specific genus, Brassica, effects may differ between different vegetables, 
and there may be alternative routes of metabolism for the different ITC (namely 
sulforaphane in the broccoli studies). There is speculation that there may be 
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differential effects of different Brassica vegetables on cancer risk because of differences 
in their phytochemical constitution (Gasper et al., 2005). Other factors that may explain 
the differential excretion of ITCs between individuals include the amount of chewing, 
which affects the release of myrosinase from the vegetable. In the case of cooked 
vegetables, where myrosinase has been inactivated, conversion of glucosinolates to 
ITCs still occurs via the gastrointestinal microflora, so differences in ITC excretion 
between individuals also may be related to differences in the gastrointestinal 
microflora. Finally, there it is supposed that the GSTs affect the rate of ITC excretion, 
rather than the absolute amount excreted; in which case, a single urinary measurement 
of ITC excretion would have little value within either a feeding study or epidemiologic 
study designed to account for this difference in rate (Steck & Hebert, 2009). 
In conclusion, this PhD research revealed a protective effect exerted by both regular 
intake and a single portion of broccoli, as far as DNA damage is concerned, in young 
male smokers who are exposed to oxidative stress. This outcome may be due to 
improved antioxidant status and synergic action of all the bioactive compounds 
present in broccoli. 
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3.6 TOPIC II: Effect of anthocyanins on angiogenic and pro-thrombotic properties of 
endothelial cells in vitro 
Abstract 
Anthocyanins (ACNs), compounds of the flavonoid class, are natural pigments that 
provide colours from dark blue to purple to fruits and vegetables, including edible 
berries. Studies that investigated the effects of ACNs on health showed that these 
flavonoids possess anti-inflammatory and anti-carcinogenic properties. Delphinidin-3-
glucoside (Dp-3-glc) and cyanidin-3-glucoside (Cy-3-glc) are two ACNs contained in 
berries. These two compounds are able to inhibit tumor cell proliferation, but it is not 
known whether they can also act on pro-angiogenic and the pro-thrombotic properties 
of endothelial cells.  
An in vitro study was designed to investigate the effect of Dp-3-glc on the angiogenic 
and the pro-coagulant activities of human microvascular endothelial cells (HMEC-1).  
HMEC-1 were incubated for up to 24h with culture media ± Dp-3-glc (0.1, 1, 10, 100 
µM) alone (i.e. resting conditions) or in combination with purified proangiogenic factor 
(VEGF, 50 ng/mL), or bacterial endotoxin (LPS, 10 µg/mL), stimulated conditions. After 
incubation, angiogenesis was evaluated by the capillary-like tube formation in 
Matrigel and the wound healing assay, while procoagulant activity was tested by the 
thrombin generation assay (TG) and Tissue Factor (TF) expression by antigen, one-
stage recalcification assay on normal plasma and mRNA quantitation. 
HMEC-1 were also incubated for 24h with culture media ± Cy-3-glc (0.1, 1, 10, 100 µM) 
alone or in combination with purified proangiogenic factor (VEGF) to evaluate if Cy-3-
glc was able to affect HMEC-1 angiogenesis, by the capillary-like tube formation in 
Matrigel and the wound healing assay. 
The results show that Dp-3-glc inhibited capillary tube formation both in resting and 
in VEGF-stimulated conditions, reaching statistically significant reduction and 
inhibition of stimulus at 100 µM (p<0.05). At the same concentration, Dp-3-glc 
significantly reduced the migration of resting HMEC-1; interestingly, the inhibition of 
the migratory VEGF-dependent stimulus started at the Dp-3-glc concentration of 1 µM. 
In the TG assay Dp-3-glc significantly counteracted the pro-thrombotic stimulus of LPS 
starting from 10 µM on HMEC-1 intact monolayers; while the ACN inhibited LPS-
induced TF expression at 100 µM concentration. Differently, Cy-3-glc did not show any 
effect on capillary-like tube formation and migration of HMEC-1 both alone and in 
combination with VEGF. 
In conclusion, the data show that Dp-3-glc can affect angiogenic, migratory and 
procoagulant properties of endothelial cells. These findings, together with the known 
capacity of Dp-3-glc to affect tumor cell proliferation, make this compound a potential 
cancer chemopreventive agent. 
 
Introduction  
Anthocyanins: chemical structure, sources and bioavailability 
Berries such as cranberries, blueberries, strawberries, blackcurrant and raspberries 
contain significant amounts of non-nutritive phytochemicals including the 
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polyphenols and other antioxidants. Polyphenols are defined chemically as substances 
that have an aromatic ring with an hydroxyl substituents, including esters and 
glycosides. Because of the diverse range of their chemical structures, polyphenols are 
grouped into different classes, depending on the number of phenol rings they possess 
and the type and number of structural elements binding the phenolic rings together 
(Manach et al., 2004). The classes include: simple phenolic acids (e.g. ferulic acid, gallic 
acid, Figure 3.6.1); stilbenes (e.g. resveratrol, Figure 3.6.1); more complex chalcones 
(e.g. phloridzin, Figure 3.6.1); flavonoids, split into seven subclasses that include 
flavonols (e.g. quercetin, Figure 3.6.1), flavanols (e.g. epigallocatechingallate, Figure 
3.6.1), flavones, flavanones, flavanonols, isoflavones and anthocyanins (Nicholson et 
al., 2008).  
 
 
Figure 3.6.1 Chemical structures of selected polyphenols (Nicholson et al., 2008) 
Anthocyanins (ACNs) are flavonoids, which are the largest group of water-soluble 
pigments, occur ubiquitously in the plant kingdom and confer bright red or blue 
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coloration on many fruits (particularly berries), vegetables, grains, flowers and leaves. 
They can be find in nature in different structural arrangements (Figure 3.6.2), 
depending on the number of glycosilating sugars, their position in the aglycone 
(anthocyanidin) and the degree and nature of esterification of the sugar with aliphatic 
or aromatic acids (Giordano et al., 2007). 
Depending on the nutrition habits, ACNs daily intake has been estimated to be from 3-
15 mg up to 200 mg in US (Wu et al., 2006; Duthie, 2007; Crozier et al., 2009; Fernandes 
et al., 2010); the anthocyanidins intake in the US has been estimated to be 180-255 
mg/day (Cooke et al., 2005). 
 
 
Figure 3.6.2 Chemical structures of selected anthocyanidins (Nicholson et al., 2008) 
Bioavailability studies are considered a fundamental issue, in order to understand the 
biological effects of anthocyanins. This implies the development of sensitive and 
validated analytical methods to quantify anthocyanins in biological fluids such as 
plasma and urine. 
Following the ingestion of dietary flavonoids which exist in planta predominantly as 
glycoside conjugates, absorption of some but not all components into the circulatory 
system occurs in the small intestine (Silberberg et al., 2006). Typically, this is associated 
with hydrolysis, releasing the aglycone, as a result of the action of lactase phloridizin 
hydrolase (LPH) in the brush-border of the small intestine epithelial cells. LPH exhibits 
broad substrate specificity for flavonoid-O-β-D-glucosides, and the released aglycone 
may then enter the epithelial cells by passive diffusion as a result of its increased 
lipophilicity and its proximity to the cellular membrane (Day et al., 2000). An 
alternative site of hydrolysis is a cytosolic β-glucosidase (CBG) within the epithelial 
cells. In order for CBG-mediated hydrolysis to occur the polar glucosides must be 
transported into the epithelial cells, possibly with the involvement of the active 
sodium-dependent glucose transporter SGLT1 (Gee et al., 2000). Thus, it has been 
accepted that there are two possible routes by which the glucoside conjugates are 
hydrolysed and the resultant aglycones appear in the epithelial cells, namely 
‘LPH/diffusion’ and ‘transport/CBG’. However, a recent investigation, in which SGLT1 
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was expressed in Xenopus laevis oocytes, indicated that SLGT1 does not transport 
flavonoids and that glycosylated flavonoids, and some aglycones, have the capability 
to inhibit the glucose transporter (Kottra & Daniel, 2007). Prior to passage into the 
blood stream the aglycones undergo metabolism, forming sulfate, glucuronide and/or 
methylated metabolites through the respective action of sulfotransferases (SULT), 
uridine-5′-diphosphate glucuronosyltransferases (UGTs) and catechol-O-
methyltransferases (COMT). There is also efflux of at least some of the metabolites 
back into the lumen of the small intestine and this is thought to involve members of 
the adenosine triphosphate (ATP)-binding cassette (ABC) family of transporters 
including multidrug resistance protein (MRP) and P-glycoprotein (P-gp). Once in the 
bloodstream, metabolites can be subjected to phase II metabolism with further 
conversions occurring in the liver, where enterohepatic transport in the bile may result 
in some recycling back to the small intestine (Donovan et al., 2006).  
Flavonoids and their metabolites not absorbed in the small intestine can be absorbed in 
the large intestine but will be subjected to the action of the colonic microflora, which 
will cleave conjugating moieties and subject the resultant aglycones to ring fission, 
leading to the production of phenolic acids and hydroxycinnamates. These can be 
absorbed and ultimately excreted in urine in substantial quantities that, in most 
instances, are well in excess of the flavonoid metabolites that entered the circulatory 
system via the small intestine. 
A detailed review on the bioavailability of polyphenols in humans was published in 
2005 by Manach and colleagues (Manach et al., 2005). Much of the research covered 
involved feeding volunteers a single supplement and monitoring the levels of 
flavonoids in plasma and urine over a 24 h period. As flavonoid metabolites were 
rarely available, analysis almost invariably involved treatment of samples with 
mollusc glucuronidase/sulfatase preparations and subsequent quantification of the 
released aglycones by HPLC using either absorbance, fluorescence or electrochemical 
detection. While at the time such studies provided valuable insights, it is important to 
appreciate their potential shortcomings. Namely, information yielded on the 
metabolites produced is very indirect, and quantitative estimates, although precise, are 
not necessarily accurate as there are few data on the efficiency with which the enzymes 
hydrolyse individual metabolites and release the aglycone (Mullen et al., 2008a). 
Indeed, the only study on the subject to date reports that the use of enzyme hydrolysis 
results in an underestimation of isoflavone metabolites (Gu et al., 2005). Anthocyanins, 
for people who eat berries and drink red wine on a routine basis, are major dietary 
components. Although there are exceptions, unlike other flavonoids that are absorbed 
and excreted, most anthocyanins do not appear to undergo extensive metabolism of 
the parent glycosides to glucurono, sulfo or methyl derivatives (McGhie et al., 2003; 
Ichiyanagi et al., 2005). In feeding studies with animals and humans, typically ca. 0.1% 
of the quantities ingested, and sometimes much less, has been detected in urine. The 
available data imply that the determinants of absorption and excretion are influenced 
not only by the nature of the sugar moiety but also by the structure of the 
anthocyanidin aglycone (McGhie et al., 2003; Wu et al., 2005). The complex array of 
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information on anthocyanin bioavailability obtained with human and animal test 
systems has been reviewed by Prior and Wu (Prior & Wu, 2006) . One of the reasons 
for the complicated picture that has emerged is that many feeds have involved berry or 
fruit supplements containing several structurally diverse anthocyanins. For instance, 
black raspberries contain five cyanidin-3-O-sugar conjugates ranging from mono to 
trisaccharides while blueberries contain a total of 12 anthocyanins, principally 3-O-
glucosides, galactosides and arabinosides of cyanidin, delphinidin, petunidin  and 
malvidin (McGhie et al., 2003). This makes the complex anthocyanin content of plasma 
and urine exceedingly difficult, if not impossible, to assess in terms of absorption, 
excretion and potential phase I and phase II metabolism, especially when 3′-O-
methylation can convert cyanidin to peonidin, and delphinidin to petunidin, and 5′-O-
methylation converts petunidin to malvidin. Much simpler anthocyanin profiles are 
found in strawberries and blackberries, both of which contain one predominant 
anthocyanin, pelargonidin-3-O-glucoside in the former and cyanidin-3-O-glucoside in 
the latter (Wu et al., 2006). As a consequence, data on anthocyanin bioavailability after 
ingestion of these berries by humans are potentially more straightforward to interpret. 
In a recent human study, 200 g of strawberries containing 222 µmol of pelargonidin-3-
O-glucoside and trace quantities of pelargonidin-3-O-rutinoside (13 µmol) and 
cyanidin-3-O-glucoside (6 µmol) were consumed by six subjects, after which plasma 
and urine were collected over a 24 h period (Mullen et al., 2008b). The plasma 
contained a pelargonidin-O-glucuronide in substantial quantities along with non-
quantifiable amounts of three other pelargonidin-O-glucuronides and pelargonidin-3-
O-glucoside, the latter perhaps derived from removal of the 6″-rhamnose moiety from 
pelargonidin-3-O-rutinoside. The main pelargonidin-O-glucuronide had a Cmax of 274 
± 24 nmol/L, a Tmax of 1.1 ± 0.4 h, in keeping with small intestine absorption, and T1/2 
of 2.1 ± 0.7 h. All the plasma anthocyanins also appeared in urine along with small 
quantities of pelargonidin aglycone and a pelargonidin-O-sulfate. The pelargonidin-O-
glucuronide, that was the main metabolite in plasma, was by far the predominant 
component in urine, accounting over 0–24 h for 1498 nmol of a total of 1672 nmol of 
anthocyanins excreted. This corresponds to 0.75% of pelargonidin-3-O-glucoside 
intake. There is, therefore, no evidence of substantive post-absorption metabolism 
prior to excretion. In an earlier feeding study with strawberries, Felgines and co-
workers (Felgines et al., 2003) reported a urinary excretion equivalent to 1.8% of the 179 
µmol of ingested pelargonidin-3-O-glucoside and this is also similar to values obtained 
in a 15–60 µmol dose study with strawberries (Carkeet et al., 2008). These urinary 
recoveries are high for anthocyanins, and suggest that pelargonidin-3-O-glucoside is 
absorbed more readily that other anthocyanins. In a separate human feeding study 
with 200 g of blackberries containing 960 µmol of cyanidin-3-O-glucoside, 12 
anthocyanins were excreted including unmetabolised cyanidin-3-O-glucoside, a 
cyanidin-O-glucuronide and a peonidin-O-glucuronide in quantities equivalent to 
0.16% of intake (Felgines et al., 2005). This suggests that pelargonidin-3-O-glucoside, 
while it is metabolized to fewer products, may be absorbed more readily than 
cyanidin-3-O-glucoside. However, the high cyanidin-3-O-glucoside content of the 
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blackberry supplement may have had an impact on absorption and/or excretion. In the 
circumstances, it would be of interest to carry out a feeding study and to determine not 
only the urine but also the plasma anthocyanin profile after ingestion of blackberries 
and strawberries containing similar quantities of anthocyanins. After a single dose of 
black currant (87.9 µmol, 58.8 mg of ACNs), the pharmacokinetics of delphinidin-3-
glucoside (Dp-3-glc), delphinidin-3-rutinoside (Dp-3-rut), cyaniding-3-glucoside (Cy-3-
glc) and cyaniding-3-rutinoside (Cy-3-rut) were analyzed in human plasma: Tmax 
were equal for Dp-3-rut and Cy-3-rut (1.25h), which were greater than the values of 
Dp-3-glc and Cy-3-glc (0.75h). These suggest that absorption is influenced by the 
difference in the sugars moiety. The Cmax and AUC values varied in the order: Dp-3-
rut>Cy-3-glc>Dp-3-glc>Cy-3-glc, which was the same order as the quantity of the four 
components in the black currant ACNs ingested (Nakamura et al., 2010). These data 
confirmed the previous study of the same authors (Matsumoto et al., 2001). In another 
study with the ingestion of a single dose of black currant juice (330 mL, providing 98.2 
mg of Dp-3-glc, 493.3 mg of Dp-3-rut, 60.2 mg of Cy-3-glc, 358.2 mg of Cy-3-rut and 
29.3 mg of 4 unidentified ACNs) in the morning, blood samples were collected in the 
following 6h and urine until the following day at 4 pm. The four major native 
anthocyanidin glycosides of blackcurrant juice, delphinidin-3-glucoside, delphinidin-3-
rutinoside, cyanidin-3-glucoside and cyanidin-3-rutinoside, were detected and 
identified in low amounts by HPLC and LC-MS in plasma and urine post-ingestion. 
Elimination of the anthocyanins was fast (maximum excretion after 1 h) and plasma 
levels (0–128.6 nmol/l) and total urinary excretion (0.07– 1.35 mg; 0.007–0.133% of the 
dose ingested) were low (Rechner et al., 2002). The quantitative results derived in this 
study indicate that the majority of the ingested polyphenols from the blackcurrant 
juice are subjected to metabolism in the colon. The ingestion of high amounts of 
polyphenols have also been linked with increased urinary excretion of hippuric acids, 
such as hippuric acid, 3-hydroxyhippuric acid, and 4-hydroxyhippuric acid (Rechner et 
al., 2002). 
Another source of ACNs is blood orange juice, which contains 72 mg/L of ACNs 
(mainly represented by Cy-3-glc, 25.8 mg/L, Dp-3-glc, 4 mg/L and cyanidin-3-(6-
malonylglucoside), Cy-M-glc, 17.9 mg/L). The analysis of samples obtained from 
human plasma and urine after the ingestion of a single dose of two-fold concentrated 
blood orange juice (500 mL), permitted to detect the three compounds in biological 
samples. Plasma levels after 1h of the ingestion were: Cy-3-glc 1.98±0.55 ng/mL, Dp-3-
glc 0.20±0.04 ng/mL, Cy-M-glc 0.38±0.06 ng/mL; urinary excretion whitin 4 h after the 
ingestion was respectively: 1.51±0.55 µg, 14.89±3.28 µg and 3.07±0.50 µg for Dp-3-glc, 
Cy-3-glc and Cy-M-glc (Giordano et al., 2007). A regular consumption of blood orange 
juice (600 mL/day for 21 days) provided 3.5 mg/100 mL of Cy-3-glc, and 1.2 mg/100 mL 
of cyanidin-3-glucoside-6’’-malonyl (Cy-3-glc-6-M) in a dietary intervention study by 
Riso and colleagues (2005). The Cy-3-glc plasma concentration was very low and close 
to the detection limit of the instrument at baseline and after the washout period (about 
0.6 nmol/L on average) and increased to 8 nmol/L after 3 weeks of blood orange juice 
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intake, i.e., an increase of more than 10-fold. Both the aglycon and the Cy-3-glc-6-M 
were not detected in plasma (Riso et al., 2005). 
Wild blueberry (WB, Vaccinium augustifolium) is composed of different anthocyanidins 
such as delphinidin, malvidin, petunidin, cyanidin and peonidin. Del Bo’ and 
colleagues (2010) investigated ACNs absorption, metabolism, and distribution in the 
plasma, liver, brain, and their excretion in urine and feces in the Sprague-Dawley (SD) 
rats fed a wild blueberry-enriched diet (8%) over time (4 and 8 weeks). Anthocyanins 
were not detected in the plasma, liver, and brain samples after dietary treatments. 
Since they are rapidly metabolized and the animals were sacrificed 3-4 h after the last 
meal, it was not possible to detect their native forms in the plasma, liver, or brain 
tissues. ACNs content in the urine significantly increased at 8 weeks compared to that 
at 4 weeks (i.e., Cy-gal, Cy-glc, Pt-gal, Pn-gal, Pt-ara, Mv-gal, and Mv-glc-ac). ACNs 
that were not absorbed or excreted by bile, were detected in the feces. Pn-gal, Pt-ara, 
and Pn-glc-ac were the dominant excretory products after WB consumption (Del Bo et 
al., 2010a). Phenolic acids and in particular hippuric acid were the principal 
metabolites detected in all the analyzed tissues. The amount of metabolites increased 
with time of exposure to the ACNs, suggesting a modulatory effect on metabolic 
pathways or an increased efficiency in absorption/excretion in the older animals (8 
weeks vs 4 weeks) (Del Bo et al., 2010a). 
A point of note is that anthocyanins are readily distinguished from other flavonoids as 
they undergo re-arrangements in response to pH. The red flavylium cation 
predominates at pH 1–3 but as the pH increases to 4 and above the colourless carbinol 
pseudobase is the major component along with smaller amounts of the colourless 
chalcone pseudobase and the blue quinoidal base (Clifford et al., 2000). Anthocyanins 
are traditionally extracted and analyzed in acidic medium as the red flavylium cation 
is the most stable form. However, it is not known what forms predominate in vivo. The 
limited available experimental evidence indicates that, in the acidic conditions that 
prevail in the stomach, anthocyanins are in the red flavylium form, but once they enter 
more basic conditions in the small intestine the carbinol pseudobase is likely to 
predominate. It could be that the colourless carbinol pseudobase is the main form in 
the small intestine where it undergoes limited absorption, possibly being metabolised 
to conjugates that are overlooked because they cannot be converted to red flavylium 
forms prior to the eventual analysis. It is also possible that significant amounts of the 
carbinol pseudobase might pass into the large intestine where degradation, to as-yet 
undetermined products, occurs due to the action of colonic bacteria. More subtle 
scenarios may exist, and detailed information is unlikely to be forthcoming until ring-
labelled 14C-anthocyanins become available (Crozier et al., 2009). 
The percentage of intake that is absorbed varies with structure (for example being 
significantly modulated by which sugars are attached to a flavonoid aglycone), and the 
food matrix. The exact yields and proportions of metabolites from any substrate will 
vary not only with the individual's genetic profile but also with the composition and 
competence of that individual's intestinal microflora. Any biological effects produced 
by these metabolites will be a function of the concentration achieved at the relevant site 
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and the susceptibility of the organelle (receptor, enzyme, transporter, etc.) that again 
might vary with the individual's genetic profile. It is not possible to quantify the 
magnitude of the variation produced by these factors, but it would not be 
unreasonable to assume an order of magnitude overall (Crozier et al., 2009). 
There is now emerging evidence that some phytochemicals, at concentrations that 
might be achieved under normal dietary circumstances, can exert modulatory effects in 
cells through selective actions on multiple intracellular signalling cascades, which are 
vital for cellular functions such as growth, proliferation and death (apoptosis). The 
identification of these molecular targets is an important first step that must be attained 
before the molecular mode(s) of action can be elucidated and understood, and this 
understanding is essential in order to formulate dietary strategies that might manage 
or even prevent certain non-communicable diseases. Emphasis on the mode of action 
in subsequent sections will cover investigations that either deal with clinical and 
preclinical studies or in vitro investigations that use either phenolic compounds and/or 
their main in vivo metabolites at concentrations that, at least, approach what might be 
achieved through diet (Crozier et al., 2009). 
 
Biological activities of ACNs 
Anthocyanins possess a variety of pharmacological properties rendering them 
interesting as potential chemo-preventive agents. Antioxidant activity (capacity to 
scavenge free-radicals) shown by ACNs in vitro studies has been thought to be the 
most important property, because it is involved in the onset development of many of 
the chronic degenerative diseases (LDL oxidation in atheroma plaque development, 
DNA oxidation and cancer, oxidation and ageing, inflammation, etc.) (Espin et al., 
2007). However many recent studies reported the effects of ACNs on cellular events 
related to tumor progression or promotion (Fimognari et al., 2008). Promising research 
has shown that ACNs may serve an important role in promoting health by reducing 
the risk of atherosclerosis and cancer, and ameliorating inflammation (Neto, 2007). 
Chemoprevention, which is referred to as the use of nontoxic natural or synthetic 
chemicals to intervene in multistage carcinogenesis, has emerged as promising 
approach to reduce the risk cancer and to control cancer, alternative therapy that has 
some limitation and drawbreaks in treating patients. Rational and successful 
implementation of  chemopreventive strategies rely on the precise understanding of 
underlying molecular mechanisms. Alteration of carcinogen metabolism and 
subsequent DNA adduction may represent an important mechanism by which a given 
agent modulates chemically-induced carcinogenesis in the initiation stage. Modulation 
of carcinogen metabolism, cell-cycle regulation and/or induction if apoptosis are two 
of the main mechanisms considered for recent chemopreventive strategies (Fimognari 
et al., 2008). 
 Antioxidant activity 
The phenolic structure of anthocyanins conveys marked antioxidant activity in model 
systems via donation of electrons or transfer of hydrogen atoms from hydroxyl 
moieties to free radicals. Several studies confirmed antioxidant properties of ACNs.  
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Accumulation of oxidative DNA damage over the human lifespan may be a significant 
factor in cancer development (Halliwell, 2002). Reactive oxygen species generated 
endogenously through aerobic metabolism are potent genotoxins, causing mutations, 
DNA strand breakage and oxidative DNA base damage in vitro and in vivo. The 
anticarcinogenic value of a diet high in fruits and vegetables may be due to the 
relatively high abundance of antioxidants in these foods, which act to inhibit oxidative 
DNA damage through a variety of mechanisms including free radical scavenging and 
metal chelation. Berry extracts and individual berry components, including the 
anthocyanins, are strong antioxidants in vitro and exhibit a broad spectrum of 
antioxidant activity in chemical and cellular systems (Duthie, 2007). Flavonoids are 
strong metal chelators and are able to suppress peroxyl and hydroxyl radical-induced 
supercoiled DNA strand scission and generation of reactive oxygen species from 
activated human granulocytes (Gasiorowski et al., 1997; Duthie et al., 2000). Quercetin, 
the anthocyanidin cyanidin and its glycoside cyanidin 3-glycoside are powerful 
inhibitors of oxidant-induced DNA damage in normal human colon mucosal cells in 
vitro (Duthie et al., 2005), while 3-glucopyranosides of delphinidin, cyanidin, 
petunidin, peonidin and malvidin ameliorate the effects of vitamin E depletion on 
oxidative DNA damage in rat liver (Ramirez-Tortosa et al., 2001). Black raspberry 
extract significantly inhibits O-8oxo-dG formation and tumorigenesis in animals 
treated with the carcinogen AZM (Harris et al., 2001). Regular blood orange juice 
consumption (600 mL/day for 21 days) determined a significant increase in 
lymphocyte DNA resistance to oxidative stress in a human intervention trial (Riso et 
al., 2005). The effect of the intake of a single portion of blood orange juice (BOJ, 300 ml, 
providing 150 mg vitamin C) on mononuclear blood cell (MNBC) DNA damage, 
compared with a drink supplemented with the same amount of vitamin C (C-drink) or 
sugars (S-drink). DNA damage significantly decreased 3 h after BOJ intake (about 18 
%; P<0.01) and remained constant at 24 h (about 16 %; P<0.01). No effect of the C-drink 
and S-drink was observed (Guarnieri et al., 2007). An in vitro study was assessed to 
determine if the organic red oranges have a higher phytochemical content (i. e., 
phenolics, anthocyanins and ascorbic acid), total antioxidant activity and in vitro 
bioactivity, in terms of protective effect against oxidative damage at cellular level, than 
nonorganic red oranges. Results demonstrated that organic oranges had significantly 
higher total phenolics, total anthocyanins and ascorbic acid levels than the 
corresponding non-organic oranges (all p<0.05). Moreover, the organic orange extracts 
had a higher total antioxidant activity capacity of inhibiting the production of 
conjugated diene containing lipids and free radicals in rat cardiomyocytes and 
differentiated Caco-2 cells, respectively (Tarozzi et al., 2006). In another in vitro study, 
HUVEC were treated with ferulic acid, quercetin and resveratrol (Nicholson et al., 
2008). Quantitative RT–PCR studies indicated that resveratrol (0.1 µM) significantly 
increased the expression of the gene encoding endothelial NO synthase (eNOS), which 
synthesises the vasodilator molecule NO, and both resveratrol and quercetin decreased 
expression of the potent vasoconstrictor, endothelin-1 (ET-1), while ferulic acid had no 
effect. The effects of resveratrol (0.1 µM) were also investigated when HUVEC were 
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under oxidative stress following treatment with H2O2 (0–50 µM), which dose-
dependently increased expression of eNOS and ET-1. Resveratrol stimulated eNOS 
mRNA in the absence of H2O2 and still allowed the increase with H2O2, but the effects 
were not additive. In contrast, resveratrol blocked the stimulatory effect of H2O2 on ET-
1 expression. Hence, resveratrol has potent effects at a physiological concentration (0.1 
µM) that would be expected to result in vasodilation and therefore help reduce blood 
pressure and the risk of CVD (Nicholson et al., 2008). 
Anthocyanins, including cyanidin and several glycosides are antimutagens in both the 
Ames and sister chromatid exchange (SCE) genotoxicity tests (Gasiorowski et al., 1997) 
and effectively inhibit oxidative DNA damage in rat smooth muscle cells (Lazze et al., 
2003). Anthocyanins are bioactive in different in vivo model systems. An effect on the 
resistance of H2O2-induced DNA damage was detected in the Sprague-Dawley (SD) rat 
fed a wild blueberry-enriched diet (8%) over time (8 weeks), but not after four weeks. 
No significant effect was detected in plasma antioxidant capacity at four and eight 
weeks (Del Bo et al., 2010b). Hepatic O-8oxo-dG was significantly decreased in vitamin 
E-deficient rats fed a complex anthocyanin extract containing glucosides of 
delphinidin, cyanidin, petunidin, peonidin and malvidin (1 g/kg diet) for 2 wk 
(Ramirez-Tortosa et al., 2001). However, in a study using only cyanidin-3-glycoside at a 
more nutritionally relevant concentration, no effect was seen on endogenous DNA 
strand breakage and oxidative base damage in isolated lymphocytes and O-8oxo-dG 
levels in liver and colon from vitamin E-deficient rats. Moreover, lymphocytes isolated 
from vitamin E-deficient rats fed cyanidin- 3-glycoside were as susceptible to induced 
oxidative stress as rats fed control diet (Duthie et al., 2005). These data suggest that 
certain polyphenols can modulate oxidative DNA damage in vivo, but others cannot. 
Moreover, in those studies where complex anthocyanin extracts or single anthocyanin 
aglycones or glycosides have been shown to be affective against oxidative damage, the 
phytochemicals have generally been fed at supra-nutritional or pharmacological doses.  
Modulation of phase I and II drug metabolizing enzyme activities and 
inhibition of DNA damage 
Berry phytochemicals may exert their anticarcinogenic effect by modulating the 
enzyme systems that metabolise carcinogens or procarcinogens to genotoxins. 
Activation of the procarcinogen may be inhibited or it may be converted to a less 
reactive compound before it is able to bind to DNA and initiate mutagenesis and 
carcinogenesis. 
Berry extracts inhibit mutagenesis by metabolically activated carcinogens in the Ames 
test, but are not as effective against carcinogens acting directly on DNA (Ono et al., 
2003). Several freeze-dried berry extracts inhibit NMBA-induced esophageal cancer in 
vivo, with strawberry, black raspberry and blackberry preparations decreasing 
esophageal papilloma numbers by 24–56% relative to control animals. Inhibition of 
tumorigenesis was associated with a concomitant decrease in the level of the DNA 
adduct, O-6-methylguanine, suggesting that the berry extract was acting to inhibit 
formation of the mutagenic agent from the procarcinogen (Kresty et al., 2001). 
Moreover, tumor burden was reduced up to 64% when berry extract was fed after 
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cancer initiation by NMBA indicating that berry extracts function as potent 
chemoprotectants at a number of sites along the cancer cascade. The cytochrome P450 
superfamily of enzymes metabolise a large number of procarcinogens to reactive 
intermediates that covalently bind to DNA and induce malignant transformation P450 
activity can be induced or inhibited by flavonoids. Ellagic acid inhibits mutagenesis 
and carcinogenesis by acting on both P450 xenobiotic metabolism and several phase 2 
detoxifying enzymes. Rats fed ellagic acid have significantly fewer carcinogen-induced 
hepatic and esophageal tumours and this reduction in tumour burden is associated 
with changes in the activity of several enzymes involved in carcinogen activation and 
detoxification. Liver P450 reductase activity was decreased significantly (25%) in rats 
fed ellagic acid for 23 days, while glutathione transferase (GST), NADPH quinone 
reductase and UDP glucuronyltransferase (UDPGT) activities increased. In vitro 
studies indicate that specific isozymes of rat liver P450s are inhibited by ellagic acid, 
with those isozymes inhibited the most, generally the most important in the 
bioactivation of procarcinogens in rats and humans (Ahn et al., 1996). In addition to 
altering activation or binding of the chemical carcinogen with DNA, black raspberry 
extract also alters expression of genes associated with inflammation and 
carcinogenesis. COX-2 gene expression and subsequently prostaglandin production 
and nitric oxide synthase activity are inhibited in premalignant rat esophageal cells 
following feeding with berry extract (Stoner et al., 2006). A study on human colorectal 
adenocarcinoma HT-29 cancer cells was carried out to evaluate if anthocyanin fractions 
from high bush blueberry cultivars affect the activity of the detoxifying enzymes GST 
and QR. The QR activity was lower in all cells treated with an anthocyanin fraction 
from Tifblue, Powderblue, Brightblue, and Brightwell cultivars than in control cells (P 
< 0.05). The activity decreased gradually when treated with increased concentrations of 
anthocyanin fractions (50-150 µg/mL) in the Tifblue and Powderblue cultivars. The 
GST activity was lower (P < 0.05) in cells treated with anthocyanin fractions from all of 
the cultivars and at all concentrations (Srivastava et al., 2007) 
Inhibition of cell growth and induction of apoptosis 
Anthocyanidins, including delphinidin, malvidin, peonidin and petunidin inhibit 
proliferation of cancer cells derived from various tissues including colon, breast, blood 
and lung at high micromolar concentrations (Cooke et al., 2005), as shown in Table 
3.6.1. Similarly, cyanidin and a mixture of several of its glycosides dose-dependently 
inhibit HCT116 and HT29 colon cancer cell growth, with an IC50 of 63 and 780µM, 
respectively (Serraino et al., 2003). In general, potency reflects the chemical structure of 
the polyphenol with the anthocyanin glycoside less effective than the parent aglycone 
(Cooke et al., 2005). Cyanidin and its glucoside cyanidin-3-glycoside, reduce oxidant-
induced DNA strand breakage in normal human lymphocytes ex vivo and are as 
potent chemoprotectants as the flavonols quercetin and myricetin. Moreover, the 
anthocyanins were more effective than several other antioxidants including 
kaempferol, silymarin, vitamin C, vitamin E and its water-soluble analogue Trolox 
suppress cancer cell metastasis by inhibiting the motility, adhesiveness and 
invasiveness of the metastatic human lung cancer cell line A549 (Chen et al., 2006). 
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Cultured lung cells pretreated with anthocyanin metabolites (0–100 µM) for 24 h have 
a reduced capacity to migrate through a matrigel layer. Both cyaniding-3-glucoside 
and cyaniding-2-rutinoside inhibited cell invasion by approximately 40% at the highest 
concentration tested (Chen et al., 2006). Cyanidin 3-glucoside was also a potent 
inhibitor of cell adhesion (Chen et al., 2006). A study on human colorectal 
adenocarcinoma HT-29 cancer cells was carried out to evaluate if anthocyanin fractions 
from high bush blueberry cultivars increase apoptosis using two different methods: 
DNA fragmentation and caspase-3 activity. The results indicated that apoptosis was 
confirmed in HT-29 cells when treated with anthocyanins from blueberry cultivars at 
50-150 µg/mL concentrations (Srivastava et al., 2007). 
 
Table 3.6.1 Summary of in vitro growth inhibitory effects of anthocyandins, anthocyanins and 
anthocyanin-rich extracts on different cell lines adapted from (Cooke et al., 2005). 
Compounds References  
Delphinidin (Meiers et al., 2001; Katsube et al., 2003; Lazze et al., 2004; Marko et al., 
2004; Zhang et al., 2005) 
Cyanidin (Meiers et al., 2001; Kang et al., 2003; Katsube et al., 2003; Hyun & 
Chung, 2004; Marko et al., 2004; Zhang et al., 2005) 
Malvidin (Meiers et al., 2001; Hyun & Chung, 2004; Zhang et al., 2005) 
Peonidin (Marko et al., 2004) 
Pelargonidin (Marko et al., 2004; Zhang et al., 2005) 
Petunidin (Zhang et al., 2005) 
Delphinidin-3-galactoside (Katsube et al., 2003) 
Delphinidin-3-glucoside (Katsube et al., 2003; Olsson et al., 2004) 
Cyanidin-3-galactoside (Meiers et al., 2001) 
Cyanidin-3-glucoside (Fimognari et al., 2004; Olsson et al., 2004) 
Malvidin-3-glucoside (Meiers et al., 2001; Olsson et al., 2004) 
Chokeberry extract (Malik et al., 2003; Olsson et al., 2004; Zhao et al., 2004) 
Grape extract (Singletary et al., 2003; Olsson et al., 2004; Zhao et al., 2004) 
Cherry extract (Kang et al., 2003; Zhao et al., 2004) 
Bilberry extract (Katsube et al., 2003) 
Black currant extract (Olsson et al., 2004) 
Cranberry anthocianins (Seeram et al., 2004) 
 
Several studies report that anthocyanins inhibit tumor formation in vivo. Mammary 
tumor formation, multiplicity and tumor volume is decreased in DMBA-treated female 
rats fed 15 different anthocyanins from grape juice (Singletary et al., 2003), while 
anthocyanins, given either as a mixture (estimated as 6.4 mg/day), a single pure 
cyanidin solution (estimated as 1.6 mg/day) or as freeze-dried tart cherries (600 
mg/day) inhibit dysplasia in cancer-susceptible mice (Apcmin). Mice consuming 
anthocyanins, cyanidin or tart cherries had significantly fewer and smaller caecal 
adenomas than mice consuming the control diet. The authors calculated that the 
comparative human doses required to modulate tumor formation would be 
approximately 2.4 or 0.6 g of anthocyanins or cyanidin, respectively, which is 
obviously supraphysiological and unachievable by normal dietary intervention 
(Serraino et al., 2003). Disturbingly, tart cherry consumption was associated with a 
significantly increased tumor volume in the small intestine. Conversely, cyanidin 3-
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glucoside decreased the number of malignant and benign skin tumors in mice treated 
with DMBA as an initiator and TPA as promotor (Ding et al., 2006) 
Some anthocyanins suppress cancer cell growth in vitro by modifying cell signalling 
pathways. Benzo[a]pyrene diolepoxide (BPDE) treatment of mouse epidermal JB6 CI 
41 cells induces activated protein 1 (AP-1) and nuclear factor kappaB (NFkB). Changes 
in expression of these proteins, which function normally to regulate cell proliferation 
and cell cycle control, are believed to be involved in human cancer development. 
Pretreatment of JB6 CI 41 mouse cells with methanol-extracted black raspberry 
fractions (1–100 µg/mL) dose-dependently inhibits carcinogen-induced AP-1 or NFkB 
protein expression in a luciferase reporter assay without affecting carcinogen/DNA 
binding (Huang et al., 2002). Inhibition of the AP-1 pathway or NFkB activation was 
mediated by a decrease in the phosphorylation of members of the MAPK protein 
family and inhibition of IkBα phosphorylation and degradation, respectively (Huang 
et al., 2002). Berry extracts were inhibitory only when given prior to or during 
carcinogen exposure. Similarly, methanol-extracted blackberry extract dramatically 
inhibited BPDE-induced activation of AP-1 and NFkB and subsequent expression of 
vascular endothelial growth factor (VEGF) and COX-2, proteins believed to have a key 
role in tumor promotion and progression. Further studies indicated that the blackberry 
extract was altering the cell signalling pathways responsible for activating AP-1 and 
NFkB by inhibiting MAPKs activity and IkBα phosphorylation (Lu et al., 2006). 
Blackberry and strawberry extracts and cyaniding-3-glucoside produced similar effects 
in the AP-1 and MAPK pathways in JB6 mouse cell treated with UVB or TPA (Feng et 
al., 2004; Wang et al., 2005; Ding et al., 2006). Whether down-regulation of this gene 
cascade alters tumorigenesis in vivo remains to be established. The process of 
metastasis, the spread of malignant cancer cells from their primary location to 
secondary sites in the body, is dependent on specific changes within the tumor. Cancer 
cells must attain increased motility, surface adhesion properties and increased 
extracellular protease activity to facilitate cell movement and invasiveness. 
Degradation and rupture of the extracellular matrix by proteases such as 
metalloproteinases (MMPs), serine proteinases and cathepsins, allow cancer cell 
migration and metastasis. Two glucosides of the anthocyanidin cyanidin (cyanidin 3-
rutinoside and cyanidin 3-glucoside) reduce the invasive ability of the highly 
metastatic human lung cancer cell line A549 by differentially altering transcription of 
several proteases involved in carcinogenesis (Chen et al., 2006). Expression of matrix 
metalloproteinase-2 (MMP-2) and urokinase-plasminogen activator (u-PA) was 
inhibited, while conversely, expression of tissue inhibitor of matrix metalloprotein-2 
(TIMP-2) and plasminogen activator inhibitor (PAI), endogenous inhibitors of MMP-2 
and u-PA, respectively, was increased (Chen et al., 2006). Extracts from blueberry 
down-regulate MMP activity and increase TIMP-1 and TIMP-2 activity in human 
prostate cancer cells in vitro (Manach et al., 2004). In a study of Katsube et al. (2003), 
among ethanol extracts of 10 edible berries, bilberry extract was found to be the most 
effective at inhibiting the growth of HL60 human leukemia cells and HCT116 human 
colon carcinoma cells in vitro. Bilberry extract induced apoptotic cell bodies and 
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nucleosomal DNA fragmentation in HL60 cells. The proportion of apoptotic cells 
induced by bilberry extract in HCT116 was much lower than that in HL60 cells, and 
DNA fragmentation was not induced in the former. Of the extracts tested, that from 
bilberry contained the largest amounts of phenolic compounds, including 
anthocyanins, and showed the greatest 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical 
scavenging activity. Pure delphinidin and malvidin, like the glycosides isolated from 
the bilberry extract, induced apoptosis in HL60 cells. These results indicate that the 
bilberry extract and the anthocyanins, bearing delphinidin or malvidin as the aglycon, 
inhibit the growth of HL60 cells through the induction of apoptosis. Only pure 
delphinidin and the glycoside isolated from the bilberry extract, but not malvidin and 
the glycoside, inhibited the growth of HCT116 cells (Katsube et al., 2003). Another 
study evaluated the bioactivities of phenolic compounds in rabbiteye blueberries and 
assessed their potential antiproliferation and apoptosis induction effects using two 
colon cancer cell lines, HT-29 and Caco-2. Polyphenols in three blueberry cultivars, 
Briteblue, Tifblue, and Powderblue, were extracted, freeze-dried and further separated 
into phenolic acids, tannins, flavonols, and anthocyanins. The dried extracts and 
fractions were added to the cell culture medium to test for antiproliferation activities 
and induction of apoptosis. Flavonol and tannin fractions resulted in 50% inhibition of 
cell proliferation at concentrations of 70-100 and 50-100 µg/mL in HT-29 and Caco-2 
cells, respectively. The phenolic acid fraction showed relatively lower bioactivities 
with 50% inhibition at ca. 1000 µg/mL. The greatest antiproliferation effect among all 
four fractions was from the anthocyanin fractions. Both HT-29 and Caco-2 cell growth 
was significantly inhibited by >50% by the anthocyanin fractions at concentrations of 
15-50 µg/mL. Anthocyanin fractions also resulted in 2-7 times increases in DNA 
fragmentation, indicating the induction of apoptosis (Yi et al., 2005). In the study of 
Shin et al (2009), the authors investigated if the anthocyanins isolated from meoru 
(Vitis coignetiae Pulliat) exerted antiproliferative and anti-invasive and apoptotic 
effects on human hepatoma Hep3B cells. It was found that the anthocyanins could 
inhibit cell growth by 75% at the concentration of 400 µg/mL for 48 h. Flow cytometric 
analysis showed that the anthocyanins increased the amount of DNA fragments (sub-
G1 fraction) in a dose-dependent manner, which is closely related to mitochondrial 
dysfunction and reduction in antiapoptotic proteins (Bcl-2, xIAP, cIAP-1, and cIAP-2). 
The anthocyanins also significantly inhibited the migration and invasion of Hep3B 
cells through a matrigel-coated chamber (Shin et al., 2009). Anthocyanins, cyanidin-3-
glucoside (Cy-3-glc) and delphinidin-3-glucoside (Dp-3-glc) and their respective 
vinylpyranoanthocyanin-catechins (portisins) inhibited, in a dose-dependent manner, 
the growth of the breast cancer cell line (ER-α) MCF-7. The cytotoxicity effect was 
higher when cells were treated with Dp-3-glc and its respective portisin, however this 
did not correspond to modification on mRNA ER expression (Fernandes et al., 2010). 
Inhibition of angiogenesis 
Angiogenesis is the process by which new blood vessels are formed from pre-existing 
vessels. Angiogenesis, a normal physiological process in growth and development and 
in wound healing, is also a fundamental step in the transition of tumors from a benign 
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to a malignant or invasive state. Tumors induce angiogenesis by secreting growth 
factors such as vascular endothelial growth factor (VEGF) to induce capillary growth 
into the tumor allowing tumor expansion and spread. VEGF is a chemical signal 
produced by cells that stimulates the growth of new blood vessels. It is part of the 
system that restores the oxygen supply to tissues when blood circulation is inadequate. 
When VEGF is over-expressed, it can contribute to disease. Solid cancers cannot grow 
beyond a limited size without an adequate blood supply; cancers that can express 
VEGF are able to grow and metastasize (Folkman, 2006).  
 
 
Figure 3.6.3 Interaction of key-players of the angiogenic process. Ang 1/2, angiopoetin 1 and 2; 
bFGF, basic fibroblast growth factor; CEC, circulating endothelial cell; EC, endothelial 
cell; ECM, extracellular matrix; EPC, endothelial progenitor cell; HIF, hypoxia-
inducible factor; MMP, matrix metalloproteinase; NO, nitric oxide; PDGF, 
plateletderived growth factor; SMC, smooth muscle cell; TGF-b, tumor growth factor-
b; TNF-a, tumour necrosis factor-a; TSP-1, thrombospondin-1; and VEGF, vascular 
endothelial growth factor. Adapted from (de Vos et al., 2004). 
 
Cancer cells can dissociate from the main tumor and be carried in the circulation to a 
site distant from the primary tumor where they implant and begin formation of a 
secondary tumor (Figure 3.6.3). 
Several berry derivatives have potent anti-angiogenesis properties in vitro. In a series 
of elegant experiments, berry extracts (wild blueberry, bilberry, cranberry, elderberry, 
raspberry seed and strawberry) were tested for their ability to inhibit angiogenesis via 
altered VEGF expression and invasiveness. Human HaCaT keratinocytes, which are 
normally quiescent, retain the ability to initiate angiogenesis in response to certain 
stimuli. Each of the berry extracts inhibited hydrogen peroxide and TNF-α induced 
VEGF expression in these cells. Inducible VEGF expression was related to the 
flavonoid component of the berry extracts, independently of their antioxidant potential 
(Roy et al., 2002). Moreover, in the same study, berry extracts were able to inhibit 
angiogenesis in human dermal microvascular endothelial cells (Roy et al., 2002). 
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Similarly, crude whole black raspberry extract (at a concentration of 0.1% w/v) was 
antiangiogenic in a human placental tissue-based fibrin clot angiogenesis assay (Liu et 
al., 2005). Fractionation of crude extract revealed a highly potent anti-angiogenic 
component that accounted for only 1% of the fresh weight of the whole berries. This 
highly active fraction completely inhibited angiogenic initiation and vessel sprouting. 
Several active compounds, including gallic acid, were subsequently identified, 
although none was as effective individually as the whole fraction, indicating that these 
compounds act synergistically (Liu et al., 2005). Berry extracts can also inhibit 
angiogenesis in animals. Hemangiomas are abnormally dense collections of dilated 
capillaries that can occur in the skin or internal organs and have been used to model 
angiogenesis in vivo. Mouse endothelioma cells (EOMA) injected into compatible host 
animals proliferate to form blood vessel conduits that fuse with the systemic 
circulation, drawing blood into the hemangioma. EOMA cells pretreated in culture 
either with wild blueberry or a proprietary berry mix (OptiBerry) were unable to form 
hemangioma tumors as effectively as placebo-treated cells after injection into host 
mice. In the wild blueberry treatment group, less that 50% of the animals tested 
positive for the presence of a hemangioma and in those animals that tested positively, 
tumor mass was below 50% of that observed in the untreated group. Moreover, 
macrophage infiltration was significantly lower in these animals (Atalay et al., 2003). 
Macrophages, recruited to sites of inflammation or infection, produce growth factors 
and cytokines that regulate angiogenesis. Berry extracts may work to inhibit 
angiogenesis by inhibiting inducible expression of NFkB and basal expression of 
monocyte chemotactic protein 1 (MCP-1) (Atalay et al., 2003). 
Basal and VEGF-stimulated HUVEC migration and proliferation are potently inhibited 
by delphinidin (10-20 µg/mL). Flow cytometric analysis demonstrated that delphinidin 
inhibition of proliferation is correlated with the blockade of cell cycle in G(0)/G(1) 
phase. Western blot analysis showed that delphinidin reverses the VEGF-induced 
decrease in expression of cyclin-dependent kinase inhibitor p27(kip1) and the VEGF-
induced increase of cyclin D1 and cyclin A, both being necessary to achieve the G(1)-
to-S transition. Furthermore, delphinidin inhibits neovascularisation in vivo in 
chorioallantoic membrane model (Favot et al., 2003). 
Among the tested anthocyanidins (cyanidin, delphinidin, malvidin, pelargonidin, 
peonidin and petunidin), Lamy and colleagues (2006) found that delphinidin was the 
most potent angiogenic inhibitor. In vitro, low concentrations of delphinidin (25 µM) 
inhibited VEGF-induced tyrosine phosphorylation of VEGF receptor (VEGFR)-2, 
leading to the inhibition of downstream signaling triggered by VEGFR-2. Inhibition of 
VEGFR-2 by delphinidin repressed the VEGF-induced activation of ERK-1/2 signaling 
and the chemotactic motility of HUVEC as well as their differentiation into capillary-
like tubular structures in Matrigel and within fibrin gels. In vivo, delphinidin (300 µM) 
was able to suppress basic fibroblast growth factor-induced vessel formation in the 
mouse Matrigel plug assay (Lamy et al., 2006).  
Recently, tumor vascular targeting has expanded to include not only endothelial cells 
(EC) but also smooth muscle cells (SMC), which contribute to a mature and functional 
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vasculature. In a more recent study, Lamy showed that delphinidin (25 µM) also 
inhibits activation of the platelet-derived growth factor (PDGF)-BB receptor-beta 
[platelet-derived growth factor receptor-beta (PDGFR-beta)] in SMC and that this 
inhibition may contribute to its antitumor effect. The inhibitory effect of delphinidin on 
PDGFR-beta was very rapid and led to the inhibition of PDGF-BB-induced activation 
of extracellular signal-regulated kinase (ERK)-1/2 signaling, in a dose-dependent 
manner, with a complete inhibition at 20 µM, and of the chemotactic motility of SMC, 
as well as the differentiation and stabilization of EC and SMC into capillary-like 
tubular structures in a three-dimensional co-culture system. Using an anthocyan-rich 
extract of berries, the authors showed that berry extracts were able to suppress the 
synergistic induction of vessel formation by basic fibroblast growth factor-2 and 
PDGF-BB in the mouse Matrigel plug assay. Oral administration of the berry extract 
also significantly retarded tumor growth in a lung carcinoma xenograft model (Lamy 
et al., 2008). 
A very recent study (Matsunaga et al., 2010) was designed to examine the 
antiangiogenic properties and antioxidant activities of the main anthocyanidins 
(delphinidin, cyanidin and malvidin) found as constituents in Vaccinium myrtillus 
(bilberry) anthocyanosides (VMA) and of N-acetyl-L-cysteine (NAC). Each of these 
anthocyanidins concentration-dependently inhibited VEGF-induced tube formation in 
a co-culture of human umbilical vein endothelial cells (HUVECs) and fibroblasts, the 
effect of each anthocyanidin being significant at 3 and/or 10 µM, while NAC 
significantly inhibited such tube formation at 1 µM (the only concentration tested). 
Moreover, each anthocyanidin (0.3-10 µM) and NAC (1-1000 µM) concentration-
dependently scavenged the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. The 
inhibitory effects against angiogenesis were similar among the anthocyanidins, as were 
those against the DPPH radical. Moreover, their radical-scavenging effects were 
induced by concentrations that were at or below those that induced their 
antiangiogenic effects. These findings indicate that the inhibitory effect of VMA on 
angiogenesis may depend on those of its main constituent anthocyanidins 
(delphinidin, cyanidin and malvidin), presumably via antioxidant effects (Matsunaga 
et al., 2010). 
Antinflammatory activity 
Other effects of ACNs associated with protection from oxidative stress involve their 
role in reducing the inflammatory response as demonstrated by a decline of markers 
such IL-1-β, IL-6, TNF-α in rats (Tsuda et al., 2002) and in humans (Bagchi et al., 2004; 
Neto, 2007).  
In a review on anti-inflammatory compounds of plant origin, Calixto and colleagues 
(2004) found that many phenolic compounds exert their effects through the 
modulation of the cytokine system. In particular the effects described for ACNs and 
phorogucinol derivates seem to be dependent on the blockade of NFkB activation, but 
might also include the inhibition of other pro-inflammatory pathways (Calixto et al., 
2004). Tsuda and colleagues (2002) reported that oral administration of Cy-3-glc 
suppressed the zymosan-induced response in rats. Treatments with Cy-3-glc also 
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reduced the elevation of NOx, TNF-α, IL-1β, IL-6 and CINC-1 concentrations. 
Furthermore, Cy-3-glc normalized several acute phase proteins in rats treated with 
zymosan. Kim and co-authors (2006) examined the inhibition of the expression of some 
inflammatory genes associated with ischemia-reperfusion (I/R) injury by anthocyanins 
isolated from black soybean seed coat in (TNF-α)-treated bovine aortic endothelial 
cells. In addition, its potential use on I/R-injury was investigated using rats subjected 
to 30-min occlusion of left descending coronary artery followed by 24-h reperfusion. 
Western blot analysis and luciferase activity assay showed that anthocyanins inhibited 
TNF-α-induced VCAM-1, ICAM-1, and COX-2 levels, which is through NFkB-
dependent pathway. Further, anthocyanins protected myocardiac injury from I/R in 
rats (Kim et al., 2006). CD40 is a member of TNF receptor superfamily that provides 
activation signals not only in antigen-presenting cells but also in a variety of non-
immune cells, including vascular cells like endothelial cells (ECs). Intracellular tumor 
necrosis factor receptor-associated factors (TRAFs) translocation to lipid rafts is a key 
element in CD40-induced signaling. Treatment of ECs with anthocyanin (Cy-3-glc and 
Pn-3-glc, 100µM) prevented from CD40-induced proinflammatory status, measured by 
production of IL-6, IL-8, and monocyte chemoattractant protein-1 through inhibiting 
CD40-induced NFkB activation. TRAF-2 played pivotal role in CD40–NFkB pathway 
as TRAF-2 small interference RNA (siRNA) diminished CD40-induced NFkB 
activation and inflammation. TRAF-2 overexpression increased CD40-mediated NFkB 
activation. Moreover, TRAF-2 almost totally recruited to lipid rafts after stimulation by 
CD40 ligand and depletion of cholesterol diminished CD40-mediated NFkB activation. 
Exposure to anthocyanin not only interrupted TRAF-2 recruitment to lipid rafts but 
also decreased cholesterol content in Triton X-100 insoluble lipid rafts. However, 
anthocyanin did not influence the interaction between CD40 ligand and CD40 
receptor. So the authors conclude that their findings suggest that anthocyanin protects 
from CD40-induced proinflammatory signaling by preventing TRAF-2 translocation to 
lipid rafts through regulation of cholesterol distribution, which thereby may represent 
a mechanism that would explain the anti-inflammatory response of anthocyanin (Xia et 
al., 2007). 
Sustained microglial activation in the central nervous system (CNS) has been 
extensively investigated in age-related neurodegenerative diseases and has been 
postulated to lead to neuronal cell loss in these conditions. Lau and co- authors (2007) 
investigated the effect of blueberry extract on preventing inflammation-induced 
activation of microglia. Results indicated that treatments with blueberry extract 
inhibited the production of the inflammatory mediator nitric oxide (NO) as well as the 
cytokines IL-1β and TNFα, in cell conditioned media from lipopolysaccharide (LPS)-
activated BV2 microglia. Also, mRNA and protein levels of inducible nitric oxide 
synthase and COX-2 in LPS-activated BV2 cells were significantly reduced by 
treatments with blueberry extract (Lau et al., 2007) 
Relationship thrombosis-tumor: the role of endothelium 
Endothelial cells are involved in many aspects of vascular biology, including: 
vasoconstriction and vasodilatation, and hence the control of blood pressure; blood 
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clotting (thrombosis & fibrinolysis); atherosclerosis; formation of new blood vessels 
(angiogenesis); inflammation and swelling (oedema) (Grandel & Grimminger, 2003). 
Endothelial cells also play an important role in the passage of various materials and of 
white blood cells from bloodstream to tissues and vice versa (Figure 3.6.4). In some 
organs, endothelial cells are highly differentiated to perform specialized 'filtering' 
functions. Examples of such unique endothelial structures include the renal 
glomerulus and the blood-brain barrier (Grandel & Grimminger, 2003).  
Under physiological conditions, endothelial cells generate an active antithrombotic 
surface that inhibits clotting activation and reduce the adhesion of platelets and other 
circulating cells. When exposed to physical or biochemical stimuli, endothelium 
undertakes a series of phenotypic changes that leads to a shift towards a 
prothrombotic condition. In particular, bacterial products (e.g. lipopolysaccharide, 
LPS), as well as inflammatory cytokines, stimulate endothelial cells to express 
procoagulant tissue factor (TF) and cell adhesion molecules (Dauphinee & Karsan, 
2006). It seems that LPS directly induce the prothrombotic state by upregulating the 
endothelial expression of TF through an NFkB-dependent mechanism (Parry & 
Mackman, 1995). 
 
Figure 3.6.4 Endothelium is the layer of thin specialized epithelium, comprised of a simple 
squamous layer of cells that line the interior surface of blood vessels, forming an 
interface between circulating blood in the lumen and the rest of the vessel wall (simple 
squamous epithelium). Endothelial cells line the entire circulatory system, from the 
heart to the smallest capillary (Jaffe, 1987). 
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These modifications can lead to the activation of the blood clotting cascade (Figure 
3.6.5), which culminates in fibrin generation, in addition to increasing cellular adhesion 
processes, which can further stimulate localized coagulation. These phenomena are 
also involved in the progression of chronic inflammatory diseases and are of particular 
relevance at  microcirculation level, where the interactions between the vascular wall 
and circulating cells are enhanced. TF, also known as FIII, is a cell-bound 
transmembrane glycoprotein that is constitutively expressed by fibroblasts and smooth 
muscle cells of the vessel wall (Furie & Furie, 2008). It is also constitutively expressed 
in many tissues such as the brain, heart, lungs, kidneys, testes, and placenta, 
highlighting the importance of this glycoprotein (Semeraro & Colucci, 1997). 
Inflammatory stimuli (eg, LPS in sepsis), adhesion molecules (eg, P-selectin expressed 
on activated platelets and CD40 ligand expressed on activated white blood cells), 
inflammatory cytokines (eg, interleukin-6 and tumor necrosis factor), and oxidized 
low-density lipoprotein (LDL) can induce TF expression in monocytes and endothelial 
cells (Grignani & Maiolo, 2000). Circulating microparticles derived from monocytes 
and other cell types have also been shown to express TF on their surface (Panes et al., 
2007). 
Figure 3.6.5 Overview of the coagulation cascade 
 
TF not only plays an important role in coagulation but also mediates intracellular 
signaling events in inflammation, apoptosis, embryonic development, and cell 
migration (Rao & Pendurthi, 2005). In veins, endothelial cell activation results in the 
expression of adhesion molecules that then tether TF-bearing monocytes or 
microparticles onto their surface. It is thought that these tethered cells may trigger 
venous thrombosis (Furie & Furie, 2008). TF-bearing cells or microparticles provide the 
key cellular surface for the initiation of coagulation (Furie & Furie, 2008). Coagulation 
is initiated when TF binds to circulating FVIIa, forming a catalytic complex, TF-FVIIa, 
the so-called extrinsic tenase complex, on the phospholipid surface of the TF-bearing 
cell membrane (Hoffman & Monroe, 2007; Furie & Furie, 2008). See also Figure 3.6.5. 
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The extrinsic tenase complex then activates FIX and FX, and the resultant FXa converts 
a small amount of prothrombin (FII) to thrombin. This small amount of thrombin 
triggers the amplification phase by activating platelets as well as FV, FVIII, and FXI. 
Activated platelets provide a surface on which the coagulation factors assemble 
together. FXIa generates additional FIXa, which then binds to FVIIIa on the surface of 
activated platelets to form the intrinsic tenase complex. This complex propagates 
coagulation by efficiently activating FX. FXa binds to FVa on the surface of activated 
platelets to form the prothrombinase complex. A potent activator of prothrombin, the 
prothrombinase complex triggers a burst of thrombin generation (Hoffman & Monroe, 
2007; Furie & Furie, 2008). 
Blood coagulation and cancer biology are strictly related. In patients with cancer, blood 
coagulation is activated in the direction of a prothrombotic state. Moreover, a pro-
coagulant environment may promote cancer progression in different ways. Blood 
coagulation proteins interact with cells in the vasculature to maintain hemostasis. 
However, many proteins that are involved in coagulation and anticoagulation, as well 
as fibrinolysis, are also found in extravascular tissues. In different organs, these 
proteins may be involved in cell-signaling mechanisms, through interaction with cell 
receptors like protease-activated receptors (PARs). Such interactions may drive 
inflammation, angiogenesis and cell proliferation. The potential procarcinogenic 
actions of proteases like thrombin may be counteracted by the anticoagulant and anti-
inflammatory actions of the protein C-thrombomodulin mechanism (ten Cate & 
Falanga, 2008). Patients with hematologic malignancies are at high risk of thrombotic 
or hemorrhagic complications. The incidence of these events is greatly variable and is 
influenced by many factors, including the type of disease, the type of chemotherapy, 
and the use of a central venous device. As in solid tumors, a number of clinical risk 
factors have been identified and contribute to the increasing thrombotic rate in 
hematologic malignancies. Biologic properties of the tumor cells can influence the 
hypercoagulable state of patients with these malignancies by several mechanisms. Of 
interest, oncogenes responsible for neoplastic transformation in leukemia also may be 
involved in clotting activation (Falanga & Marchetti, 2009). In the blood of cancer 
patients, the balance is usually shifted towards a procoagulant direction. The resulting 
excess thrombin- and fibrin-forming activity promotes venous thrombosis and may in 
the extravascular compartment stimulate cancer progression. The activation of 
platelets and their interaction with leukocytes may propagate this process. In addition 
to the therapeutic modulation of the prothrombotic environment, the induction of 
specific anticoagulant proteins including thrombomodulin may have effects on tumor 
growth or dissemination, but the nature of these effects still remains hard to predict 
(ten Cate & Falanga, 2008). Recently, emphasis has been given to the potential risk of 
cancer therapy (both surgery and chemotherapy) in enhancing the risk for 
thromboembolic disease. Possible contributory causes for thromboembolic disease in 
cancer include the capacity of tumor cells and their products to interact with platelets, 
clotting and fibrinolytic systems, as well as their interactions with endothelial cells and 
tumor-associated macrophages. Cytokine release, acute phase reaction and 
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neovascularization may contribute, in cancer patient, to in vivo clotting activation, 
which is well documented by several plasmatic markers of an hypercoagulable state. 
Last but not least, a direct pathogenetic role of clotting activation in the progression of 
malignancy has been repeatedly proposed on the basis of pharmacological studies 
with anticoagulant/fibrinolytic drugs in experimental animals and selected clinical 
malignancies, as well as, lately, in genetically modified animal models (e.g. mice 
transgenic for PAI-1) (Donati, 1994). 
 
Given this background and the important role of vegetables and fruits intake in the 
protection and prevention against tumor development, it is of interest to determine 
bioactive compounds action at the microvascular level. In particular little is known 
about the effects of phytochemicals on angiogenesis and procoagulant activity of 
endothelial cells. 
We designed an in vitro study to investigate the effect of selected fruit bioactive 
compounds, delphinidin-3-glucoside (Dp-3-glc) and cyanidin-3-glucoside (Cy-3-glc) 
(Figure 3.6.6), on different endothelial cell functions involved in both angiogenesis and 
hemostasis. 
 
Figure 3.6.6 Chemical structures of Cyanidin-3-glucoside (Cy-3-glc)  
and Delphinidin-3-glucoside (Dp-3-glc) 
 
3.7 Materials and methods 
 
Endothelial cells 
The immortalized human microvascular endothelial cell line-1 (HMEC-1) was kindly 
supplied by Dr. F.J. Candal (CDC, Centers for Disease Control and Prevention, 
Atlanta, GA, USA) (Ribeiro et al., 1995). HMEC-1 were grown in RPMI 1640 medium 
(Gibco, Gaithersburg, MD, U.S.A.) supplemented with 5% fetal bovine serum (FBS, 
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Gibco), 2 mM L-glutamine (Gibco), 10 ng/ml epidermal growth factor (ICN, Costa 
Mesa, CA, U.S.A.) and 1 µg/ml hydrocortisone (ICN), 100 µg/ml streptomycin (Bristol-
Myers Squibb, Princeton, NJ, USA), 5 µg/ml amphotericin B (Bristol-Myers Squibb). 
HMEC-1 were kept in a 5% CO2/95% air atmosphere in a humidified incubator 
(Heraeus, Milan, Italy) at 37°C and serially passaged in T25 flasks (Falcon, Becton 
Dickinson, Mountain View, CA, USA) by trypsin/EDTA treatment (0.25% 
trypsin/EDTA solution, Life Technologies, Inc., Rockville, MD, U.S.A.) at 1:3 split ratio, 
twice a week. At the end of each experiment, endothelial cells were counted under 
microscopy and the Trypan Blue exclusion test was used to determine cell viability. 
More than 95% of cells resulted viable in all experiments. 
Preparation of Pool of platelet-poor plasma (PPP) 
Pool of platelet-poor plasma (PPP) was isolated from citrated blood of 40 healthy 
volunteers by double sequential centrifugation at 3,000 g for 15 min at room 
temperature, aliquoted, snap-frozen in liquid nitrogen, and stored at -80°C until 
testing. 
 
3.7.1 Angiogenesis study 
Since most cancers are dependent on the growth of tumor blood vessels, angiogenesis 
may thus provide an efficient strategy to delay or block tumor growth. Capillary-like 
formation assay is a reliable approach able to test pro- or or anti-angiogenic properties 
of a chemical compound (Folkman, 2003). The method is based on the differentiation 
of endothelial cells to form capillary-like structures on a basement membrane matrix, 
Matrigel. It is a matrix of a mouse basement membrane neoplasm. Matrigel is 
composed of a complex mixture of basement proteins, including laminin, type IV 
collagen, entactin/nitrogen and proteoheparan sulfate, and also contains growth 
factors. Migration and proliferation of endothelial cells are critical steps in 
angiogenesis since these events allow cells to disseminate from pre-existing vessels to 
form new capillary structures. 
 
Capillary-like tube formation assay in Matrigel 
A Matrigel-based capillary-genesis assay was performed on HMEC-1 to assess the 
ability of these cells to form an organized tubular network. Standard Delphinidin-3-O-
glucoside (Dp-3-glc) and Cyanidin-3-glucoside (Cy-3-glc) were purchased from 
Polyphenols Laboratory (Sadnes, Norway), their chemical structures are represented in 
Figure 3.6.6. They were stored dried at -20°C until the execution of each experiment. 
Appropriate amounts of Dp-3-glc and Cy-3-glc were dissolved in RPMI 1640 medium 
at the appropriate concentrations just before each experiment. The day before the 
experiment confluent HMEC-1 were starved overnight with fresh RPMI 1640 medium 
supplemented with 1% FBS. Growth factor-reduced Matrigel® (Becton Dickinson) was 
thawed overnight on ice at +4°C. The day of the assay Matrigel was placed on the 
bottom of 96-well plate, and left at 37°C for 1h to gelificate. Starved HMEC-1 were 
collected  by enzymatic detachment (0.25% trypsin-EDTA), counted and re-suspended 
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in RPMI 1640 medium supplemented with 0.5% FBS. Then, 10,000 HMEC-1 cells/well 
were seeded on Matrigel and incubated at 37°C in a 5% CO2-humidified atmosphere 
with 50 ng/mL of purified recombinant human (rHu) VEGF165 (R&D System,  
Minneapolis, MN), in absence or presence of increasing doses of Dp-3-glc and Cy-3-glc 
(0.1-1-10-100 µM). In resting condition experiments, the effect of ACN was evaluated 
in the absence of VEGF pro-angiogenic stimulus. After 24h of incubation tube 
formation was examined under inverted light microscopy (LEICA DM IRB, Germany). 
Digital images were acquired using a microcamera system (Optikam PRO 3 Digital 
Camera, Ponteranica, Italy) at 5X magnification. Three images per well were randomly 
taken in different areas of the well, selecting those areas that were distinct and distant 
enough to not overlap each other. Total tube length was determined by an image 
analysis software (Image J, National Institutes of Health, Bethesda, MD, U.S.A.). Photo 
capture and tube length quantification were performed by two observers blinded to 
treatment group. Results are expressed as mm tube length/cm2 area.  
Wound healing assay 
A wound healing assay was set-up to determine the capacity of HMEC-1 to 
migrate/proliferate in both resting and rHu VEGF165-stimulated condition. The same 
method was recently used in our laboratory to determine the ability of heparins to 
affect HMEC-1 migration (Vignoli et al., in press 2010).  
Particularly, HMEC-1 were collected by enzymatic detachment (0.25% trypsin-EDTA 
solution), counted and re-suspended in RPMI 1640 medium with 5% FBS. Then 10,000 
cell/well (100 µL) were seeded in a 96-well culture plate and incubated at 37°C in a 5% 
CO2-humidified atmosphere until they reached the confluence (i.e. 3-4 days). In the 
middle of the well, a wound was created by aspiration of cells with vacuum system 
using a p10 µl tip. After 2 washes with RPMI 1640 medium, pre-treatment images were 
acquired using a microcamera system (5X objective), as explained for capillary-like 
tube formation assay. Then washing medium was removed and HMEC-1 were 
incubated at 37°C in the incubator with 50 ng/mL of purified VEGF165, in absence or 
presence of increasing doses of Dp-3-glc and Cy-3-glc (0.1-1-10-100 µM). In resting 
condition experiments, the effect of ACN was evaluated in the absence of VEGF pro-
angiogenic stimulus. After 18h incubation post-treatment images were acquired. For 
each well pre- and post-treatment images were compared, and the area occupied by 
migrating/proliferating cells (“re-growth area”) was calculated using the ImageJ 1.42q 
software. Results are expressed as percentage of re-growth, assuming the area 
occupied by control cells as 100% of re-growth.  
3.7.2 HMEC-1 pro-coagulant properties 
Activation of the coagulation system and ensuing thrombin generation is dependent 
on expression of TF and the simultaneous down-regulation of endothelial-bound 
anticoagulant mechanisms and endogenous fibrinolysis. Thrombin generation (TG), 
converting fibrinogen to fibrin and leading to clot formation, is the endpoint of a 
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complex series of proteolytic reactions, as reported in detail in the introduction of this 
topic (Gailani & Broze, 1991; Hemker & Beguin, 1995). 
In previous works conducted in the Hemostasis & Thrombosis Center in Bergamo, 
treatment of HMEC-1 with LPS induced a time-dependent increase in TF expression 
evaluated as activity, antigen and mRNA expression with a maximum effect at 4-6h 
and then a progressive decline towards basal values at 24-48h (Vignoli et al., 2006). In 
order to evaluate the activity of Dp-3-glc on LPS-induced TF-expression, we chose the 
4h time point, i.e. when the effect of the bacterial endotoxin stimulus was maximum. 
 
Thrombin generation assay (TG) on HMEC-1 intact monolayer 
HMEC-1 were collected by enzymatic detachment (0.25% trypsin-EDTA solution), 
counted and re-suspended in RPMI 1640 medium containing 5% FBS. Then 10,000 
cell/well (100 µL) were seeded in a 96-well plate and incubated at 37°C and 5% CO2 in 
a humidified atmosphere. At confluence (i.e. 3-4 days), HMEC-1 were incubated for 4h 
in complete culture medium with increasing concentrations of Dp-3-glc (1, 10, 100 µM) 
both in the absence or presence of 10 µg/ml LPS (Lipopolysaccharide, bacterial 
endotoxin from Escherichia coli, Sigma) or complete culture medium (control cells, 
CTR). Additional experiments were performed with Dp-3-glc alone with 24h of 
incubation. At the end of incubation, HMEC-1 were washed 3 times with phosphate-
buffered saline (PBS, pH 7.4), and immediately tested for their capacity to induce 
thrombin generation (TG) in normal pool plasma (PPP) by the Calibrated Automated 
Thrombogram (CAT) assay (Hemker et al., 2006). This method uses a low-affinity 
fluorogenic substrate for thrombin to monitor the formation and inhibition of 
thrombin in a plasma sample triggered by TF, phospholipids, and CaCl2. Briefly, 80 µl 
PFP was added to each culture well plate together with 20 µl of HEPES, or rHuTF (1 
pM and 5 pM plus 4 µM phospholipids) or calibration factor (CAL). After 10 minutes 
at 37°C, the reaction was started by the addition of 20 µl of a mixture containing the 
fluorogenic substrate (Z-Gly-Gly-Arg-AMC; Bachem, Bubendorf, Switzerland) and 
CaCl2. Fluorescence was read in a Fluoroskan Ascent reader (Thermo Labsystems, 
Helsinki, Finland), and thrombin generation curves (Figure 3.7.2.1) were calculated 
using Thrombinoscope software (Thrombinoscope, Maastricht, The Netherlands). TG 
curves were described in terms of lag-time, time to Peak (ttPeak), and area under the 
curve (endogenous thrombin potential, ETP). 
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Figure 3.7.2.1 The parameters of the thrombogram. A) Lag-time (min), B) Peak height (nM), C) 
Endogenous thrombin potential (ETP) (= area under the curve)(nM x min), D) 
maximal rising slope (nM/min), E) time to peak (min), (Hemker & Beguin, 1995). 
 
TG of HMEC-1 lysates 
HMEC-1 were collected by enzymatic detachment (0.25% trypsin-EDTA solution), 
counted and re-suspended in RPMI 1640 medium containing 5% FBS. Then 106 cells 
were seeded in T25 flasks and incubated at 37°C and 5% CO2 in a humidified 
atmosphere until they were confluent (3-4 days). LPS in the absence or presence of Dp-
3-glc (1, 10, 100 µM) or culture medium (control cells, CTR) was then added. After 4h, 
cells were washed three times with saline, detached by scraping and re-suspended in 
saline for cell count. 
TG was evaluated in HMEC-1 lysates (3x106 cells/mL PBS), obtained after three cycles 
of freezing/thawing, by the CAT assay in PPP (Hemker et al., 2006). Briefly, 80 µl 
plasma was pipetted into the well of a microtiter plate together with 20 µl of HMEC-1 
PBS lysate, or rHuTF (1 pM and 5 pM plus 4 µM phospholipids) or calibration factor 
(CAL). After 10 minutes at 37°C, the reaction was started by the addition of 20 µl of a 
mixture containing the fluorogenic substrate (Z-Gly-Gly-Arg-AMC) and CaCl2. TG 
was quantified as described above. 
HMEC-1 procoagulant activity  
HMEC-1 lysates were prepared as for TG evaluation. PCA was evaluated in HMEC-1 
lysates by the one-stage re-calcification assay of PPP. PCA was referred to a calibration 
curve constructed with different dilutions (up to 10-6) of a standard rabbit brain 
thromboplastin (RBT; Sigma). Results are expressed as standard thromboplastin 
arbitrary units (URBT)/106 cells, 1 unit the activity of 1 mEquiv/ ml of RBT in the 
coagulation assay. 
HMEC-1 TF antigen 
HMEC-1 were collected by enzymatic detachment (0.25% trypsin-EDTA solution), 
counted and re-suspended in RPMI 1640 medium containing 5% FBS. Then 106 cells 
were seeded in T25 flasks and incubated at 37°C and 5% CO2 in a humidified 
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atmosphere until they were confluent (3-4 days). LPS in the absence or presence of Dp-
3-glc (1, 10, 100 µM) or culture medium (CTR) was then added. After 4h, cells were 
washed three times with saline, detached by scraping and re-suspended in saline for 
cell count. 
TF antigen levels were quantified in HMEC-1 extracts (0.5x106 cell/mL) in TRIS buffer 
(50 mmol/l Tris, 100 mmol/l NaCl and 1% Triton-X 100, pH 7.5) by IMUBIND® Tissue 
factor ELISA (American Diagnostica Inc., Stamford, CT, USA) according to the 
manufacturer’s instructions. Results are expressed as pg/106 cells. 
HMEC-1 TF mRNA expression 
Evaluation of mRNA expression of TF in HMEC-1 was determined with Real Time RT-
PCR. HMEC-1 were cultured and treated in T25 flasks as for the previous experiments. 
Then 1.5x106 washed cells were re-suspended in 350 µL guanidinium thiocyanate and 
stored at -80°C until RNA extraction. 
Total cellular RNA was extracted using RNeasy® Mini kit (Qiagen). Retro-
transcription of cDNA was performed with RT-kit plus (Nanogen Advanced 
Diagnostics S.r.L., Italy) according to manufacturer’s instructions. cDNA was used for 
amplification of Tissue Factor (TF) in Real Time PCR (Rotor Gene™ 6000, Explera a 
Qiagen Company, Italy). Simultaneous amplification of the invariant housekeeping 
gene glyceraldheyde-3-phosphate dehydrogenase (GAPDH) was performed. The 
following oligonucleotides were used : TF forward: 5’- AGG TGG GAA CAA AAG 
TGA ATG TG-3’, and TF reverse exon 4-5: 5’-TTT TGG CTG TTT TCT TTC CTG AAC-
3’; GAPDH forward: 5’-GAA GGT GAA GGT CGG AGT C-3’ and GAPDH reverse: 5’-
GAA GAT GGT GAT GGG ATT TC-3’, (Laboratoires Eurobio, Les Uils, France). 
Thermocycling consisted of: 2 min at 95°C for Go Taq®  Hot Start Polymerase 
activation, 50 cycles of 15 sec at 95°C followed by of 60 sec at 56°C (acquiring step), and 
60 sec at 72°C and stopped with a melting curve (ramp from 50°C to 99°C rising by 1°C 
each step, waiting for 90 sec of pre-melt conditioning on first step and 5 sec for each 
step afterwards). 
PCR amplification was performed with Go Taq qPCR Master Mix (Promega 
Corporation, Madison, USA): 12.5 µL of Go Taq qPCR Master Mix 2X, 0.5 µL of each 
oligonucleotide (0.08 µM), 2 µL of cDNA (100 ng) and 9.5 µL of nuclease-free water in 
a final volume of 25 µL. Data analysis was performed with comparative quantitation of 
Ct sample values. The internal calibrator selected was CTR (not treated cells) with 
reported concentration of 1 fold. Then the ratio of TF on GAPDH values used as 
control was calculated for each sample.  
 
Statistical analysis 
Student’s paired and unpaired t-test was used for the determination of significance 
levels between the different treatments. Differences were considered significant when 
p<0.05. 
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3.8 Results and discussion TOPIC II 
 
3.8.1 Angiogenesis study 
 
Capillary-like tube formation assay in Matrigel 
To assess whether Dp-3-glc and Cy-3-glc might affect the formation of capillary-like 
tubes, HMEC-1 were seeded on Matrigel and treated for 24h with 0.1-1-10-100 µM Dp-
3-glc or Cy-3-glc in the absence of exogenous pro-angiogenic stimuli (i.e. resting 
condition).  
A 
 
B 
 
Figure 3.8.1.1  Effect of Dp-3-glc on capillary-like tube formation. Dp-3-glc showed a significant 
inhibitory effect in tube formation at the 100 μM concentration in resting (panel A) 
and VEGF-stimulated (panel B) conditions. Data are expressed as the mean of three 
independent experiments ± SD. * p<0.05 vs CTR; § p<0.05 vs VEGF. 
 
As shown in Figure 3.8.1.1-A, only at 100 µM concentration Dp-3-glc affected in a 
statistically significant manner (p<0.005) the capacity of HMEC-1 to form the capillary-
like tubes, with a reduction of 50% compared to control cells (CTR). Similar 
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experiments were performed with rHuVEGF165-stimulated HMEC-1. Treatment with 
50 ng/ml rHuVEGF165 induced a statistically significant (p<0.005) increase in capillary 
tube length compared to control cells. The addition of Dp-3-glc was able to dose-
dependently counteract VEGF stimulus, reaching a complete inhibition at the 
concentration of 100 µM (p<0.05) (Figure 3.8.1.1-B). 
 
A 
 
B 
 
 
Figure 3.8.1.2 Effect of Cy-3-glc on capillary-like tube formation. Cy-3-glc did not show a significant 
inhibitory effect in tube formation in resting (panel A) and VEGF-stimulated (panel B) 
conditions. Data are expressed as the mean of three independent experiments ± SD. 
 * p<0.05 vs CTR 
Differently, Cy-3-glc in the same experimental conditions did not show any statistically 
significant inhibitory effect on the formation of capillary structures, in either resting or 
VEGF-stimulated HMEC-1 (Figure 3.8.1.2). 
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Wound healing assay 
The effect of Dp-3-glc and Cy-3-glc on HMEC-1 migration/proliferation was tested in 
both resting and VEGF-stimulated conditions by the wound healing assay.  
In resting conditions (Figure 3.8.1.3-A), 100 µM Dp-3-glc significantly decreased by 
90% the migration of HMEC-1 (p<0.0001). At lower Dp-3-glc concentrations no 
statistically significant effects on HMEC-1 migration were observed. VEGF induced a 
significant (p<0.001) increase in HMEC-1 re-growth: this effect that was significantly 
counteracted by Dp-3-glc starting from the concentration of 1 µM, reaching a complete 
(100%) inhibition at 100 µM (p<0.01), (Figure 3.8.1.3-B). 
A 
 
B 
 
 
Figure 3.8.1.3 Effect of Dp-3-glc on migration in the wound healing assay. Dp-3-glc showed a 
significant inhibitory effect of re-growth area at the maximum concentration in resting 
conditions (panel A) and at 1 μM in combination with VEGF (panel B). Data are 
expressed as the mean of three independent experiments ± SD. * p<0.05 vs CTR; § 
p<0.05 vs VEGF. 
 
 
 
114 
 
As observed with the capillary-like tube formation assay, Cy-3-glc did not show any 
statistically significant effect on HMEC-1 migration in both resting and VEGF-
stimulated condition (Figure 3.8.1.4). 
 
A 
  
B 
 
Figure 3.8.1.4 Effect of Cy-3-glc on migration in the wound healing assay. Cy-3-glc did not show a 
significant inhibitory effect in re-growth area in resting (A, on the left) and VEGF-
stimulated (B, on the right) conditions. Data are expressed as the mean of three 
independent experiments ± SD. *p<0.05 vs CTR 
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3.8.2 HMEC-1 pro-coagulant properties 
 
TG on HMEC-1 intact monolayer 
The study of the effect of Dp-3-glc on endothelial cell-induced TG was performed in 2 
different experimental conditions: resting and LPS-stimulated HMEC-1. 
In the absence of any procoagulant stimulus, the treatment with Dp-3-glc (from 4h to 
24h) did not significantly affect TG potential of HMEC-1 monolayer (data not shown). 
Differently, as shown in Figure 3.8.2.1, the pro-thrombotic stimulus of LPS induced an 
increase in TG potential of HMEC-1, expressed by a significant (p<0.05) reduction in 
lag-time (1.9 vs 5.1 min) and ttPeak (6.8 vs 10.0 min), and an increase of ETP (1021 vs 
749 nM*min) compared to control cells. Dp-3-glc significantly counteracted the 
prothrombotic stimulus of LPS starting from 10 µM: at this concentration, the values of 
lag-time, ttPeak and ETP were similar to that of unstimulated HMEC-1 cells.  
 
  
Figure 3.8.2.1 Dp-3-glc anti-thrombotic effect on TG potential of LPS-stimulated HMEC-1 
monolayer. Dp-3-glc showed a significant effect (* p<0.05 vs CTR; § p<0.05 vs LPS) 
on thrombogram parameters when added to LPS. Data are expressed as mean ± SD of 
three independent experiments. Red square: Lag-time (min); green triangle: ETP 
(nM*min); blue diamond: ttPeak (min). 
 
TG of HMEC-1 lysates 
TG of PBS lysates of HMEC-1 treated with LPS demonstrated a significant (p<0.05) 
reduction in lag-time (4.1 vs 8.5 min) and ttPeak (10.3 vs 14.3 min), and an increase of 
ETP (1118 vs 975 nM*min) compared to control cells. The addition of Dp-3-glc did not 
significantly affect any TG parameter (Figure 3.8.2.2).  
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Figure 3.8.2.2 Dp-3-glc effect on TG potential of HMEC-1 lysates. LPS induced a statistically 
significant effect on the three parameters considered (* p<0.05 vs CTR): the addition of 
Dp-3-glc to LPS did not determine any statistically significant effect compared to LPS 
alone. Data are expressed as mean ± SD of three independent experiments. Red square: 
Lag-time (min); green triangle: ETP (nM*min); blue diamond: ttPeak (min). 
 
HMEC-1 procoagulant activity  
Figure 3.8.2.3 shows the results of PCA determination in cell lysates after 4 h 
incubation of HMEC-1 with LPS in absence or presence of increasing concentrations of 
Dp-3-glc. LPS induced a significant (p<0.05) increase of TF-PCA; while Dp-3-glc at hte 
concentration of 100 µM produced a statistically relevant inhibition of 59% in URBT as 
compared to LPS-treated lysates (p<0.05). 
 
 
 
Figure 3.8.2.3 Effect of Dp-3-glc on PCA of HMEC-1 stimulated with LPS. Dp-3-glc showed a 
significant effect (* p<0.05 vs CTR, § p<0.05 vs LPS) at the maximum concentration 
tested. Data are expressed as mean ± SD of three independent experiments. 
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HMEC-1 TF antigen 
Figure 3.8.2.4 shows the results of TF antigen determination in extracts of HMEC-1 
after 4 h incubation of these cells with LPS, in absence or presence of increasing 
concentrations of Dp-3-glc. In particular, TF antigen was dose-dependently decreased 
by Dp-3-glc, reaching a 25% inhibition at the concentration of 100 µM (p<0.05). 
 
 
Figure 3.8.2.4 Effect of Dp-3-glc on TF antigen expression by HMEC-1 stimulated with LPS. 
Data are expressed as mean ± SD of three independent experiments.  
 * p<0.05 vs CTR, § p<0.05 vs LPS  
 
HMEC-1 TF mRNA expression 
The expression of TF was determined by quantitative Real Time RT-PCR on HMEC-1 
treated with LPS in combination with Dp-3-glc for 4h. A significant increase (85%) of 
TF mRNA expression was induced by LPS treatment (p<0.05). The combination with 
the anthocyanin Dp-3-glc determined a significant effect at the maximum 
concentration tested (100 µM), with a inhibition of 28% versus LPS alone, as shown in 
Figure 3.8.2.5. 
 
Figure 3.8.2.5 Dp-3-glc effect on TF mRNA expression of HMEC-1. Data are expressed as mean ± 
SD of three independent experiments.* p<0.05 vs CTR; § p<0.05 vs LPS. 
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3.8.3 Discussion 
In the present study we evaluated whether two anthocyanins (i.e. Dp-3-glc and Cy-3-
glc, mainly represented in black currant, wild blueberry, blood orange, and other 
colored fruits and vegetables) can affect angiogenic properties of endothelium; 
moreover, we investigated on the capacity of Dp-3-glc to affect thrombotic properties 
of microvascular endothelial cells.  
The anti-proliferative activity of these natural compounds against cancer cell lines 
have been already studied and available in the literature. 
Katsube and colleagues (2003) demonstrated that, among ethanol extracts of 10 edible 
berries, bilberry extract was found to be the most effective at inhibiting the growth of 
HL60 human leukemia cells and HCT116 human colon carcinoma cells in vitro. In 
particular, the anthocyanin Dp-3-glc was able to inhibit the growth of HCT116 cells of 
85% and 80% with the concentrations 863 µM and 431 µM respectively; while for HL60 
cells of 75% with 216 µM (Katsube et al., 2003). 
Olsson and colleagues (2004) investigated on the effects of 10 different extracts of fruits 
and berries on cell proliferation of colon cancer cells HT29 and breast cancer cells 
MCF-7. The fruits and berries used were rosehips, blueberries, black currant, black 
chokeberries, apple, sea buckthorn, plum, lingonberries, cherries, and raspberries. The 
extracts decreased the proliferation of both colon cancer cells HT29 and breast cancer 
cells MCF-7, and the effect was concentration-dependent. In particular, standards Dp-
3-glc and Cy-3-glc decreased significantly (p<0.001) the proliferation of both cell lines 
to a high extent (87 and 82% respectively) at the concentration of 200 µg/mL (431 µM) 
in the medium. At a lower concentration of the anthocyanin standards, i.e. 20 µg/mL, 
no effects was found on the proliferation of HT29 and MCF-7 cells (Olsson et al., 2004).  
Fimognari et al (2004) investigated the in vitro capacity of the anthocyanin cyanidin-3-
O-beta-glucopyranoside (Cy-3-glc) to induce apoptosis in Jurkat T-lymphoblastoid, as 
well as apoptosis and differentiation in HL-60 promyelocytic cells. Although Cy-3-glc 
induced apoptosis (as well as necrosis) in the two systems, HL-60 cells were much less 
sensitive than T-lymphoblastoid cells. In particular, IC50 for Jurkat cells was 391 µM, 
while in HL-60 cells the growth inhibition of 37% was reached with the concentration 
of 446 µM. Moreover, treatment of HL-60 cells with Cy-3-glc caused differentiation 
into macrophage-like cells and granulocytes. The authors conclude that these 
interesting biological properties should encourage further investigation into the 
chemopreventive and/or chemotherapeutic potential of Cy-3-glc (Fimognari et al., 
2004). 
Recently, Fernandes and colleagues (2010) published a work on the influence of 
anthocyanins and other polyphenols on breast cancer cell (MCF-7) proliferation. The 
antiproliferative effect was higher when cells were treated with Dp-3-glc, even if it was 
not followed by modification of ER expression. Differently, Cy-3-glc showed no 
significant antiproliferative effect on MCF-7 proliferation (Fernandes et al., 2010). 
However, no studies are available on the effects of anthocyanins on tumor-indiced 
neoangiogenesis. Angiogenesis, the formation of new vessels, has a major role in 
119 
 
tumor growth, dissemination and metastasis in both solid and hematological tumors 
(Folkman, 2003). Angiogenesis is driven by microvascular endothelial cells, which 
upon activation by angiogenic growth factors degrade their basement membrane, 
migrate into the interstitial matrix, proliferate and form new capillary structures 
(Marchetti et al., 2003). The angiogenic switch in cancer is a highly complex event and 
involves several tumor-derived factors. Inhibition of angiogenesis is one of the 
proposed strategies to control cancer.  
The results of our angiogenesis study indicate that Dp-3-glc can interfere with both 
resting and activated endothelium, by a standard stimulus like VEGF. In fact, we 
obtained an increase in capillary tube formation and cell migration induced by VEGF 
respect to basal HMEC-1, while treatment Dp-3-glc was able to inhibit VEGF stimulus 
at 1 µM concentration. Differently, Cy-3-glc did not show the same effect. The different 
behaviour of the two anthocyanins could be due to their different chemical structure 
given that the only structural feature which differs in their structures is the 
hydroxylation pattern in ring B (Figure 3.6.6), as hypothesized also by Fernandes et al 
(2010). No in vitro studies are available on the effects of Dp-3-glc and Cy-3-glc on 
microvascular endothelial cells, in fact the attention has been more directed to the anti-
angiogenic activity exerted by anthocyanidins. Delphinidin (Dp), aglycone form of 
Dp-3-glc, was recently demonstrated to inhibit proliferation migration and 
angiogenesis of human umbilical vein endothelial cells (HUVECs) (Favot et al., 2003; 
Lamy et al., 2006; Lamy et al., 2008; Matsunaga et al., 2010). Briefly, Matsunaga and 
colleagues (2010) examined the anti-angiogenic properties and antioxidant activities of 
the main anthocyanidins (delphinidin, cyanidin and malvidin) found as constituents 
in bilberry (Vaccinium myrtillus). Each of these anthocyanidins dose-dependently 
inhibited VEGF-induced tube formation in a co-culture of HUVECs and fibroblasts, 
with the effect of each anthocyanidin being significant at 3 and/or 10 µM. Moreover, 
their radical-scavenging effects were induced by concentrations that were at or below 
those that induced their anti-angiogenic effects (Matsunaga et al., 2010). Lamy and 
colleagues in 2006 conducted a study where, among the anthocyanidins tested 
(cyanidin, delphinidin, malvidin, pelargonidin, peonidin and petunidin), delphinidin 
was the most potent angiogenic inhibitor. In vitro, low concentrations of Dp inhibited 
VEGF-induced tyrosine phosphorylation of VEGF receptor (VEGFR)-2, leading to the 
inhibition of downstream signaling triggered by VEGFR-2. Inhibition of VEGFR-2 by 
Dp reserved the VEGF-induced activation of ERK-1/2 signaling and the chemotactic 
motility of HUVECs as well as their differentiation into capillary-like tubular 
structures in Matrigel and within fibrin gels. In vivo, Dp was able to suppress basic 
fibroblast growth factor-induced vessel formation in the mouse Matrigel plug assay 
(Lamy et al., 2006). In a subsequent study (2008), Lamy and colleagues showed that Dp 
also inhibits activation of the platelet-derived growth factor (PDGF)-BB receptor-β 
[platelet-derived growth factor receptor-beta (PDGFR-β)] in pulmonary aortic smooth 
muscle cells (PASMC) and that this inhibition may contribute to its antitumor effect. 
The inhibitory effect of delphinidin on PDGFR-β was very rapid and led to the 
inhibition of PDGF-BB-induced activation of extracellular signal-regulated kinase 
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(ERK)-1/2 signaling and of the chemotactic motility of PASMC, as well as the 
differentiation and stabilization of HUVEC and PASMC into capillary-like tubular 
structures in a three-dimensional co-culture system. Using an anthocyan-rich extract of 
berries, the authors showed that berry extracts were able to suppress the synergistic 
induction of vessel formation by basic fibroblast growth factor-2 and PDGF-BB in the 
mouse Matrigel plug assay. Oral administration of the berry extract also significantly 
retarded tumor growth in a lung carcinoma xenograft model. Taken together, these 
results provide new insight into the molecular mechanisms underlying the 
antiangiogenic activity of delphinidin that will be helpful for the development of 
dietary-based chemopreventive strategies (Lamy et al., 2008). Favot and colleagues 
(2003) verified that VEGF-stimulated HUVEC cell migration and proliferation were 
potently inhibited by Dp in concentration-dependent manner (with maximum effect of 
50% inhibition for migration and proliferation at 64 µM). Flow cytometric analysis 
demonstrated that Dp inhibition of proliferation is correlated with the blockade of cell 
cycle in G(0)/G(1) phase. Western blot analysis showed that Dp reversed the VEGF-
induced decrease in expression of cyclin-dependent kinase inhibitor p27(kip1) and the 
VEGF-induced increase of cyclin D1 and cyclin A, both being necessary to achieve the 
G(1)-to-S transition. Furthermore, Dp inhibited neovascularisation in vivo in 
chorioallantoic membrane model (Favot et al., 2003). In a series of experiments, berry 
extracts were tested for their ability to inhibit angiogenensis via altered VEGF 
expression and invasiveness (Roy et al., 2002). Anti-angiogenic properties were 
investigated in two cell lines: immortalized HaCaT human keratinocytes and human 
microvascular dermal endothelial (HMVE) cells. First the effect of selected berry 
samples on TNFα and H2O2-induced VEGF expression by HaCaT cells was 
investigated. The authors speculate that the flavonoid component of berry samples 
may be responsible for the observed effect on inducible VEGF expression and release. 
Next, an in vitro angiogenesis assay was performed with HMVE cells; two of the berry 
mix samples (50µg/mL) impaired in vitro angiogenesis (Roy et al., 2002). 
Our study of anti-coagulant effects of Dp-3-glc was carried out on HMEC-1 
stimulated by LPS, a known activator of endothelial pro-coagulant response. In these 
experiments, the dose of LPS was used according to a standard procedure established 
on the basis of recent studies (Falanga et al., 2003). TF is the major activator of blood 
coagulation. The reduction in TF expression on microvascular endothelial cells may be 
important for maintaining physiological endothelial function and preventing 
thrombotic microangiopathies. The results of our study indicate that Dp-3-glc 
significantly counteract LPS-induced TF expression at microvascular site starting at 10 
µM concentration when tested with TG assay on intact monolayer of HMEC-1. 
Determination of TG on HMEC-1 lysates did not reveal any anti-coagulant effect, even 
at the highest dose tested. On the contrary, in the subsequent experiments performed, 
Dp-3-glc treatment (100 µM) induced a significant reduction in total PCA on HMEC-1 
lysates, determined with the one-stage recalcification assay. The further quantitation of 
TF, as antigen and as mRNA expression, showed a significant inhibition induced of 
LPS activation of HMEC-1 procoagulant conditions by 100 µM Dp-3-glc. 
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To our knowledge, there are no other studies in the literature investigating the anti-
thrombotic effect of anthocyanins on microvascular cell lines models. 
Yamamoto and colleagues (2006) found that mulberry (Morus alba) varieties could be 
grouped into subclasses with either anti- or prothrombotic activities. A shear-induced 
in vitro platelet reactivity/thrombolysis test (Gorog Thrombosis Test) was used to 
screen for antiplatelet and thrombolytic activities. In case of effectiveness, it was 
followed by an in vivo test of laser-induced thrombosis in mice. Antioxidant activities 
and polyphenolic contents were also evaluated and they did not affect platelets but 
might enhance endogenous thrombolysis, thus causing an overall antithrombotic effect 
(Yamamoto et al., 2006).  
Berry phytochemicals have been widely studied with in vitro and animal models and 
different protective effects were demonstrated, as reported in detail in the introduction 
of this topic (paragraph 3.7). 
However, which single berry constituent(s) induce this protective response remains 
uncertain, and in the vast majority of studies the concentration of extract or 
phytochemical employed is substantially higher than could ever be achieved 
nutritionally (Duthie, 2007). We have also to consider that berry compounds are 
extensively metabolized and further converted by colonic microflora into related 
molecules. These compounds may persist in vivo, accumulate in target tissues and 
contribute significantly to the biological effects. Moreover, the levels of this type of 
phytochemicals may be underestimated due to limitations in laboratory extraction 
procedures because these compounds may bind to proteins, etc., causing their 
extraction for chemical analyses to be difficult (Seeram, 2008). However, the 
anthocyanins delphinidin-3-glucoside and cyanidin-3-glucoside, selected for this 
study, have been reported to be incorporated into human plasma with their structures 
maintained or converted from other structures (see also paragraph 3.6 for details). 
 
3.9 Conclusions TOPIC II 
Our results, together with the known capacity of Dp-3-glc to affect tumor cell 
proliferation, make this compound a potential cancer chemopreventive agent. 
Although considerable progress has been made in understanding the role that 
bioactive compounds, like anthocyanins, play in affecting human health and disease, 
there are still important gaps in our knowledge concerning the biology and chemistry 
of these compounds. Future studies should be designed to enhance our knowledge of 
the intricate roles and functions that ACNs can act at both cellular and molecular level. 
Moreover there is little evidence from human intervention studies, which provide the 
confirmation of the protective role of bioactive compounds. This in vitro study 
supports a protective effect on human endothelium. However, the concentration tested 
in vitro hardly could be achieved in vivo. Thus, the next step might be organization of a 
human feeding study where biomarkers of angiogenesis, such as VEGF, or marker of 
coagulation status, such as TF, TG and PCA could be easily analyzed in plasma 
samples.  
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In conclusion, our results support health promotion strategies that favour fruit and 
vegetable consumption for prevention and protection against chronic diseases. 
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4. GLOSSARY 
 
Angiogenensis: the physiological process involving the growth of new blood vessels 
from pre-existing vessels, essential for the supply of nutrients and oxygen to any 
growing tissue, including tumors. 
Anthocyanidin: polyphenol, flavonoid, aglycone form of anthocyanidin. 
Anthocyanin: polyphenol, flavonoid, which are the largest group of water-soluble 
pigments; they occur ubiquitously in the plant kingdom and confer bright red or 
blue coloration on many fruits (particularly berries), vegetables, grains, flowers 
and leaves. They can be found in different structural arrangements depending 
on the number of glycosilating sugars, their position in the aglycone 
(anthocyanidin) and the degree and nature of esterification of the sugar with 
aliphatic or aromatic acids. 
Antioxidant: a molecule capable of inhibiting the oxidation of other molecules. 
Oxidation is a chemical reaction that transfers electrons from a substance to an 
oxidizing agent. Oxidation reactions can produce free radicals. In turn, these 
radicals can start chain reactions that damage cells. Antioxidants terminate these 
chain reactions by removing free radical intermediates, and inhibit other 
oxidation reactions. They do this by being oxidized themselves, so antioxidants 
are often reducing agents such as thiols, ascorbic acid or polyphenols. 
Bioactive compound: a chemical compound or substance produced by a living 
organism, found in nature that usually has a pharmacological or biological 
activity. 
Bioavailability: in pharmacology, used to describe the fraction of an administered 
dose of unchanged drug that reaches the systemic circulation, one of the 
principal pharmacokinetic properties of drugs. Nutrient bioavailability is the 
proportion of a nutrient that is absorbed from the diet and used for normal body 
functions. 
Biomarker: a characteristic that is objectively measured and evaluated as an indicator 
of normal biological processes, pathogenic processes, or pharmacologic 
responses to a therapeutic intervention. 
Biotransformation: the chemical modification (or modifications) made by an organism 
on a chemical compound. It means chemical alteration of chemicals such as (but 
not limited to) nutrients, amino acids, toxins, or drugs in the body. It is also 
needed to render nonpolar compounds polar so that they are not reabsorbed in 
renal tubules and are excreted. 
Blood: a specialized bodily fluid that delivers necessary substances to the body's cells – 
such as nutrients and oxygen – and transports waste products away from those 
same cells. 
BMI: body mass index, is a heuristic measure of body weight based on a person's 
weight and height (weight in kg/(height in m)2). 
Brassica:  a genus of plants in the mustard family (Brassicaceae or Cruciferae). 
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Broccoli: is a plant of the family Brassicaceae (formerly Cruciferae). It is classified in 
the Italica cultivar group of the species Brassica oleracea. Broccoli has large flower 
heads, usually green in color, arranged in a tree-like fashion on branches 
sprouting from a thick, edible stalk. The mass of flower heads is surrounded by 
leaves. 
Cancer: a class of diseases in which a cell, or a group of cells display uncontrolled 
growth (division beyond the normal limits), invasion (intrusion on and 
destruction of adjacent tissues), and sometimes metastasis (spread to other 
locations in the body via lymph or blood). These three malignant properties of 
cancers differentiate them from benign tumors, which are self-limited, and do 
not invade or metastasize.  
Carcinogen: any substance, radionuclide or radiation, that is an agent directly 
involved in causing cancer. This may be due to the ability to damage the 
genome or to the disruption of cellular metabolic processes. Several radioactive 
substances are considered carcinogens, but their carcinogenic activity is 
attributed to the radiation, for example gamma rays and alpha particles, which 
they emit. Common examples of carcinogens are inhaled asbestos, certain 
dioxins, and tobacco smoke. 
Chronic disease: a disease that is long-lasting or recurrent. The term chronic describes 
the course of the disease, or its rate of onset and development. Examples of 
chronic diseases include: asthma, chronic osteoarticular diseases, chronic 
respiratory diseases, diabetes mellitus, cardiovascular diseases, osteoporosis, 
cancer. 
Clotting: a complex process by which blood forms clots. It is an important part of 
hemostasis (the cessation of blood loss from a damaged vessel), wherein a 
damaged blood vessel wall is covered by a platelet and fibrin-containing clot to 
stop bleeding and begin repair of the damaged vessel. Disorders of coagulation 
can lead to an increased risk of bleeding (hemorrhage) or obstructive clotting 
(thrombosis). 
COMET assay: Single Cell Gel Elecrophoresis, a sensitive technique for the detection 
of DNA damage at the level of the individual eukaryotic cell. It involves the 
encapsulation of cells in a low-melting-point agarose suspension, lysis of the 
cells in neutral or alkaline (pH>13) conditions, and electrophoresis of the 
suspended lysed cells. This is followed by visual analysis with staining of DNA 
and calculating fluorescence to determine the extent of DNA damage. 
Cruciferae: an older name of Brassicaceae, meaning "cross-bearing", because the 
four petals of their flowers are reminiscent of a cross. 
Diet: the sum of food consumed by a person or other organism. 
DNA: DeoxyriboNucleic Acid, a nucleic acid that contains the genetic instructions 
used in the development and functioning of all known living organisms. 
DNA damage: it may be due to environmental factors and normal metabolic processes. 
Affects the primary structure of the double helix; that is, the bases themselves 
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are chemically modified. These modifications can in turn disrupt the molecules' 
regular helical structure by introducing non-native chemical bonds or bulky 
adducts that do not fit in the standard double helix. There are five main types of 
damage to DNA due to endogenous cellular processes. oxidation of bases [e.g. 8-
oxo-7,8-dihydroguanine (8-oxoG)] and generation of DNA strand interruptions 
from reactive oxygen species. alkylation of bases (usually methylation), such as 
formation of 7-methylguanine, 1-methyladenine, 6-O-Methylguanine; hydrolysis 
of bases, such as deamination, depurination and depyrimidination; "bulky 
adduct formation" (i.e. benzo[a]pyrene diol epoxide-dG adduct); mismatch of 
bases, due to errors in DNA replication, in which the wrong DNA base is 
stitched into place in a newly forming DNA strand, or a DNA base is skipped 
over or mistakenly inserted. 
Endothelium: the thin layer of cells that lines the interior surface of blood vessels, 
forming an interface between circulating blood in the lumen and the rest of the 
vessel wall. These cells are called endothelial cells. Endothelial cells line the 
entire circulatory system, from the heart to the smallest capillary. Endothelial 
tissue is a specialized type of epithelium tissue (one of the four types of 
biological tissue in animals). More specifically, it is simple squamous 
epithelium. 
Epidemiology: the study of patterns of health and illness and associated factors at the 
population level. It is the cornerstone method of public health research, and 
helps inform evidence-based medicine for identifying risk factors for disease 
and determining optimal treatment approaches to clinical practice and for 
preventative medicine. In the study of communicable and non-communicable 
diseases, epidemiologists are involved in outbreak investigation to study design, 
data collection, statistical analysis, documentation of results and submission for 
publication. 
Flavonoid: a class of plant secondary metabolites, belonging to the class of 
polyphenols. 
Polyphenol: a chemical compound belonging to a group of chemical substances found 
in plants, characterized by the presence of more than one phenol unit or 
building block per molecule. Derived from secondary plant metabolism of the 
shikimate pathway. 
Functional food: any healthy food claimed to have a health-promoting or disease-
preventing property beyond the basic function of supplying nutrients. 
Genotype: the genetic constitution of a cell, an organism, or an individual (i.e. the 
specific allele make-up of the individual) usually with reference to a specific 
character under consideration. 
Glucosinolate: a class of organic compounds that contain sulfur and nitrogen and are 
derived from glucose and an amino acid. They occur as secondary metabolites of 
almost all plants of the order Brassicales (including the family Brassicaceae, 
Capparidaceae and Caricaceae), but also in the genus Drypetes (family 
Euphorbiaceae). 
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GST: Glutathione-S-Transferase family enzymes, which catalyse the conjugation of 
reduced glutathione — via a sulfhydryl group — to electrophilic centers on a 
wide variety of substrates.This activity detoxifies endogenous compounds such 
as peroxidised lipids, as well as breakdown of xenobiotics. GSTs may also bind 
toxins and function as transport proteins. The mammalian GST super-family 
consists of cytosolic dimeric isoenzymes of 45–55 kDa size that have been 
assigned to at least six classes: Alpha, Mu, Pi, Theta, Zeta and Omega. 
Health claims: a statement usually put on food labels, they are claims by 
manufacturers of food products that their food has been scientifically 
demonstrated to reduce the risk of developing a disease or condition. 
HMEC-1: Human microvascular endothelial cell line 1. They are an immortalized cell 
line that retains microvascular endothelial cell characteristics. HMEC-1 cells 
exhibit typical cobblestone morphology when grown in monolayer culture, 
rapidly form tubules when cultured on Martigel. HMEC-1 cells express cell 
surface molecules typically associated with endothelial cells and cell adhesion 
molecules. 
Human intervention study: used to test interventions designed to change behavior, 
including dietary intakes and physical activity. Such trials require a high level of 
commitment by participants. 
Inflammation: a protective attempt by the organism to remove the injurious stimuli 
and to initiate the healing process. Inflammation can be classified as either acute 
or chronic. Acute inflammation is the initial response of the body to harmful 
stimuli and is achieved by the increased movement of plasma and leukocytes 
(especially granulocytes ) from the blood into the injured tissues. A cascade of 
biochemical events propagates and matures the inflammatory response, 
involving the local vascular system, the immune system, and various cells 
within the injured tissue. Prolonged inflammation, known as chronic 
inflammation, leads to a progressive shift in the type of cells present at the site 
of inflammation and is characterized by simultaneous destruction and healing of 
the tissue from the inflammatory process. 
Isothiocyanate: the chemical group –N=C=S, formed by substituting sulfur for oxygen 
in the isocyanate group. Many natural isothiocyanates from plants are produced 
by enzymatic conversion of metabolites called glucosinolates. 
LPS: lipopolysaccharides, large molecules consisting of a lipid and a polysaccharide 
joined by a covalent bond; they are found in the outer membrane of Gram-
negative bacteria, act as endotoxins and elicit strong immune responses in 
animals. 
Lymphocyte: a type of white blood cell in the vertebrate immune system. 
Metabolic syndrome: a combination of medical disorders that increase the risk of 
developing cardiovascular disease and diabetes.  
Metabolism: the set of chemical reactions that happen in living organisms to maintain 
life. 
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mRNA: messenger RiboNucleic Acid, it is a molecule of RNA encoding a chemical 
"blueprint" for a protein product. mRNA is transcribed from a DNA template, 
and carries coding information to the sites of protein synthesis: the ribosomes. 
Here, the nucleic acid polymer is translated into a polymer of amino acids: a 
protein. In mRNA as in DNA, genetic information is encoded in the sequence of 
nucleotides arranged into codons consisting of three bases each. Each codon 
encodes for a specific amino acid, except the stop codons that terminate protein 
synthesis. This process requires two other types of RNA: transfer RNA (tRNA) 
mediates recognition of the codon and provides the corresponding amino acid, 
while ribosomal RNA (rRNA) is the central component of the ribosome's protein 
manufacturing machinery. 
Nutrigenomics:  the study of the effects of foods and food constituents on gene 
expression. It is about how our DNA is transcribed into mRNA and then to 
proteins and provides a basis for understanding the biological activity of food 
components. Nutrigenomics has also been described by the influence of genetic 
variation on nutrition by correlating gene expression or single-nucleotide 
polymorphisms with a nutrient's absorption, metabolism, elimination or 
biological effects. By doing so, nutrigenomics aims to develop rational means to 
optimise nutrition, with respect to the subject's genotype. 
Oxidative stress: an imbalance between the production and manifestation of reactive 
oxygen species and a biological system's ability to readily detoxify the reactive 
intermediates or to repair the resulting damage. Disturbances in the normal 
redox state of tissues can cause toxic effects through the production of peroxides 
and free radicals that damage all components of the cell, including proteins, 
lipids, and DNA. 
Phytochemical: chemical compounds that occur naturally in plants. The term is 
generally used to refer to those chemicals that may affect health, but are not yet 
established as essential nutrients. 
Plasma: the yellow liquid component of blood in which the blood cells in whole blood 
are normally suspended. It makes up about 55% of the total blood volume. It is 
the intravascular fluid part of extracellular fluid (all body fluid outside of cells). 
It is mostly water (90% by volume) and contains dissolved proteins, glucose, 
clotting factors, mineral ions, hormones and carbon dioxide (plasma being the 
main medium for excretory product transportation). Blood plasma is prepared 
by spinning a tube of fresh blood containing an anti-coagulant in a centrifuge 
until the blood cells fall to the bottom of the tube. 
Polymorphism: genetic polymorphism is the simultaneous occurrence in the same 
locality of two or more discontinuous forms in such proportions that the rarest 
of them cannot be maintained just by recurrent mutation. Genetic 
polymorphism is actively and steadily maintained in populations by natural 
selection. 
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Prevention: preventive medicine or preventive care refers to measures taken to 
prevent diseases, (or injuries) rather than curing them or treating their 
symptoms. 
Serum: the component that is neither a blood cell (serum does not contain white or red 
blood cells) nor a clotting factor; it is the blood plasma with the fibrinogens 
removed. Serum includes all proteins not used in blood clotting (coagulation) 
and all the electrolytes, antibodies, antigens, hormones, and any exogenous 
substances (e.g., drugs and microorganisms). 
TF: Tissue Factor, also called platelet tissue factor, factor III, thrombokinase, or CD142. 
It is a protein present in subendothelial tissue, platelets, and leukocytes 
necessary for the initiation of thrombin formation from the zymogen 
prothrombin. 
TG: Thrombin Generation, converting fibrinogen to fibrin and leading to clot 
formation. It is the endpoint of a complex series of proteolytic reactions of the 
clotting cascade. 
Thrombosis: the formation of a blood clot (thrombus; Greek: θρόµβος) inside a blood 
vessel, obstructing the flow of blood through the circulatory system. When a 
blood vessel is injured, the body uses platelets and fibrin to form a blood clot to 
prevent blood loss. Alternatively, even when a blood vessel is not injured, blood 
clots may form in the body if the proper conditions present themselves. 
VEGF: Vascular Endothelial Growth Factor, a signal protein produced by cells that 
stimulates the growth of new blood vessels. It is part of the system that restores 
the oxygen supply to tissues when blood circulation is inadequate. VEGF's 
normal function is to create new blood vessels during embryonic development, 
new blood vessels after injury, muscle following exercise, and new vessels 
(collateral circulation) to bypass blocked vessels. When VEGF is over-expressed, 
it can contribute to disease. Solid cancers cannot grow beyond a limited size 
without an adequate blood supply; cancers that can express VEGF are able to 
grow and metastasize. 
Wound healing:  an intricate process in which an organ repairs itself after injury. The 
classic model of wound healing is divided into three or four sequential, yet 
overlapping, phases: (1) hemostasis (not considered a phase by some authors), 
(2) inflammatory, (3) proliferative and (4) remodeling. The proliferative phase is 
characterized by angiogenesis, collagen deposition, granulation tissue 
formation, epithelialization, and wound contraction.  
 
 
136 
 
APPENDIX 1- PUBLICATION AND TRAINING ACTIVITIES 
Picozzi C., Bonacina G., Vigentini I., Foschino R. (2010) Genetic diversity in 
Italian Lactobacillus sanfranciscensis strains assessed by Multilocus Sequence Typing and 
Pulsed Field Gel Electrophoresis analyses. Microbiology. 2010 Jul; 156(Pt 7):2035-45. 
Epub 2010 Apr 1 
 
Riso P., Martini D., Moller P., Loft S., Bonacina G., Moro M., Porrini M. DNA 
damage and repair activity after broccoli intake in young healthy smokers. Mutagenesis 
2010 Aug 16. [Epub ahead of print] 
 
Vignoli A., Marchetti M., Russo L., Cantatalino E., Diani E., Bonacina G., Falanga 
A. “LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features 
elicited by leukemia, lung cancer, or breast cancer cells”, Cancer Investigations, in press.  
 
Bonacina G., poster communication 1st year PhD “Protective role of vegetable 
food consumption: mechanisms and hypothesis”; 12th Workshop on the 
Developments in the Italian PhD Research on Food Science Technology and 
Biotechnology, University of Reggio Calabria, Reggio Calabria, September 12-14, 2007, 
pp 501-502 
 
Bonacina G., poster communication 2nd year PhD “Protective role of vegetable 
food consumption: mechanisms and hypothesis”; 14th Workshop on the 
Developments in the Italian PhD Research on Food Science Technology and 
Biotechnology, Università degli Studi di Sassari, Oristano, September 16-18, 2009, pp 
97-99 
 
Bonacina G., oral communication 3rd year PhD “Protective role of bioactive 
dietary compounds: mechanisms and hypothesis”; 15th Workshop on the 
Developments in the Italian PhD Research on Food Science Technology and 
Biotechnology, Università degli Studi di Napoli Federico II, Portici, September 15-17 
2010, pp 13-17 
 
Marchetti M., Vignoli A., Cantalino E., Diani E., Bonacina G., Falanga A. Poster 
communication 3047 “Very low molecular weight heparins retain the capacity to 
inhibit endothelial cell migration and capillary-like tube formation induced by tumor 
cells” 51st American Society of Hematology (ASH) Annual Meeting and Exposition 
(December 5-8, 2009), New Orleans, LA, USA 
 
Bonacina G., Marchetti M., Vignoli A., Diani E., Porrini M. and Falanga A.; 
poster selected for oral presentation: “Effects of an anthocyanin from wild blueberries 
(delphinidin-3-glucoside) on the proangiogenic and prothrombotic properties of 
endothelial cells” 5th International Conference on Thrombosis and Hemostasis Issues 
137 
 
in Cancer (ICTHIC) (April 23-25, 2010), Stresa, Italy, published on Thrombosis 
Research Volume 125, Supplement 2, (April 2010), page S189 
 
Vignoli A., Marchetti M., Cantatalino E., Diani E., Bonacina G., Falanga A. Poster 
communication: “Very low molecular weight heparins (LMWH) retain the capacity to 
inhibit endothelial cell migration and capillary-like tube formation induced by tumor 
cells” 5th International Conference on Thrombosis and Hemostasis Issues in Cancer 
(ICTHIC) (April 23-25, 2010), Stresa, Italy, published on Thrombosis Research Volume 
125, Supplement 2, (April 2010), page S191 
 
Bonacina G., Marchetti M., Vignoli A., Diani E., Panova-Noeva M., Riso P., 
Porrini M. and Falanga A. Oral communication “Delphinidin-3-glucoside, an 
anthocyanin from wild blueberries, protects endothelial cells by proangiogenic and 
prothrombotic stimuli” XXI Congresso Nazionale SISET 2010 (October 28-31 2010, 
Bologna, Italy) 
 
RESEARCH PROJECTS 
 
Consumo di Brassicaceae e protezione dallo stress ossidativo: studio di intervento 
dietetico nell'uomo- Ministry of Education, University and Research (MIUR)-PRIN 
prot. 2005058197 
 
Environmental Cancer Risk, Nutrition and Individual Susceptibility (ECNIS) Network 
of Excellence (operating in the context of the 6th EU Framework Programme for 
Research and Development) entitled the ‘ECNIS Comet Assay Validation Group’ 
(ECVAG) for the purpose of validation of the comet assay with respect to measures of 
DNA damage formation and its repair, with special focus on its application in 
biomonitoring studies. 
 
Use of biosensors within a multidisciplinary approach for the study of degenerative 
disease prevention through diet 
Cariplo Foundation grant number 2007.5810 
 
Progetto di Ricerca Finalizzata Oncologica 2006 - Caratterizzazione delle molecole 
coinvolte nella regolazione delle angiogenesi tumorali 
Fondazione Monzino Centro Cardiologico S.p.A., Milano & Hemostasis and 
Thrombosis Center, Ospedali Riuniti di Bergamo. 
138 
 
APPENDIX 2- COPIES OF PAPERS 
 
 
139 
 
 
 
140 
 
 
 
141 
 
 
 
142 
 
 
 
143 
 
 
 
144 
 
 
 
145 
 
 
146 
 
XXI Congresso Nazionale SISET 2010 (October 28-31 2010, Bologna, Italy) 
Oral communication 
 
147 
 
5th International Conference on Thrombosis and Hemostasis Issues in Cancer 
(ICTHIC) (April 23-25, 2010) 
Poster selected for oral presentation. 
 
 
148 
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Esprima il suo gradimento per i seguenti alimenti con un punteggio da 1 
(meno gradito) a 9 (più gradito). 
       
  ORTAGGI E FRUTTA    45 Gnocchi   
    46 Lasagne   
1 Insalata    47 Polenta   
2 Pomodori da insalata    48 Ravioli ripieni di carne   
3 Carote    49 Ravioli ripieni di verdura   
4 Patate    50 Pizza   
5 Patatine fritte       
6 Spinaci      LEGUMI E DERIVATI   
7 Melanzane       
8 Broccoli    51 Fagioli   
9 Cavolfiore    52 Piselli   
10 Cavolini di Bruxelles    53 Lenticchie   
11 Cavolo cappuccio    54 Soia   
12 Zucchine    55 Tofu   
13 Zucca       
14 Aglio      CARNE, PESCE, UOVA   
15 Cipolla       
16 Arance    56 Carne in generale   
17 Banane    57 Bistecca   
18 Mele    58 Arrosto   
19 Pere    59 Polpette   
20 Mandarini    60 Pollo   
21 Uva    61 Tacchino   
22 Pesche    62 Maiale   
23 Albicocche    63 Carne in scatola   
24 Prugne    64 Mortadella   
25 Kiwi    65 Prosciutto cotto   
26 Melone    66 Prosciutto crudo   
27 
Frutta secca (noci, nocciole, 
mandorle…)    67 
Salame 
  
    68 Pancetta   
  DOLCI, CEREALI E DERIVATI    69 Bresaola   
    70 Fegato di vitello   
28 
Dolci in generale 
   71 
Pesce fresco in generale (orata, 
trota…)   
29 
Biscotti secchi 
    72 
Pesce azzurro (alice, sgombro, 
sardine…)   
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30 Biscotti farciti     73 Tonno in scatola   
31 Biscotti al cacao     74 Gamberetti   
32 Merendine ripiene al cioccolato     75 Vongole   
33 Merendine ripiene marmellata     76 Uova in generale   
34 Merendine ripiene crema     77 Frittata   
35 Croissants        
36 Crackers normali       LATTE E DERIVATI   
37 Crackers integrali        
38 Pane comune     78 Latte intero   
39 Pane integrale     79 Latte scremato    
40 Panino burro e marmellata     80 Yogurt bianco   
41 Pasta     81 Yogurt alla frutta   
42 
Pasta integrale 
    82 
Formaggi freschi (mozzarella, 
crescenza...)   
43 
Riso 
    83 
Formaggi stagionati 
(parmigiano, fontina...)   
44 
Riso integrale 
    84 
Formaggi molli (certosino, 
asiago...)   
  BEVANDE E ALCOLICI       PRODOTTI VARI   
85 Acqua minerale naturale     95 Burro   
86 Acqua minerale gassata     96 Olio d’oliva   
87 Birra     97 Olio di semi   
88 Vino bianco     98 Aceto   
89 
Vino rosso 
    99 
Sugo a base di pomodoro e 
cipolla   
90 
Superalcolici 
    100 
Sugo a base di pomodoro e 
aglio   
91 Bibite analcoliche     101 Ragù   
92 The     102 Pesto alla genovese   
93 Caffè     103 Gelato alla frutta   
94 Infusi e tisane     104 Gelato alla crema   
        105 Cioccolato   
        106 Marmellata di frutta   
        107 Miele   
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SEMPRE 
N° VOLTE A 
SETTIMANA 
N° 
VOLTE 
AL MESE 
MAI NOTE 
 
             
PRIMI            
Pasta/riso al pomodoro            
Pasta/riso al ragù            
Pasta con verdure            
Minestrone, passato…            
Pasta/minestra di 
legumi            
             
SECONDI            
Spezzatino            
Carne alla pizzaiola            
             
CONTORNI            
Pomodori            
Peperoni            
Carote            
Insalata            
Spinaci, erbette            
Broccoli            
Cavolini di Bruxelles            
Cavolfiori            
Verze            
Cime di rapa            
Melanzane            
Zucca            
             
FRUTTA            
Arance            
Mandarini            
Pompelmi            
Kiwi            
             
ALTRO            
Pizza margherita            
Pizza con verdure            
Torte salate con 
verdure            
153 
 
             
BEVANDE            
Tè            
Tè verde            
Vino bianco            
Vino rosso            
Caffè            
Succhi di frutta            
Spremuta d'arance            
             
CONDIMENTI            
Olio d'oliva            
Olio di semi            
Burro            
       
NOTE  
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DIARIO ALIMENTARE  
   
NOME 
COGNOME 
DIETA STANDARD 
   
DATA 
   
COLAZIONE   
alimento / piatto quantità 
    
    
   
SPUNTINO   
    
    
    
   
PRANZO   
    
    
   
SPUNTINO   
    
    
    
    
   
CENA   
    
    
    
    
    
    
   
SPUNTINO   
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DIARIO ALIMENTARE  
   
NOME 
COGNOME 
DIETA BROCCOLI 
   
DATA 
   
COLAZIONE   
alimento / piatto quantità 
    
    
    
    
   
SPUNTINO   
    
    
   
PRANZO   
    
    
    
    
   
SPUNTINO   
    
    
   
CENA   
    
    
    
    
    
   
SPUNTINO   
    
    
 
